breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Predicted mutations | |||||||
---|---|---|---|---|---|---|---|
evidence | seq id | position | mutation | freq | annotation | gene | description |
RA | CP000731 | 81 | N→G | 100% | intergenic (–/‑151) | – / → repA | –/replication protein A |
RA | CP000731 | 5,779 | C→T | 10.3% | intergenic (+296/‑1192) | cadX → / → USA300HOU_pUSA300HOUMR0010 | cadmium efflux regulator/MarR family transcriptional regulator |
RA | CP000731 | 5,784 | A→G | 8.6% | intergenic (+301/‑1187) | cadX → / → USA300HOU_pUSA300HOUMR0010 | cadmium efflux regulator/MarR family transcriptional regulator |
JC | CP000731 | 6,552 | +28 bp | 100% | intergenic (+1069/‑419) | cadX → / → USA300HOU_pUSA300HOUMR0010 | cadmium efflux regulator/MarR family transcriptional regulator |
RA | CP000731 | 12,012 | A→G | 10.1% | intergenic (+175/+48) | USA300HOU_pUSA300HOUMR0014 → / ← USA300HOU_pUSA300HOUMR0015 | recombinase/hypothetical protein |
RA | CP000731 | 12,017 | C→T | 11.0% | intergenic (+180/+43) | USA300HOU_pUSA300HOUMR0014 → / ← USA300HOU_pUSA300HOUMR0015 | recombinase/hypothetical protein |
RA | CP000731 | 25,663 | Δ1 bp | 100% | coding (316/333 nt) | USA300HOU_pUSA300HOUMR0031 → | hypothetical protein |
RA | NC_012417 | 2,287 | C→G | 11.1% | E130Q (GAA→CAA) | USA300HOU_RS14900 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 3,343 | Δ1 bp | 5.5% | intergenic (+27/‑363) | dnaN → / → USA300HOU_RS00015 | DNA polymerase III subunit beta/hypothetical protein |
RA | USA300TCH1516_ALE | 3,344 | A→T | 10.8% | intergenic (+28/‑362) | dnaN → / → USA300HOU_RS00015 | DNA polymerase III subunit beta/hypothetical protein |
RA | USA300TCH1516_ALE | 3,352:1 | +T | 5.7% | intergenic (+36/‑354) | dnaN → / → USA300HOU_RS00015 | DNA polymerase III subunit beta/hypothetical protein |
RA | USA300TCH1516_ALE | 3,353 | A→C | 5.9% | intergenic (+37/‑353) | dnaN → / → USA300HOU_RS00015 | DNA polymerase III subunit beta/hypothetical protein |
RA | USA300TCH1516_ALE | 8,213 | T→A | 5.7% | I394I (ATT→ATA) | gyrA → | DNA gyrase subunit A |
RA | USA300TCH1516_ALE | 9,710 | T→C | 14.9% | intergenic (+15/+72) | gyrA → / ← nnrD | DNA gyrase subunit A/ADP‑dependent (S)‑NAD(P)H‑hydrate dehydratase |
RA | USA300TCH1516_ALE | 9,716 | T→C | 15.3% | intergenic (+21/+66) | gyrA → / ← nnrD | DNA gyrase subunit A/ADP‑dependent (S)‑NAD(P)H‑hydrate dehydratase |
RA | USA300TCH1516_ALE | 9,719 | G→A | 14.4% | intergenic (+24/+63) | gyrA → / ← nnrD | DNA gyrase subunit A/ADP‑dependent (S)‑NAD(P)H‑hydrate dehydratase |
RA | USA300TCH1516_ALE | 9,725 | G→A | 12.1% | intergenic (+30/+57) | gyrA → / ← nnrD | DNA gyrase subunit A/ADP‑dependent (S)‑NAD(P)H‑hydrate dehydratase |
RA | USA300TCH1516_ALE | 24,137 | G→A | 5.9% | intergenic (+389/‑41) | purA → / → USA300TCH1516_00018 | Adenylosuccinate synthetase/tRNA‑Glu |
RA | USA300TCH1516_ALE | 41,166 | G→A | 9.8% | intergenic (‑33/‑67) | pbp ← / → mecR1 | Beta‑lactam‑inducible penicillin‑binding protein/Methicillin resistance mecR1 protein |
RA | USA300TCH1516_ALE | 41,171 | T→C | 8.3% | intergenic (‑38/‑62) | pbp ← / → mecR1 | Beta‑lactam‑inducible penicillin‑binding protein/Methicillin resistance mecR1 protein |
RA | USA300TCH1516_ALE | 44,009 | T→A | 5.9% | intergenic (‑44/+92) | USA300TCH1516_00035 ← / ← USA300HOU_RS00180 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 53,905 | C→G | 5.1% | S281R (AGC→AGG) | USA300HOU_RS00220 → | hypothetical protein |
RA | USA300TCH1516_ALE | 70,101 | A→T | 6.1% | I228N (ATT→AAT) | argF_1 ← | Ornithine carbamoyltransferase |
RA | USA300TCH1516_ALE | 77,971:1 | +C | 7.1% | intergenic (+80/‑347) | USA300HOU_RS00350 → / → USA300HOU_RS00355 | Monoacylglycerol lipase/hypothetical protein |
RA | USA300TCH1516_ALE | 77,973 | A→T | 7.2% | intergenic (+82/‑345) | USA300HOU_RS00350 → / → USA300HOU_RS00355 | Monoacylglycerol lipase/hypothetical protein |
RA | USA300TCH1516_ALE | 77,975 | Δ1 bp | 7.0% | intergenic (+84/‑343) | USA300HOU_RS00350 → / → USA300HOU_RS00355 | Monoacylglycerol lipase/hypothetical protein |
RA | USA300TCH1516_ALE | 77,984 | T→C | 8.7% | intergenic (+93/‑334) | USA300HOU_RS00350 → / → USA300HOU_RS00355 | Monoacylglycerol lipase/hypothetical protein |
RA | USA300TCH1516_ALE | 79,612 | A→T | 11.5% | intergenic (+221/‑39) | USA300HOU_RS00355 → / → cmoB | hypothetical protein/tRNA U34 carboxymethyltransferase |
RA | USA300TCH1516_ALE | 79,619 | T→A | 11.2% | intergenic (+228/‑32) | USA300HOU_RS00355 → / → cmoB | hypothetical protein/tRNA U34 carboxymethyltransferase |
RA | USA300TCH1516_ALE | 79,626 | A→T | 10.6% | intergenic (+235/‑25) | USA300HOU_RS00355 → / → cmoB | hypothetical protein/tRNA U34 carboxymethyltransferase |
RA | USA300TCH1516_ALE | 85,835 | T→A | 5.5% | intergenic (+854/‑166) | nikE_1 → / → copB | Nickel import ATP‑binding protein NikE/Copper‑exporting P‑type ATPase B |
RA | USA300TCH1516_ALE | 92,982 | C→T | 12.8% | intergenic (‑67/‑70) | ricR_1 ← / → glpE | Copper‑sensing transcriptional repressor RicR/Thiosulfate sulfurtransferase GlpE |
RA | USA300TCH1516_ALE | 92,987 | A→G | 15.3% | intergenic (‑72/‑65) | ricR_1 ← / → glpE | Copper‑sensing transcriptional repressor RicR/Thiosulfate sulfurtransferase GlpE |
RA | USA300TCH1516_ALE | 99,276 | G→C | 11.1% | intergenic (+70/+2) | USA300HOU_RS00465 → / ← tetA_1 | hypothetical protein/Tetracycline resistance protein, class C |
RA | USA300TCH1516_ALE | 109,958 | G→A | 7.4% | intergenic (+37/‑184) | plc → / → USA300HOU_RS00515 | 1‑phosphatidylinositol phosphodiesterase/putative lipoprotein |
RA | USA300TCH1516_ALE | 109,964 | T→A | 7.2% | intergenic (+43/‑178) | plc → / → USA300HOU_RS00515 | 1‑phosphatidylinositol phosphodiesterase/putative lipoprotein |
RA | USA300TCH1516_ALE | 109,970 | T→C | 7.5% | intergenic (+49/‑172) | plc → / → USA300HOU_RS00515 | 1‑phosphatidylinositol phosphodiesterase/putative lipoprotein |
RA | USA300TCH1516_ALE | 110,660 | T→A | 7.0% | I173I (ATT→ATA) | USA300HOU_RS00515 → | putative lipoprotein |
RA | USA300TCH1516_ALE | 111,512 | A→G | 27.3% | S194S (TCA→TCG) | USA300HOU_RS00520 → | putative lipoprotein |
RA | USA300TCH1516_ALE | 111,516 | C→A | 26.5% | Q196K (CAA→AAA) | USA300HOU_RS00520 → | putative lipoprotein |
RA | USA300TCH1516_ALE | 115,755 | T→A | 13.2% | intergenic (+22/‑129) | btr → / → yxeP_1 | HTH‑type transcriptional activator Btr/putative hydrolase YxeP |
RA | USA300TCH1516_ALE | 115,758 | Δ1 bp | 13.1% | intergenic (+25/‑126) | btr → / → yxeP_1 | HTH‑type transcriptional activator Btr/putative hydrolase YxeP |
RA | USA300TCH1516_ALE | 115,762:1 | +T | 13.2% | intergenic (+29/‑122) | btr → / → yxeP_1 | HTH‑type transcriptional activator Btr/putative hydrolase YxeP |
RA | USA300TCH1516_ALE | 115,765 | T→A | 12.7% | intergenic (+32/‑119) | btr → / → yxeP_1 | HTH‑type transcriptional activator Btr/putative hydrolase YxeP |
RA | USA300TCH1516_ALE | 126,542 | A→G | 5.7% | I119V (ATT→GTT) | lctP_1 → | L‑lactate permease |
RA | USA300TCH1516_ALE | 134,187 | G→A | 8.2% | intergenic (‑60/‑171) | yfiY ← / → sbnA | putative siderophore‑binding lipoprotein YfiY/putative siderophore biosynthesis protein SbnA |
RA | USA300TCH1516_ALE | 168,343 | G→A | 11.8% | intergenic (+310/+38) | yfkN_1 → / ← USA300TCH1516_00148 | Trifunctional nucleotide phosphoesterase protein YfkN/hypothetical protein |
RA | USA300TCH1516_ALE | 168,350 | A→T | 12.6% | intergenic (+317/+31) | yfkN_1 → / ← USA300TCH1516_00148 | Trifunctional nucleotide phosphoesterase protein YfkN/hypothetical protein |
RA | USA300TCH1516_ALE | 168,354 | C→G | 11.9% | intergenic (+321/+27) | yfkN_1 → / ← USA300TCH1516_00148 | Trifunctional nucleotide phosphoesterase protein YfkN/hypothetical protein |
RA | USA300TCH1516_ALE | 168,358 | A→T | 10.3% | intergenic (+325/+23) | yfkN_1 → / ← USA300TCH1516_00148 | Trifunctional nucleotide phosphoesterase protein YfkN/hypothetical protein |
RA | USA300TCH1516_ALE | 171,069 | A→T | 6.5% | intergenic (+418/‑32) | USA300HOU_RS07235 → / → adhE | hypothetical protein/Aldehyde‑alcohol dehydrogenase |
RA | USA300TCH1516_ALE | 171,072 | A→T | 6.4% | intergenic (+421/‑29) | USA300HOU_RS07235 → / → adhE | hypothetical protein/Aldehyde‑alcohol dehydrogenase |
RA | USA300TCH1516_ALE | 186,459 | A→G | 8.8% | Q345R (CAA→CGA) | USA300HOU_RS00855 → | hypothetical protein |
RA | USA300TCH1516_ALE | 217,026 | A→G | 6.2% | intergenic (‑220/+33) | rocD2_1 ← / ← brnQ_1 | Ornithine aminotransferase 2/Branched‑chain amino acid transport system 2 carrier protein |
RA | USA300TCH1516_ALE | 217,027 | G→T | 6.1% | intergenic (‑221/+32) | rocD2_1 ← / ← brnQ_1 | Ornithine aminotransferase 2/Branched‑chain amino acid transport system 2 carrier protein |
RA | USA300TCH1516_ALE | 217,036 | T→A | 12.0% | intergenic (‑230/+23) | rocD2_1 ← / ← brnQ_1 | Ornithine aminotransferase 2/Branched‑chain amino acid transport system 2 carrier protein |
RA | USA300TCH1516_ALE | 217,045 | A→C | 9.3% | intergenic (‑239/+14) | rocD2_1 ← / ← brnQ_1 | Ornithine aminotransferase 2/Branched‑chain amino acid transport system 2 carrier protein |
RA | USA300TCH1516_ALE | 217,046 | C→T | 8.4% | intergenic (‑240/+13) | rocD2_1 ← / ← brnQ_1 | Ornithine aminotransferase 2/Branched‑chain amino acid transport system 2 carrier protein |
RA | USA300TCH1516_ALE | 228,312 | T→C | 8.0% | intergenic (+158/+36) | ybbH_1 → / ← USA300TCH1516_00200 | putative HTH‑type transcriptional regulator YbbH/hypothetical protein |
RA | USA300TCH1516_ALE | 228,316 | G→A | 8.3% | intergenic (+162/+32) | ybbH_1 → / ← USA300TCH1516_00200 | putative HTH‑type transcriptional regulator YbbH/hypothetical protein |
RA | USA300TCH1516_ALE | 228,319 | T→C | 8.8% | intergenic (+165/+29) | ybbH_1 → / ← USA300TCH1516_00200 | putative HTH‑type transcriptional regulator YbbH/hypothetical protein |
RA | USA300TCH1516_ALE | 253,983 | A→G | 7.4% | intergenic (+196/+166) | asbF → / ← USA300HOU_RS01125 | 3‑dehydroshikimate dehydratase/hypothetical protein |
RA | USA300TCH1516_ALE | 253,984 | G→T | 7.6% | intergenic (+197/+165) | asbF → / ← USA300HOU_RS01125 | 3‑dehydroshikimate dehydratase/hypothetical protein |
RA | USA300TCH1516_ALE | 253,991 | A→C | 7.4% | intergenic (+204/+158) | asbF → / ← USA300HOU_RS01125 | 3‑dehydroshikimate dehydratase/hypothetical protein |
RA | USA300TCH1516_ALE | 253,992 | C→T | 6.6% | intergenic (+205/+157) | asbF → / ← USA300HOU_RS01125 | 3‑dehydroshikimate dehydratase/hypothetical protein |
RA | USA300TCH1516_ALE | 254,002 | A→G | 5.1% | intergenic (+215/+147) | asbF → / ← USA300HOU_RS01125 | 3‑dehydroshikimate dehydratase/hypothetical protein |
RA | USA300TCH1516_ALE | 265,618 | A→G | 6.1% | intergenic (+18/+146) | ugpQ_2 → / ← scn_1 | Glycerophosphodiester phosphodiesterase, cytoplasmic/Staphylococcal complement inhibitor |
RA | USA300TCH1516_ALE | 265,622 | T→G | 6.4% | intergenic (+22/+142) | ugpQ_2 → / ← scn_1 | Glycerophosphodiester phosphodiesterase, cytoplasmic/Staphylococcal complement inhibitor |
RA | USA300TCH1516_ALE | 265,628 | A→T | 6.7% | intergenic (+28/+136) | ugpQ_2 → / ← scn_1 | Glycerophosphodiester phosphodiesterase, cytoplasmic/Staphylococcal complement inhibitor |
RA | USA300TCH1516_ALE | 265,629 | G→C | 6.9% | intergenic (+29/+135) | ugpQ_2 → / ← scn_1 | Glycerophosphodiester phosphodiesterase, cytoplasmic/Staphylococcal complement inhibitor |
RA | USA300TCH1516_ALE | 265,630 | A→T | 6.8% | intergenic (+30/+134) | ugpQ_2 → / ← scn_1 | Glycerophosphodiester phosphodiesterase, cytoplasmic/Staphylococcal complement inhibitor |
RA | USA300TCH1516_ALE | 265,636 | C→A | 7.6% | intergenic (+36/+128) | ugpQ_2 → / ← scn_1 | Glycerophosphodiester phosphodiesterase, cytoplasmic/Staphylococcal complement inhibitor |
RA | USA300TCH1516_ALE | 265,640 | C→T | 6.7% | intergenic (+40/+124) | ugpQ_2 → / ← scn_1 | Glycerophosphodiester phosphodiesterase, cytoplasmic/Staphylococcal complement inhibitor |
RA | USA300TCH1516_ALE | 269,671 | T→G | 9.6% | T82P (ACG→CCG) | fadA ← | 3‑ketoacyl‑CoA thiolase |
RA | USA300TCH1516_ALE | 290,156 | A→T | 5.6% | intergenic (+47/‑180) | gatB_1 → / → gatC_1 | PTS system galactitol‑specific EIIB component/PTS system galactitol‑specific EIIC component |
RA | USA300TCH1516_ALE | 299,457 | G→T | 6.0% | *390L (TGA→TTA) | tarF_1 → | Teichoic acid glycerol‑phosphate transferase |
RA | USA300TCH1516_ALE | 299,460 | A→C | 5.6% | intergenic (+2/‑274) | tarF_1 → / → tarI | Teichoic acid glycerol‑phosphate transferase/Ribitol‑5‑phosphate cytidylyltransferase 1 |
RA | USA300TCH1516_ALE | 341,450 | G→C | 14.2% | D134H (GAT→CAT) | USA300HOU_RS01525 → | hypothetical protein |
RA | USA300TCH1516_ALE | 346,350 | C→T | 5.9% | I55I (ATC→ATT) | sotB → | sugar efflux transporter |
RA | USA300TCH1516_ALE | 346,353 | A→T | 5.9% | V56V (GTA→GTT) | sotB → | sugar efflux transporter |
RA | USA300TCH1516_ALE | 346,356 | A→G | 5.3% | T57T (ACA→ACG) | sotB → | sugar efflux transporter |
RA | USA300TCH1516_ALE | 348,156 | A→C | 10.3% | A31A (GCA→GCC) | yezG_5 → | putative antitoxin YezG |
RA | USA300TCH1516_ALE | 348,159 | G→T | 10.4% | M32I (ATG→ATT) | yezG_5 → | putative antitoxin YezG |
RA | USA300TCH1516_ALE | 372,106 | T→A | 10.5% | intergenic (‑166/‑204) | ylbJ ← / → lip2 | Sporulation integral membrane protein YlbJ/Lipase 2 |
RA | USA300TCH1516_ALE | 401,399 | A→C | 9.0% | intergenic (‑184/‑57) | USA300HOU_RS01845 ← / → sutR | hypothetical protein/HTH‑type transcriptional regulator SutR |
RA | USA300TCH1516_ALE | 401,404 | G→T | 8.6% | intergenic (‑189/‑52) | USA300HOU_RS01845 ← / → sutR | hypothetical protein/HTH‑type transcriptional regulator SutR |
RA | USA300TCH1516_ALE | 413,758 | G→A | 5.7% | I167I (ATC→ATT) | metI ← | Cystathionine gamma‑synthase/O‑acetylhomoserine (thiol)‑lyase |
RA | USA300TCH1516_ALE | 413,761 | A→T | 6.0% | I166I (ATT→ATA) | metI ← | Cystathionine gamma‑synthase/O‑acetylhomoserine (thiol)‑lyase |
RA | USA300TCH1516_ALE | 413,764 | T→C | 6.0% | S165S (TCA→TCG) | metI ← | Cystathionine gamma‑synthase/O‑acetylhomoserine (thiol)‑lyase |
RA | USA300TCH1516_ALE | 418,825 | A→T | 7.2% | N53I (AAT→ATT) | rpsF → | 30S ribosomal protein S6 |
RA | USA300TCH1516_ALE | 419,955 | C→T | 7.7% | intergenic (+173/+93) | rpsR → / ← USA300HOU_RS01950 | 30S ribosomal protein S18/hypothetical protein |
RA | USA300TCH1516_ALE | 419,964 | A→T | 10.7% | intergenic (+182/+84) | rpsR → / ← USA300HOU_RS01950 | 30S ribosomal protein S18/hypothetical protein |
RA | USA300TCH1516_ALE | 419,965 | A→T | 10.7% | intergenic (+183/+83) | rpsR → / ← USA300HOU_RS01950 | 30S ribosomal protein S18/hypothetical protein |
RA | USA300TCH1516_ALE | 428,600 | T→C | 8.0% | T231A (ACT→GCT) | ahpF ← | Alkyl hydroperoxide reductase subunit F |
RA | USA300TCH1516_ALE | 428,608 | C→G | 5.6% | G228A (GGT→GCT) ‡ | ahpF ← | Alkyl hydroperoxide reductase subunit F |
RA | USA300TCH1516_ALE | 428,609 | C→G | 5.6% | G228R (GGT→CGT) ‡ | ahpF ← | Alkyl hydroperoxide reductase subunit F |
RA | USA300TCH1516_ALE | 447,278:1 | +T | 5.9% | intergenic (+266/‑20) | tst_1 → / → speC_1 | Toxic shock syndrome toxin‑1/Exotoxin type C |
RA | USA300TCH1516_ALE | 455,079 | A→T | 6.3% | intergenic (+79/‑301) | tst_3 → / → speC_5 | Toxic shock syndrome toxin‑1/Exotoxin type C |
RA | USA300TCH1516_ALE | 512,643 | A→G | 12.4% | intergenic (+711/‑6052) | recR → / → speA_2 | Recombination protein RecR/Arginine decarboxylase |
RA | USA300TCH1516_ALE | 536,863 | T→A | 9.0% | intergenic (+56/‑255) | rplY → / → pth | 50S ribosomal protein L25/Peptidyl‑tRNA hydrolase |
RA | USA300TCH1516_ALE | 536,868 | T→A | 10.0% | intergenic (+61/‑250) | rplY → / → pth | 50S ribosomal protein L25/Peptidyl‑tRNA hydrolase |
RA | USA300TCH1516_ALE | 536,876 | T→C | 5.2% | intergenic (+69/‑242) | rplY → / → pth | 50S ribosomal protein L25/Peptidyl‑tRNA hydrolase |
RA | USA300TCH1516_ALE | 536,877 | G→A | 5.2% | intergenic (+70/‑241) | rplY → / → pth | 50S ribosomal protein L25/Peptidyl‑tRNA hydrolase |
RA | USA300TCH1516_ALE | 576,902 | T→A | 5.6% | intergenic (+325/‑65) | gltX → / → cysE | Glutamate‑‑tRNA ligase/Serine acetyltransferase |
RA | USA300TCH1516_ALE | 576,908 | Δ1 bp | 7.7% | intergenic (+331/‑59) | gltX → / → cysE | Glutamate‑‑tRNA ligase/Serine acetyltransferase |
RA | USA300TCH1516_ALE | 576,915 | C→G | 11.6% | intergenic (+338/‑52) | gltX → / → cysE | Glutamate‑‑tRNA ligase/Serine acetyltransferase |
RA | USA300TCH1516_ALE | 576,920:1 | +T | 7.9% | intergenic (+343/‑47) | gltX → / → cysE | Glutamate‑‑tRNA ligase/Serine acetyltransferase |
RA | USA300TCH1516_ALE | 581,901 | G→C | 6.9% | V13L (GTG→CTG) | nusG_2 → | Transcription termination/antitermination protein NusG |
RA | USA300TCH1516_ALE | 583,939 | G→A | 6.0% | intergenic (+23/‑249) | rplA → / → rplJ | 50S ribosomal protein L1/50S ribosomal protein L10 |
RA | USA300TCH1516_ALE | 583,948 | A→T | 9.7% | intergenic (+32/‑240) | rplA → / → rplJ | 50S ribosomal protein L1/50S ribosomal protein L10 |
RA | USA300TCH1516_ALE | 583,951 | A→T | 8.0% | intergenic (+35/‑237) | rplA → / → rplJ | 50S ribosomal protein L1/50S ribosomal protein L10 |
RA | USA300TCH1516_ALE | 583,960 | T→C | 6.7% | intergenic (+44/‑228) | rplA → / → rplJ | 50S ribosomal protein L1/50S ribosomal protein L10 |
RA | USA300TCH1516_ALE | 593,430 | T→A | 7.8% | intergenic (+22/‑115) | rpoC → / → rplGB | DNA‑directed RNA polymerase subunit beta'/Ribosome‑associated protein L7Ae‑like protein |
RA | USA300TCH1516_ALE | 593,433 | T→A | 7.4% | intergenic (+25/‑112) | rpoC → / → rplGB | DNA‑directed RNA polymerase subunit beta'/Ribosome‑associated protein L7Ae‑like protein |
RA | USA300TCH1516_ALE | 594,887 | T→A | 5.8% | intergenic (+41/‑82) | rpsG → / → fusA | 30S ribosomal protein S7/Elongation factor G |
RA | USA300TCH1516_ALE | 594,888 | T→A | 5.7% | intergenic (+42/‑81) | rpsG → / → fusA | 30S ribosomal protein S7/Elongation factor G |
RA | USA300TCH1516_ALE | 597,160 | G→T | 5.4% | intergenic (+110/‑107) | fusA → / → tuf | Elongation factor G/Elongation factor Tu |
RA | USA300TCH1516_ALE | 597,163 | A→C | 5.6% | intergenic (+113/‑104) | fusA → / → tuf | Elongation factor G/Elongation factor Tu |
RA | USA300TCH1516_ALE | 598,492 | A→G | 5.9% | intergenic (+41/+241) | tuf → / ← yxeP_2 | Elongation factor Tu/putative hydrolase YxeP |
RA | USA300TCH1516_ALE | 598,495 | C→T | 5.8% | intergenic (+44/+238) | tuf → / ← yxeP_2 | Elongation factor Tu/putative hydrolase YxeP |
RA | USA300TCH1516_ALE | 604,132 | Δ1 bp | 6.3% | coding (1563/1638 nt) | araB → | Ribulokinase |
RA | USA300TCH1516_ALE | 631,535 | G→A | 7.6% | intergenic (+161/‑341) | gph_1 → / → proP | Phosphoglycolate phosphatase/Proline/betaine transporter |
RA | USA300TCH1516_ALE | 631,536 | T→C | 7.5% | intergenic (+162/‑340) | gph_1 → / → proP | Phosphoglycolate phosphatase/Proline/betaine transporter |
RA | USA300TCH1516_ALE | 631,620 | T→C | 5.8% | intergenic (+246/‑256) | gph_1 → / → proP | Phosphoglycolate phosphatase/Proline/betaine transporter |
RA | USA300TCH1516_ALE | 631,623 | C→A | 5.2% | intergenic (+249/‑253) | gph_1 → / → proP | Phosphoglycolate phosphatase/Proline/betaine transporter |
RA | USA300TCH1516_ALE | 631,632:1 | +T | 5.0% | intergenic (+258/‑244) | gph_1 → / → proP | Phosphoglycolate phosphatase/Proline/betaine transporter |
RA | USA300TCH1516_ALE | 631,637 | T→G | 5.3% | intergenic (+263/‑239) | gph_1 → / → proP | Phosphoglycolate phosphatase/Proline/betaine transporter |
RA | USA300TCH1516_ALE | 631,640 | G→A | 5.1% | intergenic (+266/‑236) | gph_1 → / → proP | Phosphoglycolate phosphatase/Proline/betaine transporter |
RA | USA300TCH1516_ALE | 659,371 | T→A | 8.3% | intergenic (+177/‑735) | USA300TCH1516_00590 → / → USA300HOU_RS03165 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 659,372 | T→G | 9.4% | intergenic (+178/‑734) | USA300TCH1516_00590 → / → USA300HOU_RS03165 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 659,375 | C→A | 7.3% | intergenic (+181/‑731) | USA300TCH1516_00590 → / → USA300HOU_RS03165 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 659,376 | T→A | 7.7% | intergenic (+182/‑730) | USA300TCH1516_00590 → / → USA300HOU_RS03165 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 667,057 | C→A | 9.0% | P16H (CCT→CAT) | USA300TCH1516_00600 → | hypothetical protein |
RA | USA300TCH1516_ALE | 667,064 | T→G | 11.9% | D18E (GAT→GAG) | USA300TCH1516_00600 → | hypothetical protein |
RA | USA300TCH1516_ALE | 692,551 | Δ1 bp | 5.2% | coding (423/1092 nt) | USA300HOU_RS03340 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 693,250 | A→G | 5.0% | A67A (GCT→GCC) | USA300HOU_RS03345 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 693,253 | G→C | 5.2% | Y66* (TAC→TAG) | USA300HOU_RS03345 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 693,258 | T→A | 7.8% | I65F (ATT→TTT) | USA300HOU_RS03345 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 693,263 | G→C | 5.4% | P63R (CCT→CGT) | USA300HOU_RS03345 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 695,604 | C→T | 5.5% | Q51* (CAA→TAA) | xerD_2 → | Tyrosine recombinase XerD |
RA | USA300TCH1516_ALE | 695,607 | G→C | 5.4% | V52L (GTT→CTT) | xerD_2 → | Tyrosine recombinase XerD |
RA | USA300TCH1516_ALE | 695,610 | A→G | 5.3% | K53E (AAG→GAG) | xerD_2 → | Tyrosine recombinase XerD |
RA | USA300TCH1516_ALE | 702,553 | T→A | 6.7% | F116I (TTT→ATT) | nhaK_1 → | Sodium, potassium, lithium and rubidium/H(+) antiporter |
RA | USA300TCH1516_ALE | 707,909 | A→T | 100% | M1M (TTG→ATG) † | znuC_1 ← | High‑affinity zinc uptake system ATP‑binding protein ZnuC |
RA | USA300TCH1516_ALE | 722,987 | C→T | 9.9% | T42I (ACA→ATA) | feuB → | Iron‑uptake system permease protein FeuB |
RA | USA300TCH1516_ALE | 724,452 | G→A | 5.9% | E197K (GAA→AAA) | feuC_1 → | Iron‑uptake system permease protein FeuC |
RA | USA300TCH1516_ALE | 739,247 | T→A | 8.0% | V161D (GTT→GAT) | pitA_1 → | Low‑affinity inorganic phosphate transporter 1 |
RA | USA300TCH1516_ALE | 739,250 | T→A | 7.8% | I162N (ATC→AAC) | pitA_1 → | Low‑affinity inorganic phosphate transporter 1 |
RA | USA300TCH1516_ALE | 740,315 | Δ1 bp | 9.0% | intergenic (+542/+46) | pitA_1 → / ← sle1_2 | Low‑affinity inorganic phosphate transporter 1/N‑acetylmuramoyl‑L‑alanine amidase sle1 |
RA | USA300TCH1516_ALE | 740,322 | G→C | 12.4% | intergenic (+549/+39) | pitA_1 → / ← sle1_2 | Low‑affinity inorganic phosphate transporter 1/N‑acetylmuramoyl‑L‑alanine amidase sle1 |
RA | USA300TCH1516_ALE | 740,328:1 | +G | 10.5% | intergenic (+555/+33) | pitA_1 → / ← sle1_2 | Low‑affinity inorganic phosphate transporter 1/N‑acetylmuramoyl‑L‑alanine amidase sle1 |
RA | USA300TCH1516_ALE | 747,521 | A→T | 5.5% | I92I (ATA→ATT) | USA300HOU_RS03630 → | hypothetical protein |
RA | USA300TCH1516_ALE | 747,522 | A→T | 5.4% | N93Y (AAT→TAT) | USA300HOU_RS03630 → | hypothetical protein |
RA | USA300TCH1516_ALE | 770,855 | A→G | 6.1% | intergenic (+41/‑209) | ybaK → / → glcR | Cys‑tRNA(Pro)/Cys‑tRNA(Cys) deacylase YbaK/HTH‑type transcriptional repressor GlcR |
RA | USA300TCH1516_ALE | 770,860 | G→A | 9.0% | intergenic (+46/‑204) | ybaK → / → glcR | Cys‑tRNA(Pro)/Cys‑tRNA(Cys) deacylase YbaK/HTH‑type transcriptional repressor GlcR |
RA | USA300TCH1516_ALE | 770,866 | A→T | 9.3% | intergenic (+52/‑198) | ybaK → / → glcR | Cys‑tRNA(Pro)/Cys‑tRNA(Cys) deacylase YbaK/HTH‑type transcriptional repressor GlcR |
RA | USA300TCH1516_ALE | 770,870 | T→A | 9.3% | intergenic (+56/‑194) | ybaK → / → glcR | Cys‑tRNA(Pro)/Cys‑tRNA(Cys) deacylase YbaK/HTH‑type transcriptional repressor GlcR |
RA | USA300TCH1516_ALE | 770,877 | A→T | 9.5% | intergenic (+63/‑187) | ybaK → / → glcR | Cys‑tRNA(Pro)/Cys‑tRNA(Cys) deacylase YbaK/HTH‑type transcriptional repressor GlcR |
RA | USA300TCH1516_ALE | 770,883 | T→C | 9.8% | intergenic (+69/‑181) | ybaK → / → glcR | Cys‑tRNA(Pro)/Cys‑tRNA(Cys) deacylase YbaK/HTH‑type transcriptional repressor GlcR |
RA | USA300TCH1516_ALE | 770,888 | C→T | 6.3% | intergenic (+74/‑176) | ybaK → / → glcR | Cys‑tRNA(Pro)/Cys‑tRNA(Cys) deacylase YbaK/HTH‑type transcriptional repressor GlcR |
RA | USA300TCH1516_ALE | 779,959 | C→T | 9.2% | intergenic (+15/+57) | csbB → / ← saeS | Putative glycosyltransferase CsbB/Histidine protein kinase SaeS |
RA | USA300TCH1516_ALE | 779,970 | G→A | 5.4% | intergenic (+26/+46) | csbB → / ← saeS | Putative glycosyltransferase CsbB/Histidine protein kinase SaeS |
RA | USA300TCH1516_ALE | 803,528 | C→T | 13.0% | intergenic (‑228/+42) | USA300HOU_RS03920 ← / ← dtpT | Putative lipid kinase/Di‑/tripeptide transporter |
RA | USA300TCH1516_ALE | 803,539 | A→G | 17.2% | intergenic (‑239/+31) | USA300HOU_RS03920 ← / ← dtpT | Putative lipid kinase/Di‑/tripeptide transporter |
RA | USA300TCH1516_ALE | 837,540:1 | +T | 11.3% | intergenic (+34/‑235) | USA300HOU_RS04100 → / → uvrB | hypothetical protein/UvrABC system protein B |
RA | USA300TCH1516_ALE | 868,373 | A→T | 5.5% | intergenic (+56/+1266) | smpB → / ← USA300HOU_RS04240 | SsrA‑binding protein/hypothetical protein |
RA | USA300TCH1516_ALE | 875,946 | A→T | 8.1% | intergenic (+49/‑172) | clfA → / → USA300HOU_RS04275 | Clumping factor A/Staphylocoagulase |
RA | USA300TCH1516_ALE | 875,947 | A→T | 7.9% | intergenic (+50/‑171) | clfA → / → USA300HOU_RS04275 | Clumping factor A/Staphylocoagulase |
RA | USA300TCH1516_ALE | 890,015 | T→G | 5.6% | intergenic (+28/‑130) | mgsR → / → gcvH | Regulatory protein MgsR/Glycine cleavage system H protein |
RA | USA300TCH1516_ALE | 890,016 | C→A | 5.4% | intergenic (+29/‑129) | mgsR → / → gcvH | Regulatory protein MgsR/Glycine cleavage system H protein |
RA | USA300TCH1516_ALE | 890,542 | T→C | 10.7% | intergenic (+17/‑47) | gcvH → / → USA300TCH1516_00820 | Glycine cleavage system H protein/hypothetical protein |
RA | USA300TCH1516_ALE | 890,548 | A→T | 11.3% | intergenic (+23/‑41) | gcvH → / → USA300TCH1516_00820 | Glycine cleavage system H protein/hypothetical protein |
RA | USA300TCH1516_ALE | 895,932 | G→A | 9.7% | intergenic (+131/+12) | metQ_2 → / ← Int‑Tn_1 | Methionine‑binding lipoprotein MetQ/Transposase from transposon Tn916 |
RA | USA300TCH1516_ALE | 895,935 | T→C | 9.4% | intergenic (+134/+9) | metQ_2 → / ← Int‑Tn_1 | Methionine‑binding lipoprotein MetQ/Transposase from transposon Tn916 |
RA | USA300TCH1516_ALE | 897,213:1 | +C | 5.7% | intergenic (‑49/+39) | Int‑Tn_1 ← / ← entA_1 | Transposase from transposon Tn916/Enterotoxin type A |
RA | USA300TCH1516_ALE | 917,327 | T→G | 7.6% | intergenic (+86/+244) | sufB_2 → / ← USA300HOU_RS04545 | FeS cluster assembly protein SufB/hypothetical protein |
RA | USA300TCH1516_ALE | 917,330 | C→A | 7.8% | intergenic (+89/+241) | sufB_2 → / ← USA300HOU_RS04545 | FeS cluster assembly protein SufB/hypothetical protein |
RA | USA300TCH1516_ALE | 927,944 | A→T | 6.1% | intergenic (+164/‑248) | ghrB_1 → / → USA300HOU_RS04615 | Glyoxylate/hydroxypyruvate reductase B/hypothetical protein |
RA | USA300TCH1516_ALE | 927,945 | A→T | 6.0% | intergenic (+165/‑247) | ghrB_1 → / → USA300HOU_RS04615 | Glyoxylate/hydroxypyruvate reductase B/hypothetical protein |
RA | USA300TCH1516_ALE | 937,158 | T→A | 13.8% | intergenic (+65/‑66) | USA300HOU_RS04665 → / → pepA_1 | NADH dehydrogenase‑like protein/Cytosol aminopeptidase |
RA | USA300TCH1516_ALE | 937,168 | G→A | 6.4% | intergenic (+75/‑56) | USA300HOU_RS04665 → / → pepA_1 | NADH dehydrogenase‑like protein/Cytosol aminopeptidase |
RA | USA300TCH1516_ALE | 940,872 | T→C | 5.3% | intergenic (+53/+3) | USA300HOU_RS04680 → / ← ptlE | Putative esterase/Neopentalenolactone D synthase |
RA | USA300TCH1516_ALE | 942,207 | A→G | 7.3% | intergenic (‑178/+71) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
RA | USA300TCH1516_ALE | 942,210 | C→G | 7.0% | intergenic (‑181/+68) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
RA | USA300TCH1516_ALE | 942,216 | T→A | 8.0% | intergenic (‑187/+62) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
RA | USA300TCH1516_ALE | 942,221 | T→A | 8.0% | intergenic (‑192/+57) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
RA | USA300TCH1516_ALE | 942,227 | C→G | 8.0% | intergenic (‑198/+51) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
RA | USA300TCH1516_ALE | 942,230 | C→T | 8.0% | intergenic (‑201/+48) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
RA | USA300TCH1516_ALE | 950,088 | T→A | 14.4% | intergenic (+82/‑280) | yugI_2 → / → USA300HOU_RS04740 | General stress protein 13/putative oxidoreductase |
RA | USA300TCH1516_ALE | 950,093 | T→A | 16.8% | intergenic (+87/‑275) | yugI_2 → / → USA300HOU_RS04740 | General stress protein 13/putative oxidoreductase |
RA | USA300TCH1516_ALE | 950,098 | T→A | 16.2% | intergenic (+92/‑270) | yugI_2 → / → USA300HOU_RS04740 | General stress protein 13/putative oxidoreductase |
RA | USA300TCH1516_ALE | 954,763 | G→A | 6.0% | intergenic (+417/+86) | gluD → / ← glpQ_1 | NAD‑specific glutamate dehydrogenase/Glycerophosphodiester phosphodiesterase |
RA | USA300TCH1516_ALE | 954,768 | A→T | 5.7% | intergenic (+422/+81) | gluD → / ← glpQ_1 | NAD‑specific glutamate dehydrogenase/Glycerophosphodiester phosphodiesterase |
RA | USA300TCH1516_ALE | 954,771 | T→C | 5.5% | intergenic (+425/+78) | gluD → / ← glpQ_1 | NAD‑specific glutamate dehydrogenase/Glycerophosphodiester phosphodiesterase |
RA | USA300TCH1516_ALE | 954,775 | T→A | 5.4% | intergenic (+429/+74) | gluD → / ← glpQ_1 | NAD‑specific glutamate dehydrogenase/Glycerophosphodiester phosphodiesterase |
RA | USA300TCH1516_ALE | 954,779 | G→A | 5.4% | intergenic (+433/+70) | gluD → / ← glpQ_1 | NAD‑specific glutamate dehydrogenase/Glycerophosphodiester phosphodiesterase |
RA | USA300TCH1516_ALE | 954,782 | A→T | 5.3% | intergenic (+436/+67) | gluD → / ← glpQ_1 | NAD‑specific glutamate dehydrogenase/Glycerophosphodiester phosphodiesterase |
RA | USA300TCH1516_ALE | 954,787 | T→C | 5.3% | intergenic (+441/+62) | gluD → / ← glpQ_1 | NAD‑specific glutamate dehydrogenase/Glycerophosphodiester phosphodiesterase |
RA | USA300TCH1516_ALE | 970,677 | G→A | 12.4% | intergenic (+23/‑306) | USA300HOU_RS04805 → / → USA300HOU_RS04810 | Ureidoglycolate lyase/hypothetical protein |
RA | USA300TCH1516_ALE | 970,681 | T→A | 12.2% | intergenic (+27/‑302) | USA300HOU_RS04805 → / → USA300HOU_RS04810 | Ureidoglycolate lyase/hypothetical protein |
RA | USA300TCH1516_ALE | 970,686 | T→A | 12.3% | intergenic (+32/‑297) | USA300HOU_RS04805 → / → USA300HOU_RS04810 | Ureidoglycolate lyase/hypothetical protein |
RA | USA300TCH1516_ALE | 970,690 | T→C | 11.5% | intergenic (+36/‑293) | USA300HOU_RS04805 → / → USA300HOU_RS04810 | Ureidoglycolate lyase/hypothetical protein |
RA | USA300TCH1516_ALE | 973,213 | C→A | 6.6% | E175* (GAG→TAG) | yitU_1 ← | 5‑amino‑6‑(5‑phospho‑D‑ribitylamino)uracil phosphatase YitU |
RA | USA300TCH1516_ALE | 977,289 | T→A | 5.2% | I190N (ATT→AAT) | clpB_1 → | Chaperone protein ClpB |
RA | USA300TCH1516_ALE | 979,347 | T→C | 5.2% | intergenic (+17/+42) | clpB_1 → / ← ampR | Chaperone protein ClpB/HTH‑type transcriptional activator AmpR |
RA | USA300TCH1516_ALE | 979,351 | G→T | 5.2% | intergenic (+21/+38) | clpB_1 → / ← ampR | Chaperone protein ClpB/HTH‑type transcriptional activator AmpR |
RA | USA300TCH1516_ALE | 979,353 | T→A | 5.2% | intergenic (+23/+36) | clpB_1 → / ← ampR | Chaperone protein ClpB/HTH‑type transcriptional activator AmpR |
RA | USA300TCH1516_ALE | 979,355 | A→C | 5.3% | intergenic (+25/+34) | clpB_1 → / ← ampR | Chaperone protein ClpB/HTH‑type transcriptional activator AmpR |
RA | USA300TCH1516_ALE | 979,359 | G→A | 5.9% | intergenic (+29/+30) | clpB_1 → / ← ampR | Chaperone protein ClpB/HTH‑type transcriptional activator AmpR |
RA | USA300TCH1516_ALE | 1,032,588 | G→T | 5.1% | intergenic (+61/+118) | yfkN_2 → / ← USA300TCH1516_00957 | Trifunctional nucleotide phosphoesterase protein YfkN/tRNA‑Ser |
RA | USA300TCH1516_ALE | 1,042,789 | T→C | 14.2% | intergenic (+19/+70) | tagE_3 → / ← catD | Poly(glycerol‑phosphate) alpha‑glucosyltransferase/Putative oxidoreductase CatD |
RA | USA300TCH1516_ALE | 1,042,796 | G→A | 16.6% | intergenic (+26/+63) | tagE_3 → / ← catD | Poly(glycerol‑phosphate) alpha‑glucosyltransferase/Putative oxidoreductase CatD |
RA | USA300TCH1516_ALE | 1,044,663 | T→C | 9.6% | intergenic (+12/+34) | yfmC_1 → / ← USA300HOU_RS05165 | Fe(3+)‑citrate‑binding protein YfmC/hypothetical protein |
RA | USA300TCH1516_ALE | 1,044,668 | G→T | 9.5% | intergenic (+17/+29) | yfmC_1 → / ← USA300HOU_RS05165 | Fe(3+)‑citrate‑binding protein YfmC/hypothetical protein |
RA | USA300TCH1516_ALE | 1,044,671 | A→T | 9.7% | intergenic (+20/+26) | yfmC_1 → / ← USA300HOU_RS05165 | Fe(3+)‑citrate‑binding protein YfmC/hypothetical protein |
RA | USA300TCH1516_ALE | 1,044,674 | C→G | 9.4% | intergenic (+23/+23) | yfmC_1 → / ← USA300HOU_RS05165 | Fe(3+)‑citrate‑binding protein YfmC/hypothetical protein |
RA | USA300TCH1516_ALE | 1,044,677 | A→T | 9.6% | intergenic (+26/+20) | yfmC_1 → / ← USA300HOU_RS05165 | Fe(3+)‑citrate‑binding protein YfmC/hypothetical protein |
RA | USA300TCH1516_ALE | 1,044,680 | A→C | 9.5% | intergenic (+29/+17) | yfmC_1 → / ← USA300HOU_RS05165 | Fe(3+)‑citrate‑binding protein YfmC/hypothetical protein |
RA | USA300TCH1516_ALE | 1,044,685 | G→A | 9.1% | intergenic (+34/+12) | yfmC_1 → / ← USA300HOU_RS05165 | Fe(3+)‑citrate‑binding protein YfmC/hypothetical protein |
RA | USA300TCH1516_ALE | 1,049,713 | G→T | 5.1% | Q457H (CAG→CAT) | menD → | 2‑succinyl‑5‑enolpyruvyl‑6‑hydroxy‑3‑ cyclohexene‑1‑carboxylate synthase |
RA | USA300TCH1516_ALE | 1,049,714 | A→C | 5.3% | M458L (ATG→CTG) | menD → | 2‑succinyl‑5‑enolpyruvyl‑6‑hydroxy‑3‑ cyclohexene‑1‑carboxylate synthase |
RA | USA300TCH1516_ALE | 1,055,119 | C→A | 5.6% | G355C (GGT→TGT) | patA_2 ← | Putative N‑acetyl‑LL‑diaminopimelate aminotransferase |
RA | USA300TCH1516_ALE | 1,055,126 | T→G | 11.2% | T352T (ACA→ACC) | patA_2 ← | Putative N‑acetyl‑LL‑diaminopimelate aminotransferase |
RA | USA300TCH1516_ALE | 1,060,234 | T→A | 10.1% | K568I (AAA→ATA) ‡ | atl_1 ← | Bifunctional autolysin |
RA | USA300TCH1516_ALE | 1,060,235 | T→A | 10.1% | K568* (AAA→TAA) ‡ | atl_1 ← | Bifunctional autolysin |
RA | USA300TCH1516_ALE | 1,078,152 | A→T | 13.1% | Q510L (CAG→CTG) | purL → | Phosphoribosylformylglycinamidine synthase subunit PurL |
RA | USA300TCH1516_ALE | 1,089,908 | T→G | 5.5% | intergenic (+61/‑364) | USA300HOU_RS05380 → / → rlmI | hypothetical protein/Ribosomal RNA large subunit methyltransferase I |
RA | USA300TCH1516_ALE | 1,089,913 | C→A | 5.7% | intergenic (+66/‑359) | USA300HOU_RS05380 → / → rlmI | hypothetical protein/Ribosomal RNA large subunit methyltransferase I |
RA | USA300TCH1516_ALE | 1,104,520 | T→A | 11.2% | L309* (TTA→TAA) | pdhB → | Pyruvate dehydrogenase E1 component subunit beta |
RA | USA300TCH1516_ALE | 1,105,994 | T→C | 100% | T12T (ACT→ACC) | pdhD → | Dihydrolipoyl dehydrogenase |
RA | USA300TCH1516_ALE | 1,107,402 | T→C | 12.7% | intergenic (+37/‑131) | pdhD → / → USA300HOU_RS05475 | Dihydrolipoyl dehydrogenase/hypothetical protein |
RA | USA300TCH1516_ALE | 1,107,417 | G→A | 9.1% | intergenic (+52/‑116) | pdhD → / → USA300HOU_RS05475 | Dihydrolipoyl dehydrogenase/hypothetical protein |
RA | USA300TCH1516_ALE | 1,128,680 | T→A | 5.8% | Y286N (TAT→AAT) | ctaB2 → | Protoheme IX farnesyltransferase 2 |
RA | USA300TCH1516_ALE | 1,137,594 | G→A | 6.6% | Y214Y (TAC→TAT) | isdB ← | Iron‑regulated surface determinant protein B |
RA | USA300TCH1516_ALE | 1,137,597 | T→C | 5.8% | S213S (TCA→TCG) | isdB ← | Iron‑regulated surface determinant protein B |
RA | USA300TCH1516_ALE | 1,155,991 | G→C | 8.0% | intergenic (+167/‑6) | mutS2 → / → trxA_2 | Endonuclease MutS2/Thioredoxin |
RA | USA300TCH1516_ALE | 1,156,333 | G→A | 6.2% | intergenic (+22/‑302) | trxA_2 → / → uvrC | Thioredoxin/UvrABC system protein C |
RA | USA300TCH1516_ALE | 1,156,337 | T→A | 6.6% | intergenic (+26/‑298) | trxA_2 → / → uvrC | Thioredoxin/UvrABC system protein C |
RA | USA300TCH1516_ALE | 1,156,341 | T→A | 6.6% | intergenic (+30/‑294) | trxA_2 → / → uvrC | Thioredoxin/UvrABC system protein C |
RA | USA300TCH1516_ALE | 1,156,346 | T→A | 5.8% | intergenic (+35/‑289) | trxA_2 → / → uvrC | Thioredoxin/UvrABC system protein C |
RA | USA300TCH1516_ALE | 1,156,350 | T→A | 5.1% | intergenic (+39/‑285) | trxA_2 → / → uvrC | Thioredoxin/UvrABC system protein C |
RA | USA300TCH1516_ALE | 1,158,427 | G→A | 9.0% | intergenic (+11/‑313) | uvrC → / → sdhC | UvrABC system protein C/Succinate dehydrogenase cytochrome b558 subunit |
RA | USA300TCH1516_ALE | 1,158,443 | T→C | 5.2% | intergenic (+27/‑297) | uvrC → / → sdhC | UvrABC system protein C/Succinate dehydrogenase cytochrome b558 subunit |
RA | USA300TCH1516_ALE | 1,177,493 | C→A | 5.1% | intergenic (+12/‑160) | arcC1_2 → / → USA300HOU_RS05870 | Carbamate kinase 1/hypothetical protein |
RA | USA300TCH1516_ALE | 1,177,496 | T→G | 5.1% | intergenic (+15/‑157) | arcC1_2 → / → USA300HOU_RS05870 | Carbamate kinase 1/hypothetical protein |
RA | USA300TCH1516_ALE | 1,218,730 | G→T | 7.1% | intergenic (+221/+42) | USA300HOU_RS06065 → / ← USA300HOU_RS06070 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 1,218,732 | C→G | 7.5% | intergenic (+223/+40) | USA300HOU_RS06065 → / ← USA300HOU_RS06070 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 1,218,734 | A→C | 7.4% | intergenic (+225/+38) | USA300HOU_RS06065 → / ← USA300HOU_RS06070 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 1,219,566 | A→T | 5.6% | Y302N (TAC→AAC) | USA300HOU_RS06070 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,219,571 | T→A | 7.6% | Q300L (CAG→CTG) | USA300HOU_RS06070 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,219,574 | T→A | 7.5% | Q299L (CAG→CTG) | USA300HOU_RS06070 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,219,579 | A→T | 6.2% | V297V (GTT→GTA) | USA300HOU_RS06070 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,221,653 | G→A | 7.1% | intergenic (+68/‑148) | rpoZ → / → coaBC | DNA‑directed RNA polymerase subunit omega/Coenzyme A biosynthesis bifunctional protein CoaBC |
RA | USA300TCH1516_ALE | 1,239,557:1 | +C | 7.9% | intergenic (+24/‑166) | USA300HOU_RS06160 → / → recG | hypothetical protein/ATP‑dependent DNA helicase RecG |
RA | USA300TCH1516_ALE | 1,239,562 | A→G | 7.9% | intergenic (+29/‑161) | USA300HOU_RS06160 → / → recG | hypothetical protein/ATP‑dependent DNA helicase RecG |
RA | USA300TCH1516_ALE | 1,239,564 | A→T | 7.7% | intergenic (+31/‑159) | USA300HOU_RS06160 → / → recG | hypothetical protein/ATP‑dependent DNA helicase RecG |
RA | USA300TCH1516_ALE | 1,239,566 | C→T | 7.8% | intergenic (+33/‑157) | USA300HOU_RS06160 → / → recG | hypothetical protein/ATP‑dependent DNA helicase RecG |
RA | USA300TCH1516_ALE | 1,239,571 | Δ1 bp | 7.3% | intergenic (+38/‑152) | USA300HOU_RS06160 → / → recG | hypothetical protein/ATP‑dependent DNA helicase RecG |
RA | USA300TCH1516_ALE | 1,245,330 | A→T | 8.0% | intergenic (+135/‑108) | fabG → / → acpP | 3‑oxoacyl‑[acyl‑carrier‑protein] reductase FabG/Acyl carrier protein |
RA | USA300TCH1516_ALE | 1,245,337 | A→T | 8.5% | intergenic (+142/‑101) | fabG → / → acpP | 3‑oxoacyl‑[acyl‑carrier‑protein] reductase FabG/Acyl carrier protein |
RA | USA300TCH1516_ALE | 1,245,338 | A→T | 8.5% | intergenic (+143/‑100) | fabG → / → acpP | 3‑oxoacyl‑[acyl‑carrier‑protein] reductase FabG/Acyl carrier protein |
RA | USA300TCH1516_ALE | 1,245,345 | A→T | 7.0% | intergenic (+150/‑93) | fabG → / → acpP | 3‑oxoacyl‑[acyl‑carrier‑protein] reductase FabG/Acyl carrier protein |
RA | USA300TCH1516_ALE | 1,254,017 | A→T | 6.9% | intergenic (+114/‑74) | rpsP → / → rimM | 30S ribosomal protein S16/Ribosome maturation factor RimM |
RA | USA300TCH1516_ALE | 1,270,460 | C→G | 7.4% | intergenic (+211/‑206) | trmFO → / → xerC_1 | Methylenetetrahydrofolate‑‑tRNA‑(uracil‑5‑)‑ methyltransferase TrmFO/Tyrosine recombinase XerC |
RA | USA300TCH1516_ALE | 1,273,925 | C→T | 9.3% | R110C (CGT→TGT) | codY → | GTP‑sensing transcriptional pleiotropic repressor CodY |
RA | USA300TCH1516_ALE | 1,273,930 | A→G | 11.7% | T111T (ACA→ACG) | codY → | GTP‑sensing transcriptional pleiotropic repressor CodY |
RA | USA300TCH1516_ALE | 1,313,113 | A→T | 9.9% | intergenic (+17/+280) | rny_1 → / ← USA300HOU_RS06485 | Ribonuclease Y/hypothetical protein |
RA | USA300TCH1516_ALE | 1,331,236 | T→A | 8.9% | S189T (TCT→ACT) | USA300HOU_RS06555 → | Monoacylglycerol lipase |
RA | USA300TCH1516_ALE | 1,331,241 | T→A | 9.5% | S190R (AGT→AGA) | USA300HOU_RS06555 → | Monoacylglycerol lipase |
RA | USA300TCH1516_ALE | 1,343,619 | A→C | 10.3% | intergenic (+32/‑98) | USA300HOU_RS06640 → / → USA300TCH1516_01248 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 1,343,622 | G→T | 10.3% | intergenic (+35/‑95) | USA300HOU_RS06640 → / → USA300TCH1516_01248 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 1,360,384 | T→A | 5.5% | H233Q (CAT→CAA) | thrB_2 → | Homoserine kinase |
RA | USA300TCH1516_ALE | 1,362,249 | A→T | 5.8% | intergenic (‑181/+37) | USA300TCH1516_01271 ← / ← lysP_1 | hypothetical protein/Lysine‑specific permease |
RA | USA300TCH1516_ALE | 1,362,255 | A→T | 8.6% | intergenic (‑187/+31) | USA300TCH1516_01271 ← / ← lysP_1 | hypothetical protein/Lysine‑specific permease |
RA | USA300TCH1516_ALE | 1,362,261 | A→T | 9.3% | intergenic (‑193/+25) | USA300TCH1516_01271 ← / ← lysP_1 | hypothetical protein/Lysine‑specific permease |
RA | USA300TCH1516_ALE | 1,362,267 | C→T | 6.6% | intergenic (‑199/+19) | USA300TCH1516_01271 ← / ← lysP_1 | hypothetical protein/Lysine‑specific permease |
RA | USA300TCH1516_ALE | 1,366,121 | A→T | 12.2% | intergenic (+420/‑34) | rpmG2_1 → / → rpsN2 | 50S ribosomal protein L33 2/Alternate 30S ribosomal protein S14 |
RA | USA300TCH1516_ALE | 1,368,899 | C→A | 5.3% | intergenic (+303/+77) | USA300TCH1516_01277 → / ← lexA_1 | hypothetical protein/LexA repressor |
RA | USA300TCH1516_ALE | 1,368,902 | A→T | 5.5% | intergenic (+306/+74) | USA300TCH1516_01277 → / ← lexA_1 | hypothetical protein/LexA repressor |
RA | USA300TCH1516_ALE | 1,373,008 | G→T | 5.1% | intergenic (+29/‑150) | USA300HOU_RS06835 → / → USA300TCH1516_01283 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 1,373,011 | A→C | 5.2% | intergenic (+32/‑147) | USA300HOU_RS06835 → / → USA300TCH1516_01283 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 1,394,305 | A→G | 7.9% | T178T (ACA→ACG) | tqsA → | AI‑2 transport protein TqsA |
RA | USA300TCH1516_ALE | 1,415,013 | C→G | 5.6% | intergenic (+24/+24) | yitU_2 → / ← mqo | 5‑amino‑6‑(5‑phospho‑D‑ribitylamino)uracil phosphatase YitU/malate:quinone oxidoreductase |
RA | USA300TCH1516_ALE | 1,416,458 | A→T | 100% | I216N (ATT→AAT) | oppD_4 ← | Oligopeptide transport ATP‑binding protein OppD |
RA | USA300TCH1516_ALE | 1,421,606 | T→C | 6.1% | intergenic (+42/+98) | pepF1_2 → / ← phoU | Oligoendopeptidase F, plasmid/Phosphate‑specific transport system accessory protein PhoU |
RA | USA300TCH1516_ALE | 1,421,610:1 | +A | 6.1% | intergenic (+46/+94) | pepF1_2 → / ← phoU | Oligoendopeptidase F, plasmid/Phosphate‑specific transport system accessory protein PhoU |
RA | USA300TCH1516_ALE | 1,421,615 | C→G | 6.3% | intergenic (+51/+89) | pepF1_2 → / ← phoU | Oligoendopeptidase F, plasmid/Phosphate‑specific transport system accessory protein PhoU |
RA | USA300TCH1516_ALE | 1,421,619 | Δ1 bp | 5.7% | intergenic (+55/+85) | pepF1_2 → / ← phoU | Oligoendopeptidase F, plasmid/Phosphate‑specific transport system accessory protein PhoU |
RA | USA300TCH1516_ALE | 1,421,625 | G→A | 6.3% | intergenic (+61/+79) | pepF1_2 → / ← phoU | Oligoendopeptidase F, plasmid/Phosphate‑specific transport system accessory protein PhoU |
RA | USA300TCH1516_ALE | 1,430,691 | C→G | 6.7% | intergenic (+800/‑60) | ybiT → / → lysC | putative ABC transporter ATP‑binding protein YbiT/Aspartokinase |
RA | USA300TCH1516_ALE | 1,430,693 | T→A | 6.7% | intergenic (+802/‑58) | ybiT → / → lysC | putative ABC transporter ATP‑binding protein YbiT/Aspartokinase |
RA | USA300TCH1516_ALE | 1,430,695 | C→G | 6.7% | intergenic (+804/‑56) | ybiT → / → lysC | putative ABC transporter ATP‑binding protein YbiT/Aspartokinase |
RA | USA300TCH1516_ALE | 1,435,075 | T→A | 9.6% | G144G (GGT→GGA) | dapH → | 2,3,4,5‑tetrahydropyridine‑2,6‑dicarboxylate N‑acetyltransferase |
RA | USA300TCH1516_ALE | 1,447,040 | T→A | 6.0% | E65D (GAA→GAT) | cobT ← | Aerobic cobaltochelatase subunit CobT |
RA | USA300TCH1516_ALE | 1,447,045 | T→A | 6.1% | I64F (ATC→TTC) | cobT ← | Aerobic cobaltochelatase subunit CobT |
RA | USA300TCH1516_ALE | 1,452,976 | G→C | 7.8% | H316D (CAC→GAC) | odhA ← | 2‑oxoglutarate dehydrogenase E1 component |
RA | USA300TCH1516_ALE | 1,465,105 | C→G | 7.8% | E18Q (GAA→CAA) | folA ← | Dihydrofolate reductase |
RA | USA300TCH1516_ALE | 1,465,110 | C→T | 7.4% | G16D (GGT→GAT) | folA ← | Dihydrofolate reductase |
RA | USA300TCH1516_ALE | 1,487,340 | T→A | 7.3% | H4895L (CAT→CTT) | ebh_1 ← | Extracellular matrix‑binding protein ebh |
RA | USA300TCH1516_ALE | 1,487,343 | T→A | 7.4% | K4894M (AAG→ATG) | ebh_1 ← | Extracellular matrix‑binding protein ebh |
RA | USA300TCH1516_ALE | 1,502,422 | C→G | 5.6% | *464S (TGA→TCA) | norB_4 ← | Quinolone resistance protein NorB |
RA | USA300TCH1516_ALE | 1,513,930 | A→T | 100% | L413F (TTA→TTT) | USA300HOU_RS07375 → | hypothetical protein |
RA | USA300TCH1516_ALE | 1,526,532 | T→A | 7.2% | K471* (AAA→TAA) | dinG_1 ← | putative ATP‑dependent helicase DinG |
RA | USA300TCH1516_ALE | 1,537,428 | A→T | 6.5% | I94I (ATT→ATA) | aroB ← | 3‑dehydroquinate synthase |
RA | USA300TCH1516_ALE | 1,539,250 | C→G | 100% | intergenic (‑349/+37) | aroC ← / ← USA300HOU_RS07505 | Chorismate synthase/hypothetical protein |
RA | USA300TCH1516_ALE | 1,540,018 | T→A | 7.8% | E43V (GAA→GTA) | ndk ← | Nucleoside diphosphate kinase |
RA | USA300TCH1516_ALE | 1,540,022 | T→A | 7.6% | M42L (ATG→TTG) | ndk ← | Nucleoside diphosphate kinase |
RA | USA300TCH1516_ALE | 1,540,026 | T→A | 5.5% | V40V (GTA→GTT) | ndk ← | Nucleoside diphosphate kinase |
RA | USA300TCH1516_ALE | 1,582,474 | G→A | 8.6% | H107H (CAC→CAT) | clpP1 ← | ATP‑dependent Clp protease proteolytic subunit 1 |
RA | USA300TCH1516_ALE | 1,582,479 | T→C | 9.3% | M106V (ATG→GTG) | clpP1 ← | ATP‑dependent Clp protease proteolytic subunit 1 |
RA | USA300TCH1516_ALE | 1,646,189 | G→C | 100% | A155G (GCA→GGA) | ypdF ← | Aminopeptidase YpdF |
RA | USA300TCH1516_ALE | 1,653,040 | A→C | 5.6% | L86V (TTA→GTA) | gcvT ← | Aminomethyltransferase |
RA | USA300TCH1516_ALE | 1,653,327 | A→G | 8.8% | intergenic (‑32/+127) | gcvT ← / ← aroK | Aminomethyltransferase/Shikimate kinase |
RA | USA300TCH1516_ALE | 1,653,332 | A→G | 9.3% | intergenic (‑37/+122) | gcvT ← / ← aroK | Aminomethyltransferase/Shikimate kinase |
RA | USA300TCH1516_ALE | 1,653,335 | C→T | 8.9% | intergenic (‑40/+119) | gcvT ← / ← aroK | Aminomethyltransferase/Shikimate kinase |
RA | USA300TCH1516_ALE | 1,653,340 | C→T | 8.0% | intergenic (‑45/+114) | gcvT ← / ← aroK | Aminomethyltransferase/Shikimate kinase |
RA | USA300TCH1516_ALE | 1,674,892 | C→G | 6.3% | D42H (GAT→CAT) | dnaG ← | DNA primase |
RA | USA300TCH1516_ALE | 1,685,129 | T→A | 7.9% | intergenic (‑141/+79) | USA300HOU_RS08395 ← / ← rpsU | hypothetical protein/30S ribosomal protein S21 |
RA | USA300TCH1516_ALE | 1,685,130 | A→G | 7.5% | intergenic (‑142/+78) | USA300HOU_RS08395 ← / ← rpsU | hypothetical protein/30S ribosomal protein S21 |
RA | USA300TCH1516_ALE | 1,685,139 | A→T | 8.4% | intergenic (‑151/+69) | USA300HOU_RS08395 ← / ← rpsU | hypothetical protein/30S ribosomal protein S21 |
RA | USA300TCH1516_ALE | 1,685,148 | C→T | 7.0% | intergenic (‑160/+60) | USA300HOU_RS08395 ← / ← rpsU | hypothetical protein/30S ribosomal protein S21 |
RA | USA300TCH1516_ALE | 1,685,149 | T→A | 7.1% | intergenic (‑161/+59) | USA300HOU_RS08395 ← / ← rpsU | hypothetical protein/30S ribosomal protein S21 |
RA | USA300TCH1516_ALE | 1,695,087 | C→T | 6.0% | intergenic (‑293/+237) | hemN_1 ← / ← lepA | Oxygen‑independent coproporphyrinogen‑III oxidase‑like protein YqeR/Elongation factor 4 |
RA | USA300TCH1516_ALE | 1,702,671 | G→C | 7.1% | I117M (ATC→ATG) | tylM1 ← | dTDP‑3‑amino‑3,6‑dideoxy‑alpha‑D‑glucopyranose N,N‑dimethyltransferase |
RA | USA300TCH1516_ALE | 1,702,674 | G→C | 6.1% | F116L (TTC→TTG) | tylM1 ← | dTDP‑3‑amino‑3,6‑dideoxy‑alpha‑D‑glucopyranose N,N‑dimethyltransferase |
RA | USA300TCH1516_ALE | 1,711,515 | T→C | 5.2% | M383V (ATG→GTG) | mntH_2 ← | Divalent metal cation transporter MntH |
RA | USA300TCH1516_ALE | 1,722,313 | G→A | 7.8% | Q3* (CAA→TAA) | yrrK ← | Putative pre‑16S rRNA nuclease |
RA | USA300TCH1516_ALE | 1,722,314 | T→C | 7.7% | L2L (TTA→TTG) | yrrK ← | Putative pre‑16S rRNA nuclease |
RA | USA300TCH1516_ALE | 1,725,379 | T→A | 5.6% | intergenic (‑100/+240) | alaS ← / ← recD2 | Alanine‑‑tRNA ligase/ATP‑dependent RecD‑like DNA helicase |
RA | USA300TCH1516_ALE | 1,725,382 | T→A | 5.6% | intergenic (‑103/+237) | alaS ← / ← recD2 | Alanine‑‑tRNA ligase/ATP‑dependent RecD‑like DNA helicase |
RA | USA300TCH1516_ALE | 1,733,445 | T→A | 5.6% | intergenic (‑26/+74) | csbD_2 ← / ← cymR | Stress response protein CsbD/HTH‑type transcriptional regulator CymR |
RA | USA300TCH1516_ALE | 1,733,446 | T→A | 5.7% | intergenic (‑27/+73) | csbD_2 ← / ← cymR | Stress response protein CsbD/HTH‑type transcriptional regulator CymR |
RA | USA300TCH1516_ALE | 1,744,473 | C→T | 100% | A67T (GCT→ACT) | apt ← | Adenine phosphoribosyltransferase |
RA | USA300TCH1516_ALE | 1,758,213 | T→A | 5.3% | K72I (AAA→ATA) | mreC ← | Cell shape‑determining protein MreC |
RA | USA300TCH1516_ALE | 1,779,807 | A→G | 6.2% | intergenic (‑113/+29) | USA300TCH1516_01664 ← / ← rplT | hypothetical protein/50S ribosomal protein L20 |
RA | USA300TCH1516_ALE | 1,779,810 | A→T | 6.2% | intergenic (‑116/+26) | USA300TCH1516_01664 ← / ← rplT | hypothetical protein/50S ribosomal protein L20 |
RA | USA300TCH1516_ALE | 1,779,813 | C→T | 6.0% | intergenic (‑119/+23) | USA300TCH1516_01664 ← / ← rplT | hypothetical protein/50S ribosomal protein L20 |
RA | USA300TCH1516_ALE | 1,794,352 | A→T | 12.4% | Y426N (TAT→AAT) | USA300HOU_RS08960 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,808,248 | C→T | 5.4% | intergenic (‑148/+121) | pfkA ← / ← accA | ATP‑dependent 6‑phosphofructokinase/Acetyl‑coenzyme A carboxylase carboxyl transferase subunit alpha |
RA | USA300TCH1516_ALE | 1,808,251 | C→A | 6.1% | intergenic (‑151/+118) | pfkA ← / ← accA | ATP‑dependent 6‑phosphofructokinase/Acetyl‑coenzyme A carboxylase carboxyl transferase subunit alpha |
RA | USA300TCH1516_ALE | 1,808,256 | T→G | 5.3% | intergenic (‑156/+113) | pfkA ← / ← accA | ATP‑dependent 6‑phosphofructokinase/Acetyl‑coenzyme A carboxylase carboxyl transferase subunit alpha |
RA | USA300TCH1516_ALE | 1,829,661 | T→A | 5.2% | T487S (ACA→TCA) | ezrA ← | Septation ring formation regulator EzrA |
RA | USA300TCH1516_ALE | 1,837,960 | A→T | 10.8% | D79E (GAT→GAA) | gph_2 ← | Phosphoglycolate phosphatase |
RA | USA300TCH1516_ALE | 1,839,436 | C→G | 6.0% | E112Q (GAA→CAA) | nagE ← | PTS system N‑acetylglucosamine‑specific EIICBA component |
RA | USA300TCH1516_ALE | 1,845,292 | C→T | 7.8% | M734I (ATG→ATA) | isdH ← | Iron‑regulated surface determinant protein H |
RA | USA300TCH1516_ALE | 1,845,295 | A→G | 8.1% | D733D (GAT→GAC) | isdH ← | Iron‑regulated surface determinant protein H |
RA | USA300TCH1516_ALE | 1,850,922 | T→A | 6.9% | Q227H (CAA→CAT) | acsA_1 ← | Acetyl‑coenzyme A synthetase |
RA | USA300TCH1516_ALE | 1,850,927 | G→C | 6.9% | Q226E (CAA→GAA) | acsA_1 ← | Acetyl‑coenzyme A synthetase |
RA | USA300TCH1516_ALE | 1,850,932 | T→A | 6.2% | H224L (CAT→CTT) | acsA_1 ← | Acetyl‑coenzyme A synthetase |
RA | USA300TCH1516_ALE | 1,869,034 | T→G | 5.3% | intergenic (‑441/+29) | ytnP ← / ← trmB | putative quorum‑quenching lactonase YtnP/tRNA (guanine‑N(7)‑)‑methyltransferase |
RA | USA300TCH1516_ALE | 1,869,035 | T→G | 5.6% | intergenic (‑442/+28) | ytnP ← / ← trmB | putative quorum‑quenching lactonase YtnP/tRNA (guanine‑N(7)‑)‑methyltransferase |
RA | USA300TCH1516_ALE | 1,869,042 | G→A | 6.5% | intergenic (‑449/+21) | ytnP ← / ← trmB | putative quorum‑quenching lactonase YtnP/tRNA (guanine‑N(7)‑)‑methyltransferase |
RA | USA300TCH1516_ALE | 1,869,043 | T→C | 6.7% | intergenic (‑450/+20) | ytnP ← / ← trmB | putative quorum‑quenching lactonase YtnP/tRNA (guanine‑N(7)‑)‑methyltransferase |
RA | USA300TCH1516_ALE | 1,869,050 | C→A | 5.5% | intergenic (‑457/+13) | ytnP ← / ← trmB | putative quorum‑quenching lactonase YtnP/tRNA (guanine‑N(7)‑)‑methyltransferase |
RA | USA300TCH1516_ALE | 1,869,051 | C→A | 5.5% | intergenic (‑458/+12) | ytnP ← / ← trmB | putative quorum‑quenching lactonase YtnP/tRNA (guanine‑N(7)‑)‑methyltransferase |
RA | USA300TCH1516_ALE | 1,870,863 | C→T | 7.0% | intergenic (‑350/+200) | srkA ← / ← dat | Stress response kinase A/D‑alanine aminotransferase |
RA | USA300TCH1516_ALE | 1,870,864 | A→G | 7.0% | intergenic (‑351/+199) | srkA ← / ← dat | Stress response kinase A/D‑alanine aminotransferase |
RA | USA300TCH1516_ALE | 1,885,368 | G→A | 5.9% | intergenic (‑150/+176) | ebh_2 ← / ← moeZ_2 | Extracellular matrix‑binding protein ebh/putative adenylyltransferase/sulfurtransferase MoeZ |
RA | USA300TCH1516_ALE | 1,885,369 | T→C | 5.3% | intergenic (‑151/+175) | ebh_2 ← / ← moeZ_2 | Extracellular matrix‑binding protein ebh/putative adenylyltransferase/sulfurtransferase MoeZ |
RA | USA300TCH1516_ALE | 1,905,775 | G→C | 5.1% | E128Q (GAA→CAA) | sigS → | RNA polymerase sigma factor SigS |
RA | USA300TCH1516_ALE | 1,909,134 | T→A | 7.6% | intergenic (‑200/‑60) | tal ← / → USA300HOU_RS09460 | Transaldolase/hypothetical protein |
RA | USA300TCH1516_ALE | 1,909,137 | T→A | 7.6% | intergenic (‑203/‑57) | tal ← / → USA300HOU_RS09460 | Transaldolase/hypothetical protein |
RA | USA300TCH1516_ALE | 1,918,555 | G→A | 5.3% | intergenic (‑273/+225) | USA300HOU_RS07235 ← / ← USA300HOU_RS09510 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 1,929,565 | C→T | 5.6% | D34N (GAT→AAT) | USA300TCH1516_01793 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,929,570 | T→G | 5.2% | E32A (GAG→GCG) | USA300TCH1516_01793 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,929,573 | C→A | 5.3% | R31L (CGC→CTC) | USA300TCH1516_01793 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,929,578 | A→G | 5.5% | I29I (ATT→ATC) | USA300TCH1516_01793 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,931,599 | A→T | 9.1% | L1217I (TTA→ATA) | USA300HOU_RS09605 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,934,780 | A→T | 6.8% | N156K (AAT→AAA) | USA300HOU_RS09605 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 1,962,391 | A→C | 5.1% | intergenic (‑280/+192) | USA300TCH1516_01825 ← / ← ydeN | tRNA‑Met/Putative hydrolase YdeN |
RA | USA300TCH1516_ALE | 1,962,395 | A→G | 5.3% | intergenic (‑284/+188) | USA300TCH1516_01825 ← / ← ydeN | tRNA‑Met/Putative hydrolase YdeN |
RA | USA300TCH1516_ALE | 1,972,372 | G→A | 6.5% | A23T (GCT→ACT) | prsA → | Foldase protein PrsA |
RA | USA300TCH1516_ALE | 1,972,377 | T→C | 9.0% | S24S (AGT→AGC) | prsA → | Foldase protein PrsA |
RA | USA300TCH1516_ALE | 1,985,405 | T→A | 7.0% | P314P (CCA→CCT) | fumC ← | Fumarate hydratase class II |
RA | USA300TCH1516_ALE | 1,997,236 | C→G | 5.2% | noncoding (53/92 nt) | USA300TCH1516_01871 ← | tRNA‑Ser |
RA | USA300TCH1516_ALE | 2,010,363 | C→T | 100% | C146Y (TGT→TAT) | USA300HOU_RS10125 ← | Putative multidrug export ATP‑binding/permease protein |
RA | USA300TCH1516_ALE | 2,042,100 | T→A | 8.4% | K338N (AAA→AAT) | gatB_2 ← | Aspartyl/glutamyl‑tRNA(Asn/Gln) amidotransferase subunit B |
RA | USA300TCH1516_ALE | 2,046,831 | A→G | 8.2% | intergenic (+39/+50) | putP → / ← USA300HOU_RS10335 | Sodium/proline symporter/hypothetical protein |
RA | USA300TCH1516_ALE | 2,046,835 | A→T | 8.2% | intergenic (+43/+46) | putP → / ← USA300HOU_RS10335 | Sodium/proline symporter/hypothetical protein |
RA | USA300TCH1516_ALE | 2,046,840 | A→T | 8.1% | intergenic (+48/+41) | putP → / ← USA300HOU_RS10335 | Sodium/proline symporter/hypothetical protein |
RA | USA300TCH1516_ALE | 2,046,844 | C→T | 7.5% | intergenic (+52/+37) | putP → / ← USA300HOU_RS10335 | Sodium/proline symporter/hypothetical protein |
RA | USA300TCH1516_ALE | 2,077,620 | T→G | 6.5% | L174L (CTA→CTC) | yxlF_3 ← | putative ABC transporter ATP‑binding protein YxlF |
RA | USA300TCH1516_ALE | 2,077,629 | C→A | 8.5% | M171I (ATG→ATT) | yxlF_3 ← | putative ABC transporter ATP‑binding protein YxlF |
RA | USA300TCH1516_ALE | 2,084,859 | C→G | 6.5% | intergenic (‑121/‑265) | USA300HOU_RS10525 ← / → hlb_1 | 65 kDa membrane protein/Phospholipase C |
RA | USA300TCH1516_ALE | 2,123,544 | T→A | 6.9% | N66I (AAT→ATT) | USA300HOU_RS10825 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 2,123,779 | T→A | 5.8% | intergenic (‑39/‑94) | USA300HOU_RS10825 ← / → lexA_2 | hypothetical protein/LexA repressor |
RA | USA300TCH1516_ALE | 2,133,485 | Δ1 bp | 6.3% | intergenic (+329/+43) | dapE → / ← USA300HOU_RS10885 | putative succinyl‑diaminopimelate desuccinylase/hypothetical protein |
RA | USA300TCH1516_ALE | 2,133,490 | A→T | 6.6% | intergenic (+334/+38) | dapE → / ← USA300HOU_RS10885 | putative succinyl‑diaminopimelate desuccinylase/hypothetical protein |
RA | USA300TCH1516_ALE | 2,133,494:1 | +G | 5.6% | intergenic (+338/+34) | dapE → / ← USA300HOU_RS10885 | putative succinyl‑diaminopimelate desuccinylase/hypothetical protein |
RA | USA300TCH1516_ALE | 2,135,944 | A→T | 5.4% | K146N (AAA→AAT) | ktrB_2 → | Ktr system potassium uptake protein B |
RA | USA300TCH1516_ALE | 2,138,306 | A→T | 5.2% | F104Y (TTT→TAT) ‡ | USA300HOU_RS10905 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 2,138,307 | A→T | 5.2% | F104I (TTT→ATT) ‡ | USA300HOU_RS10905 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 2,139,620 | T→A | 9.3% | intergenic (‑60/+851) | USA300HOU_RS10910 ← / ← groL | hypothetical protein/60 kDa chaperonin |
RA | USA300TCH1516_ALE | 2,145,549 | T→G | 5.6% | intergenic (+83/‑278) | USA300HOU_RS10945 → / → USA300HOU_RS10950 | hypothetical protein/2‑oxoglutaramate amidase |
RA | USA300TCH1516_ALE | 2,165,416 | A→T | 8.5% | intergenic (‑384/‑94) | tsaE ← / → ilvD | tRNA threonylcarbamoyladenosine biosynthesis protein TsaE/Dihydroxy‑acid dehydratase |
RA | USA300TCH1516_ALE | 2,172,067:1 | +G | 6.7% | coding (116/1047 nt) | leuB → | 3‑isopropylmalate dehydrogenase |
RA | USA300TCH1516_ALE | 2,172,075 | G→C | 9.0% | E42Q (GAA→CAA) | leuB → | 3‑isopropylmalate dehydrogenase |
RA | USA300TCH1516_ALE | 2,172,078 | T→A | 9.2% | F43I (TTT→ATT) | leuB → | 3‑isopropylmalate dehydrogenase |
RA | USA300TCH1516_ALE | 2,172,081 | G→C | 9.8% | G44R (GGT→CGT) | leuB → | 3‑isopropylmalate dehydrogenase |
RA | USA300TCH1516_ALE | 2,184,883 | G→A | 8.4% | T21I (ACA→ATA) | rpsA_2 ← | 30S ribosomal protein S1 |
RA | USA300TCH1516_ALE | 2,184,888 | T→C | 6.6% | V19V (GTA→GTG) | rpsA_2 ← | 30S ribosomal protein S1 |
RA | USA300TCH1516_ALE | 2,211,673 | T→G | 5.8% | intergenic (+666/+147) | USA300HOU_RS11275 → / ← yidC | hypothetical protein/Membrane protein insertase YidC |
RA | USA300TCH1516_ALE | 2,211,678:1 | +G | 6.3% | intergenic (+671/+142) | USA300HOU_RS11275 → / ← yidC | hypothetical protein/Membrane protein insertase YidC |
RA | USA300TCH1516_ALE | 2,211,684 | T→C | 5.9% | intergenic (+677/+136) | USA300HOU_RS11275 → / ← yidC | hypothetical protein/Membrane protein insertase YidC |
RA | USA300TCH1516_ALE | 2,224,417 | C→A | 6.1% | G253V (GGT→GTT) | atpA ← | ATP synthase subunit alpha |
RA | USA300TCH1516_ALE | 2,224,420 | T→G | 5.6% | N252T (AAC→ACC) | atpA ← | ATP synthase subunit alpha |
RA | USA300TCH1516_ALE | 2,231,527 | A→T | 6.8% | F17I (TTT→ATT) | USA300HOU_RS11415 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 2,243,494 | A→T | 7.5% | intergenic (+72/+37) | USA300HOU_RS11475 → / ← pyrG | hypothetical protein/CTP synthase |
RA | USA300TCH1516_ALE | 2,243,499 | T→A | 12.4% | intergenic (+77/+32) | USA300HOU_RS11475 → / ← pyrG | hypothetical protein/CTP synthase |
RA | USA300TCH1516_ALE | 2,243,504 | A→T | 8.5% | intergenic (+82/+27) | USA300HOU_RS11475 → / ← pyrG | hypothetical protein/CTP synthase |
RA | USA300TCH1516_ALE | 2,268,572 | A→T | 6.6% | intergenic (‑1008/+78) | USA300HOU_RS11605 ← / ← ywpJ_2 | hypothetical protein/Phosphatase YwpJ |
RA | USA300TCH1516_ALE | 2,273,482 | T→A | 6.4% | F136L (TTT→TTA) | mtlA → | PTS system mannitol‑specific EIICB component |
RA | USA300TCH1516_ALE | 2,273,489 | T→A | 5.6% | F139I (TTT→ATT) | mtlA → | PTS system mannitol‑specific EIICB component |
RA | USA300TCH1516_ALE | 2,275,552 | C→T | 5.4% | T302I (ACA→ATA) | mtlR → | Transcriptional regulator MtlR |
RA | USA300TCH1516_ALE | 2,279,705 | G→A | 100% | A943V (GCA→GTA) | ebh_3 ← | Extracellular matrix‑binding protein ebh |
RA | USA300TCH1516_ALE | 2,287,474 | T→A | 5.6% | P82P (CCA→CCT) | glmM ← | Phosphoglucosamine mutase |
RA | USA300TCH1516_ALE | 2,309,787:1 | +C | 9.3% | coding (82/1032 nt) | yfiZ_2 ← | putative siderophore transport system permease protein YfiZ |
RA | USA300TCH1516_ALE | 2,309,793:1 | +G | 9.1% | coding (76/1032 nt) | yfiZ_2 ← | putative siderophore transport system permease protein YfiZ |
RA | USA300TCH1516_ALE | 2,309,800 | Δ1 bp | 7.5% | coding (69/1032 nt) | yfiZ_2 ← | putative siderophore transport system permease protein YfiZ |
RA | USA300TCH1516_ALE | 2,309,807 | Δ1 bp | 6.1% | coding (62/1032 nt) | yfiZ_2 ← | putative siderophore transport system permease protein YfiZ |
RA | USA300TCH1516_ALE | 2,328,872 | G→C | 12.0% | F264L (TTC→TTG) | lacE ← | PTS system lactose‑specific EIICB component |
RA | USA300TCH1516_ALE | 2,346,305 | C→A | 9.2% | intergenic (‑212/+978) | alsS ← / ← USA300HOU_RS11980 | Acetolactate synthase/hypothetical protein |
RA | USA300TCH1516_ALE | 2,359,112 | A→T | 6.2% | G90G (GGT→GGA) | rpsK ← | 30S ribosomal protein S11 |
RA | USA300TCH1516_ALE | 2,372,407 | A→G | 11.2% | intergenic (+158/+34) | USA300TCH1516_02262 → / ← pbuG | hypothetical protein/Guanine/hypoxanthine permease PbuG |
RA | USA300TCH1516_ALE | 2,372,413 | C→G | 15.2% | intergenic (+164/+28) | USA300TCH1516_02262 → / ← pbuG | hypothetical protein/Guanine/hypoxanthine permease PbuG |
RA | USA300TCH1516_ALE | 2,372,419 | C→T | 14.8% | intergenic (+170/+22) | USA300TCH1516_02262 → / ← pbuG | hypothetical protein/Guanine/hypoxanthine permease PbuG |
RA | USA300TCH1516_ALE | 2,375,929 | T→C | 6.3% | N32S (AAT→AGT) | topB ← | DNA topoisomerase 3 |
RA | USA300TCH1516_ALE | 2,375,933 | C→G | 6.1% | E31Q (GAA→CAA) | topB ← | DNA topoisomerase 3 |
RA | USA300TCH1516_ALE | 2,375,937 | G→A | 5.5% | Y29Y (TAC→TAT) | topB ← | DNA topoisomerase 3 |
RA | USA300TCH1516_ALE | 2,386,589 | A→T | 5.2% | intergenic (‑130/‑32) | USA300HOU_RS12250 ← / → USA300HOU_RS12255 | hypothetical protein/putative HTH‑type transcriptional regulator |
RA | USA300TCH1516_ALE | 2,399,036 | T→C | 10.8% | intergenic (+110/+62) | fdhD → / ← USA300HOU_RS12350 | Sulfurtransferase FdhD/hypothetical protein |
RA | USA300TCH1516_ALE | 2,399,039 | A→G | 10.9% | intergenic (+113/+59) | fdhD → / ← USA300HOU_RS12350 | Sulfurtransferase FdhD/hypothetical protein |
RA | USA300TCH1516_ALE | 2,399,044 | T→G | 10.4% | intergenic (+118/+54) | fdhD → / ← USA300HOU_RS12350 | Sulfurtransferase FdhD/hypothetical protein |
RA | USA300TCH1516_ALE | 2,399,046 | C→G | 10.4% | intergenic (+120/+52) | fdhD → / ← USA300HOU_RS12350 | Sulfurtransferase FdhD/hypothetical protein |
RA | USA300TCH1516_ALE | 2,399,048 | C→A | 10.5% | intergenic (+122/+50) | fdhD → / ← USA300HOU_RS12350 | Sulfurtransferase FdhD/hypothetical protein |
RA | USA300TCH1516_ALE | 2,399,053 | C→T | 11.2% | intergenic (+127/+45) | fdhD → / ← USA300HOU_RS12350 | Sulfurtransferase FdhD/hypothetical protein |
RA | USA300TCH1516_ALE | 2,399,056 | G→A | 10.7% | intergenic (+130/+42) | fdhD → / ← USA300HOU_RS12350 | Sulfurtransferase FdhD/hypothetical protein |
RA | USA300TCH1516_ALE | 2,405,147 | A→T | 8.3% | F69L (TTT→TTA) | USA300HOU_RS12375 ← | Urea transporter |
RA | USA300TCH1516_ALE | 2,424,608 | A→G | 6.4% | intergenic (‑166/+62) | USA300HOU_RS12490 ← / ← USA300HOU_RS12495 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,424,609 | C→T | 6.8% | intergenic (‑167/+61) | USA300HOU_RS12490 ← / ← USA300HOU_RS12495 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,430,685 | Δ1 bp | 6.9% | intergenic (‑109/‑276) | suhB_2 ← / → birA_2 | Inositol‑1‑monophosphatase/Bifunctional ligase/repressor BirA |
RA | USA300TCH1516_ALE | 2,430,691:1 | +A | 7.5% | intergenic (‑115/‑270) | suhB_2 ← / → birA_2 | Inositol‑1‑monophosphatase/Bifunctional ligase/repressor BirA |
RA | USA300TCH1516_ALE | 2,432,237 | C→T | 8.1% | intergenic (+584/+63) | birA_2 → / ← USA300HOU_RS12525 | Bifunctional ligase/repressor BirA/hypothetical protein |
RA | USA300TCH1516_ALE | 2,432,240 | A→T | 8.5% | intergenic (+587/+60) | birA_2 → / ← USA300HOU_RS12525 | Bifunctional ligase/repressor BirA/hypothetical protein |
RA | USA300TCH1516_ALE | 2,432,243 | A→T | 8.9% | intergenic (+590/+57) | birA_2 → / ← USA300HOU_RS12525 | Bifunctional ligase/repressor BirA/hypothetical protein |
RA | USA300TCH1516_ALE | 2,432,246 | A→G | 8.9% | intergenic (+593/+54) | birA_2 → / ← USA300HOU_RS12525 | Bifunctional ligase/repressor BirA/hypothetical protein |
RA | USA300TCH1516_ALE | 2,448,479 | A→G | 8.2% | intergenic (‑238/+39) | yxeP_4 ← / ← hutI | putative hydrolase YxeP/Imidazolonepropionase |
RA | USA300TCH1516_ALE | 2,448,484 | A→G | 7.9% | intergenic (‑243/+34) | yxeP_4 ← / ← hutI | putative hydrolase YxeP/Imidazolonepropionase |
RA | USA300TCH1516_ALE | 2,448,493 | C→T | 9.9% | intergenic (‑252/+25) | yxeP_4 ← / ← hutI | putative hydrolase YxeP/Imidazolonepropionase |
RA | USA300TCH1516_ALE | 2,448,498 | C→T | 9.0% | intergenic (‑257/+20) | yxeP_4 ← / ← hutI | putative hydrolase YxeP/Imidazolonepropionase |
RA | USA300TCH1516_ALE | 2,449,468 | A→T | 10.3% | S97T (TCT→ACT) | hutI ← | Imidazolonepropionase |
RA | USA300TCH1516_ALE | 2,455,692 | Δ1 bp | 100% | coding (1210/1260 nt) | lyrA → | Lysostaphin resistance protein A |
RA | USA300TCH1516_ALE | 2,455,698 | 2 bp→AT | 100% | coding (1216‑1217/1260 nt) | lyrA → | Lysostaphin resistance protein A |
RA | USA300TCH1516_ALE | 2,478,130 | T→A | 6.6% | intergenic (+17/‑558) | USA300HOU_RS12760 → / → USA300HOU_RS12765 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,478,133 | T→A | 6.7% | intergenic (+20/‑555) | USA300HOU_RS12760 → / → USA300HOU_RS12765 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,479,038 | C→T | 8.7% | I486I (ATC→ATT) | USA300HOU_RS12765 → | hypothetical protein |
RA | USA300TCH1516_ALE | 2,479,041 | A→T | 9.3% | K487N (AAA→AAT) | USA300HOU_RS12765 → | hypothetical protein |
RA | USA300TCH1516_ALE | 2,479,044 | A→T | 9.7% | *488Y (TAA→TAT) | USA300HOU_RS12765 → | hypothetical protein |
RA | USA300TCH1516_ALE | 2,479,047 | A→G | 9.6% | intergenic (+3/+137) | USA300HOU_RS12765 → / ← hrtA_2 | hypothetical protein/Putative hemin import ATP‑binding protein HrtA |
RA | USA300TCH1516_ALE | 2,497,391 | C→G | 14.1% | N147K (AAC→AAG) | USA300HOU_RS12865 → | hypothetical protein |
RA | USA300TCH1516_ALE | 2,503,387 | T→C | 6.3% | N637N (AAT→AAC) | melR_2 → | Melibiose operon regulatory protein |
RA | USA300TCH1516_ALE | 2,503,398 | G→A | 5.4% | G641D (GGT→GAT) | melR_2 → | Melibiose operon regulatory protein |
RA | USA300TCH1516_ALE | 2,504,989 | T→C | 6.3% | intergenic (+293/+111) | USA300HOU_RS12890 → / ← gltT | hypothetical protein/Proton/sodium‑glutamate symport protein |
RA | USA300TCH1516_ALE | 2,509,782 | T→A | 6.5% | intergenic (‑94/‑276) | narT ← / → USA300HOU_RS12920 | putative nitrate transporter NarT/hypothetical protein |
RA | USA300TCH1516_ALE | 2,509,785 | T→A | 6.7% | intergenic (‑97/‑273) | narT ← / → USA300HOU_RS12920 | putative nitrate transporter NarT/hypothetical protein |
RA | USA300TCH1516_ALE | 2,509,792 | A→G | 6.3% | intergenic (‑104/‑266) | narT ← / → USA300HOU_RS12920 | putative nitrate transporter NarT/hypothetical protein |
RA | USA300TCH1516_ALE | 2,513,966 | A→G | 5.1% | L57S (TTG→TCG) | USA300HOU_RS12940 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 2,513,975 | C→T | 6.5% | R54Q (CGA→CAA) | USA300HOU_RS12940 ← | hypothetical protein |
RA | USA300TCH1516_ALE | 2,517,770 | A→T | 7.3% | S954S (TCT→TCA) | narG ← | Respiratory nitrate reductase 1 alpha chain |
RA | USA300TCH1516_ALE | 2,517,775 | A→C | 11.1% | S953A (TCA→GCA) | narG ← | Respiratory nitrate reductase 1 alpha chain |
RA | USA300TCH1516_ALE | 2,517,782 | T→A | 11.2% | L950L (CTA→CTT) | narG ← | Respiratory nitrate reductase 1 alpha chain |
RA | USA300TCH1516_ALE | 2,517,789 | G→T | 9.6% | A948E (GCA→GAA) | narG ← | Respiratory nitrate reductase 1 alpha chain |
RA | USA300TCH1516_ALE | 2,517,794 | A→T | 7.0% | A946A (GCT→GCA) | narG ← | Respiratory nitrate reductase 1 alpha chain |
RA | USA300TCH1516_ALE | 2,519,951 | T→G | 13.5% | P227P (CCA→CCC) | narG ← | Respiratory nitrate reductase 1 alpha chain |
RA | USA300TCH1516_ALE | 2,528,345 | T→C | 5.9% | intergenic (‑144/+42) | USA300TCH1516_02412 ← / ← zinT | hypothetical protein/Metal‑binding protein ZinT |
RA | USA300TCH1516_ALE | 2,528,349 | G→A | 6.5% | intergenic (‑148/+38) | USA300TCH1516_02412 ← / ← zinT | hypothetical protein/Metal‑binding protein ZinT |
RA | USA300TCH1516_ALE | 2,528,352 | A→G | 6.0% | intergenic (‑151/+35) | USA300TCH1516_02412 ← / ← zinT | hypothetical protein/Metal‑binding protein ZinT |
RA | USA300TCH1516_ALE | 2,528,357 | C→T | 6.0% | intergenic (‑156/+30) | USA300TCH1516_02412 ← / ← zinT | hypothetical protein/Metal‑binding protein ZinT |
RA | USA300TCH1516_ALE | 2,528,360 | T→C | 6.0% | intergenic (‑159/+27) | USA300TCH1516_02412 ← / ← zinT | hypothetical protein/Metal‑binding protein ZinT |
RA | USA300TCH1516_ALE | 2,528,364 | G→A | 5.9% | intergenic (‑163/+23) | USA300TCH1516_02412 ← / ← zinT | hypothetical protein/Metal‑binding protein ZinT |
RA | USA300TCH1516_ALE | 2,530,786 | A→G | 8.6% | intergenic (‑37/+236) | yefM ← / ← bdbD | Antitoxin YefM/Disulfide bond formation protein D |
RA | USA300TCH1516_ALE | 2,530,791 | C→T | 6.4% | intergenic (‑42/+231) | yefM ← / ← bdbD | Antitoxin YefM/Disulfide bond formation protein D |
RA | USA300TCH1516_ALE | 2,532,298 | A→T | 100% | T15T (ACA→ACT) | femA_3 → | Aminoacyltransferase FemA |
RA | USA300TCH1516_ALE | 2,538,743 | A→T | 6.0% | intergenic (‑257/+70) | gpmA_2 ← / ← fieF | 2,3‑bisphosphoglycerate‑dependent phosphoglycerate mutase/Ferrous‑iron efflux pump FieF |
RA | USA300TCH1516_ALE | 2,538,744 | A→T | 6.3% | intergenic (‑258/+69) | gpmA_2 ← / ← fieF | 2,3‑bisphosphoglycerate‑dependent phosphoglycerate mutase/Ferrous‑iron efflux pump FieF |
RA | USA300TCH1516_ALE | 2,552,027 | Δ1 bp | 7.7% | coding (1215/1734 nt) | USA300HOU_RS13150 ← | putative ABC transporter ATP‑binding protein |
RA | USA300TCH1516_ALE | 2,552,031:1 | +G | 7.9% | coding (1211/1734 nt) | USA300HOU_RS13150 ← | putative ABC transporter ATP‑binding protein |
RA | USA300TCH1516_ALE | 2,559,830 | A→G | 8.9% | intergenic (+24/+99) | bcr_2 → / ← USA300HOU_RS13190 | Bicyclomycin resistance protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,559,831 | G→A | 9.1% | intergenic (+25/+98) | bcr_2 → / ← USA300HOU_RS13190 | Bicyclomycin resistance protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,559,840 | T→G | 13.5% | intergenic (+34/+89) | bcr_2 → / ← USA300HOU_RS13190 | Bicyclomycin resistance protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,559,841 | C→A | 14.0% | intergenic (+35/+88) | bcr_2 → / ← USA300HOU_RS13190 | Bicyclomycin resistance protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,559,850 | T→C | 8.9% | intergenic (+44/+79) | bcr_2 → / ← USA300HOU_RS13190 | Bicyclomycin resistance protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,559,851 | C→T | 9.0% | intergenic (+45/+78) | bcr_2 → / ← USA300HOU_RS13190 | Bicyclomycin resistance protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,563,759 | A→G | 10.7% | intergenic (+24/‑114) | cycA_2 → / → nhaK_2 | D‑serine/D‑alanine/glycine transporter/Sodium, potassium, lithium and rubidium/H(+) antiporter |
RA | USA300TCH1516_ALE | 2,563,763 | C→G | 10.9% | intergenic (+28/‑110) | cycA_2 → / → nhaK_2 | D‑serine/D‑alanine/glycine transporter/Sodium, potassium, lithium and rubidium/H(+) antiporter |
RA | USA300TCH1516_ALE | 2,563,767 | C→T | 5.5% | intergenic (+32/‑106) | cycA_2 → / → nhaK_2 | D‑serine/D‑alanine/glycine transporter/Sodium, potassium, lithium and rubidium/H(+) antiporter |
RA | USA300TCH1516_ALE | 2,566,052 | A→G | 7.6% | intergenic (+101/+39) | nhaK_2 → / ← plaP | Sodium, potassium, lithium and rubidium/H(+) antiporter/Low‑affinity putrescine importer PlaP |
RA | USA300TCH1516_ALE | 2,566,055 | A→T | 7.8% | intergenic (+104/+36) | nhaK_2 → / ← plaP | Sodium, potassium, lithium and rubidium/H(+) antiporter/Low‑affinity putrescine importer PlaP |
RA | USA300TCH1516_ALE | 2,566,057 | A→T | 7.5% | intergenic (+106/+34) | nhaK_2 → / ← plaP | Sodium, potassium, lithium and rubidium/H(+) antiporter/Low‑affinity putrescine importer PlaP |
RA | USA300TCH1516_ALE | 2,566,059 | A→T | 7.4% | intergenic (+108/+32) | nhaK_2 → / ← plaP | Sodium, potassium, lithium and rubidium/H(+) antiporter/Low‑affinity putrescine importer PlaP |
RA | USA300TCH1516_ALE | 2,566,062 | C→T | 7.6% | intergenic (+111/+29) | nhaK_2 → / ← plaP | Sodium, potassium, lithium and rubidium/H(+) antiporter/Low‑affinity putrescine importer PlaP |
RA | USA300TCH1516_ALE | 2,566,074 | C→T | 5.5% | intergenic (+123/+17) | nhaK_2 → / ← plaP | Sodium, potassium, lithium and rubidium/H(+) antiporter/Low‑affinity putrescine importer PlaP |
RA | USA300TCH1516_ALE | 2,582,141 | Δ1 bp | 10.3% | coding (1169/1353 nt) | pnbA → | Para‑nitrobenzyl esterase |
RA | USA300TCH1516_ALE | 2,582,146:1 | +A | 10.6% | coding (1174/1353 nt) | pnbA → | Para‑nitrobenzyl esterase |
RA | USA300TCH1516_ALE | 2,608,409 | G→A | 5.6% | intergenic (‑260/‑29) | USA300HOU_RS13435 ← / → USA300TCH1516_02485 | putative oxidoreductase/hypothetical protein |
RA | USA300TCH1516_ALE | 2,608,412 | T→C | 5.7% | intergenic (‑263/‑26) | USA300HOU_RS13435 ← / → USA300TCH1516_02485 | putative oxidoreductase/hypothetical protein |
RA | USA300TCH1516_ALE | 2,608,816 | A→G | 6.3% | intergenic (+97/+163) | USA300TCH1516_02485 → / ← USA300HOU_RS13450 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,608,820 | A→T | 6.1% | intergenic (+101/+159) | USA300TCH1516_02485 → / ← USA300HOU_RS13450 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,608,825 | A→T | 10.1% | intergenic (+106/+154) | USA300TCH1516_02485 → / ← USA300HOU_RS13450 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,611,882 | T→G | 5.8% | intergenic (‑205/+7) | USA300HOU_RS13465 ← / ← USA300TCH1516_02490 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,611,883 | C→A | 5.7% | intergenic (‑206/+6) | USA300HOU_RS13465 ← / ← USA300TCH1516_02490 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,653,200 | A→G | 5.1% | M591V (ATG→GTG) | fbp → | Fructose‑1,6‑bisphosphatase class 3 |
RA | USA300TCH1516_ALE | 2,654,131 | C→G | 8.1% | L132V (CTG→GTG) | USA300HOU_RS13650 → | hypothetical protein |
RA | USA300TCH1516_ALE | 2,654,136 | T→G | 7.4% | F133L (TTT→TTG) | USA300HOU_RS13650 → | hypothetical protein |
RA | USA300TCH1516_ALE | 2,668,300 | G→T | 5.1% | intergenic (‑109/‑442) | USA300HOU_RS13735 ← / → USA300TCH1516_02539 | hypothetical protein/hypothetical protein |
RA | USA300TCH1516_ALE | 2,669,453 | C→T | 5.5% | A118V (GCT→GTT) | yicL → | putative inner membrane transporter YicL |
RA | USA300TCH1516_ALE | 2,669,457 | G→A | 5.4% | A119A (GCG→GCA) | yicL → | putative inner membrane transporter YicL |
RA | USA300TCH1516_ALE | 2,669,460 | T→C | 5.5% | I120I (ATT→ATC) | yicL → | putative inner membrane transporter YicL |
RA | USA300TCH1516_ALE | 2,704,428 | G→C | 6.1% | Q81E (CAA→GAA) | crtM ← | Dehydrosqualene synthase |
RA | USA300TCH1516_ALE | 2,725,352 | A→T | 19.9% | intergenic (‑58/+276) | USA300HOU_RS14015 ← / ← USA300HOU_RS14020 | Baeyer‑Villiger flavin‑containing monooxygenase/hypothetical protein |
RA | USA300TCH1516_ALE | 2,744,200 | G→A | 8.2% | intergenic (+137/+56) | fda → / ← mqo2 | Fructose‑bisphosphate aldolase class 1/putative malate:quinone oxidoreductase 2 |
RA | USA300TCH1516_ALE | 2,744,205 | A→G | 10.8% | intergenic (+142/+51) | fda → / ← mqo2 | Fructose‑bisphosphate aldolase class 1/putative malate:quinone oxidoreductase 2 |
RA | USA300TCH1516_ALE | 2,744,213 | T→A | 14.8% | intergenic (+150/+43) | fda → / ← mqo2 | Fructose‑bisphosphate aldolase class 1/putative malate:quinone oxidoreductase 2 |
RA | USA300TCH1516_ALE | 2,744,226 | T→C | 7.6% | intergenic (+163/+30) | fda → / ← mqo2 | Fructose‑bisphosphate aldolase class 1/putative malate:quinone oxidoreductase 2 |
RA | USA300TCH1516_ALE | 2,745,325 | T→A | 7.8% | N143I (AAT→ATT) | mqo2 ← | putative malate:quinone oxidoreductase 2 |
RA | USA300TCH1516_ALE | 2,774,463 | A→T | 5.0% | intergenic (‑93/+23) | USA300HOU_RS14290 ← / ← clfB | S‑formylglutathione hydrolase/Clumping factor B |
RA | USA300TCH1516_ALE | 2,774,846 | A→G | 5.4% | S780S (AGT→AGC) | clfB ← | Clumping factor B |
RA | USA300TCH1516_ALE | 2,775,053 | A→G | 5.5% | D711D (GAT→GAC) | clfB ← | Clumping factor B |
RA | USA300TCH1516_ALE | 2,833,387 | G→C | 10.3% | intergenic (‑723/+367) | lipA_2 ← / ← hisI | Lipase 1/Phosphoribosyl‑AMP cyclohydrolase |
RA | USA300TCH1516_ALE | 2,840,841 | T→A | 5.4% | intergenic (‑162/+143) | hisZ ← / ← USA300HOU_RS14555 | ATP phosphoribosyltransferase regulatory subunit/hypothetical protein |
Unassigned new junction evidence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | CP000731 | = 64 | 411 (0.740) | 34 (0.100) +33 bp |
16/94 | NT | 22.1% | intergenic (–/‑168) | –/repA | –/replication protein A |
? | CP000731 | = 27041 | 0 (0.000) | intergenic (‑194/–) | USA300HOU_pUSA300HOUMR0033/– | partitioning protein/– | |||||
* | ? | CP000731 | 3772 = | 382 (0.690) | 48 (0.100) | 17/140 | NT | 12.3% | intergenic (+388/‑96) | USA300HOU_pUSA300HOUMR0005/USA300HOU_pUSA300HOUMR0006 | hypothetical protein/hypothetical protein |
? | CP000731 | 3805 = | 353 (0.730) | intergenic (+421/‑63) | USA300HOU_pUSA300HOUMR0005/USA300HOU_pUSA300HOUMR0006 | hypothetical protein/hypothetical protein | |||||
* | ? | CP000731 | = 3781 | 387 (0.700) | 42 (0.090) | 16/140 | NT | 10.8% | intergenic (+397/‑87) | USA300HOU_pUSA300HOUMR0005/USA300HOU_pUSA300HOUMR0006 | hypothetical protein/hypothetical protein |
? | CP000731 | = 3794 | 353 (0.730) | intergenic (+410/‑74) | USA300HOU_pUSA300HOUMR0005/USA300HOU_pUSA300HOUMR0006 | hypothetical protein/hypothetical protein | |||||
* | ? | CP000731 | 7662 = | 457 (0.820) | 55 (0.110) | 14/138 | NT | 12.0% | intergenic (+272/+254) | USA300HOU_pUSA300HOUMR0010/blaZ | MarR family transcriptional regulator/beta‑lactamase |
? | CP000731 | 7700 = | 413 (0.860) | intergenic (+310/+216) | USA300HOU_pUSA300HOUMR0010/blaZ | MarR family transcriptional regulator/beta‑lactamase | |||||
* | ? | CP000731 | = 7672 | 441 (0.790) | 65 (0.140) | 19/138 | NT | 14.1% | intergenic (+282/+244) | USA300HOU_pUSA300HOUMR0010/blaZ | MarR family transcriptional regulator/beta‑lactamase |
? | CP000731 | = 7688 | 413 (0.860) | intergenic (+298/+228) | USA300HOU_pUSA300HOUMR0010/blaZ | MarR family transcriptional regulator/beta‑lactamase | |||||
* | ? | CP000731 | 11093 = | 571 (1.030) | 64 (0.130) | 28/146 | NT | 11.5% | intergenic (+98/‑166) | blaI/USA300HOU_pUSA300HOUMR0014 | beta‑lactamase regulator BlaI/recombinase |
? | CP000731 | 11129 = | 465 (0.920) | intergenic (+134/‑130) | blaI/USA300HOU_pUSA300HOUMR0014 | beta‑lactamase regulator BlaI/recombinase | |||||
* | ? | CP000731 | 11951 = | 542 (0.970) | 46 (0.100) | 18/134 | NT | 9.9% | intergenic (+114/+109) | USA300HOU_pUSA300HOUMR0014/USA300HOU_pUSA300HOUMR0015 | recombinase/hypothetical protein |
? | CP000731 | 11987 = | 386 (0.830) | intergenic (+150/+73) | USA300HOU_pUSA300HOUMR0014/USA300HOU_pUSA300HOUMR0015 | recombinase/hypothetical protein | |||||
* | ? | CP000731 | 12561 = | NA (NA) | 30 (0.060) | 6/148 | NT | NA | coding (55/675 nt) | USA300HOU_pUSA300HOUMR0016 | IS257 transposase |
? | CP000731 | = 17010 | NA (NA) | coding (52/675 nt) | USA300HOU_pUSA300HOUMR0021 | IS431 mec transposase | |||||
* | ? | CP000731 | = 17001 | NA (NA) | 32 (0.060) | 16/148 | NT | 100% | coding (61/675 nt) | USA300HOU_pUSA300HOUMR0021 | IS431 mec transposase |
? | CP000731 | = 17016 | 0 (0.000) | coding (46/675 nt) | USA300HOU_pUSA300HOUMR0021 | IS431 mec transposase | |||||
* | ? | CP000731 | 17189 = | 357 (0.640) | 32 (0.070) | 13/138 | NT | 9.3% | intergenic (‑128/+119) | USA300HOU_pUSA300HOUMR0021/USA300HOU_pUSA300HOUMR0023 | IS431 mec transposase/bacitracin ABC ATP binding cassette transporter, membrane protein |
? | CP000731 | 17225 = | 319 (0.670) | intergenic (‑164/+83) | USA300HOU_pUSA300HOUMR0021/USA300HOU_pUSA300HOUMR0023 | IS431 mec transposase/bacitracin ABC ATP binding cassette transporter, membrane protein | |||||
* | ? | CP000731 | = 17199 | 350 (0.630) | 20 (0.040) | 10/138 | NT | 6.1% | intergenic (‑138/+109) | USA300HOU_pUSA300HOUMR0021/USA300HOU_pUSA300HOUMR0023 | IS431 mec transposase/bacitracin ABC ATP binding cassette transporter, membrane protein |
? | CP000731 | = 17213 | 319 (0.670) | intergenic (‑152/+95) | USA300HOU_pUSA300HOUMR0021/USA300HOU_pUSA300HOUMR0023 | IS431 mec transposase/bacitracin ABC ATP binding cassette transporter, membrane protein | |||||
* | ? | CP000731 | 20439 = | 547 (0.980) | 63 (0.120) | 19/148 | NT | 11.6% | coding (632/675 nt) | USA300HOU_pUSA300HOUMR0027 | IS431mec transposase |
? | CP000731 | 20463 = | 457 (0.890) | coding (608/675 nt) | USA300HOU_pUSA300HOUMR0027 | IS431mec transposase | |||||
* | ? | CP000731 | = 22941 | 475 (0.850) | 23 (0.050) | 13/146 | NT | 5.0% | coding (1398/1467 nt) | USA300HOU_pUSA300HOUMR0028 | macrolide transporter |
? | CP000731 | = 22955 | 440 (0.870) | coding (1412/1467 nt) | USA300HOU_pUSA300HOUMR0028 | macrolide transporter | |||||
* | ? | CP000731 | 25265 = | 344 (0.620) | 19 (0.050) | 13/114 | NT | 6.8% | intergenic (+163/‑83) | USA300HOU_pUSA300HOUMR0030/USA300HOU_pUSA300HOUMR0031 | Sin recombinase/hypothetical protein |
? | CP000731 | 25334 = | 275 (0.700) | intergenic (+232/‑14) | USA300HOU_pUSA300HOUMR0030/USA300HOU_pUSA300HOUMR0031 | Sin recombinase/hypothetical protein | |||||
* | ? | CP000731 | = 25287 | 319 (0.570) | 24 (0.060) | 15/114 | NT | 8.7% | intergenic (+185/‑61) | USA300HOU_pUSA300HOUMR0030/USA300HOU_pUSA300HOUMR0031 | Sin recombinase/hypothetical protein |
? | CP000731 | = 25310 | 275 (0.700) | intergenic (+208/‑38) | USA300HOU_pUSA300HOUMR0030/USA300HOU_pUSA300HOUMR0031 | Sin recombinase/hypothetical protein | |||||
* | ? | CP000731 | 25306 = | 268 (0.480) | 42 (0.090) | 16/138 | NT | 15.9% | intergenic (+204/‑42) | USA300HOU_pUSA300HOUMR0030/USA300HOU_pUSA300HOUMR0031 | Sin recombinase/hypothetical protein |
? | CP000731 | 25340 = | 213 (0.440) | intergenic (+238/‑8) | USA300HOU_pUSA300HOUMR0030/USA300HOU_pUSA300HOUMR0031 | Sin recombinase/hypothetical protein | |||||
* | ? | NC_012417 | = 500 | 9402 (0.790) | 465 (0.040) | 32/148 | NT | 5.1% | pseudogene (221/709 nt) | USA300HOU_RS14890 | replication protein |
? | NC_012417 | = 511 | 8702 (0.790) | pseudogene (232/709 nt) | USA300HOU_RS14890 | replication protein | |||||
* | ? | NC_012417 | 987 = | 5283 (0.440) | 1068 (0.100) | 42/138 | NT | 20.4% | pseudogene (708/709 nt) | USA300HOU_RS14890 | replication protein |
? | NC_012417 | 1013 = | 3792 (0.370) | coding (182/192 nt) | USA300HOU_RS15665 | hypothetical protein | |||||
* | ? | NC_012417 | = 997 | 4675 (0.390) | 627 (0.060) | 57/138 | NT | 13.8% | intergenic (+9/+6) | USA300HOU_RS14890/USA300HOU_RS15665 | replication protein/hypothetical protein |
? | NC_012417 | = 1001 | 3792 (0.370) | intergenic (+13/+2) | USA300HOU_RS14890/USA300HOU_RS15665 | replication protein/hypothetical protein | |||||
* | ? | NC_012417 | 1040 = | 1454 (0.120) | 291 (0.030) | 36/124 | NT | 15.8% | coding (155/192 nt) | USA300HOU_RS15665 | hypothetical protein |
? | NC_012417 | 1090 = | 1977 (0.210) | coding (105/192 nt) | USA300HOU_RS15665 | hypothetical protein | |||||
* | ? | NC_012417 | = 1057 | 1423 (0.120) | 488 (0.050) | 49/124 | NT | 24.1% | coding (138/192 nt) | USA300HOU_RS15665 | hypothetical protein |
? | NC_012417 | = 1071 | 1977 (0.210) | coding (124/192 nt) | USA300HOU_RS15665 | hypothetical protein | |||||
* | ? | NC_012417 | = 1195 | 7491 (0.630) | 676 (0.060) | 40/144 | NT | 8.4% | intergenic (‑1/‑384) | USA300HOU_RS15665/USA300HOU_RS14895 | hypothetical protein/hypothetical protein |
? | NC_012417 | = 1199 | 8040 (0.750) | intergenic (‑5/‑380) | USA300HOU_RS15665/USA300HOU_RS14895 | hypothetical protein/hypothetical protein | |||||
* | ? | NC_012417 | = 1974 | 3470 (0.290) | 227 (0.020) | 23/138 | NT | 7.1% | intergenic (+207/+119) | USA300HOU_RS14895/USA300HOU_RS14900 | hypothetical protein/hypothetical protein |
? | NC_012417 | = 2041 | NA (NA) | intergenic (+274/+52) | USA300HOU_RS14895/USA300HOU_RS14900 | hypothetical protein/hypothetical protein | |||||
* | ? | NC_012417 | 1975 = | NA (NA) | 504 (0.050) | 23/138 | NT | 14.9% | intergenic (+208/+118) | USA300HOU_RS14895/USA300HOU_RS14900 | hypothetical protein/hypothetical protein |
? | NC_012417 | 2042 = | 3344 (0.280) | intergenic (+275/+51) | USA300HOU_RS14895/USA300HOU_RS14900 | hypothetical protein/hypothetical protein | |||||
* | ? | NC_012417 | = 1982 | 2634 (0.220) | 334 (0.030) | 32/146 | NT | 11.1% | intergenic (+215/+111) | USA300HOU_RS14895/USA300HOU_RS14900 | hypothetical protein/hypothetical protein |
? | NC_012417 | = 2027 | 2928 (0.270) | intergenic (+260/+66) | USA300HOU_RS14895/USA300HOU_RS14900 | hypothetical protein/hypothetical protein | |||||
* | ? | NC_012417 | = 1983 | 2631 (0.220) | 172 (0.010) | 26/154 | NT | 6.3% | intergenic (+216/+110) | USA300HOU_RS14895/USA300HOU_RS14900 | hypothetical protein/hypothetical protein |
? | NC_012417 | = 1995 | 2596 (0.230) | intergenic (+228/+98) | USA300HOU_RS14895/USA300HOU_RS14900 | hypothetical protein/hypothetical protein | |||||
* | ? | NC_012417 | 1983 = | NA (NA) | 277 (0.030) | 25/146 | NT | 9.4% | intergenic (+216/+110) | USA300HOU_RS14895/USA300HOU_RS14900 | hypothetical protein/hypothetical protein |
? | NC_012417 | 2028 = | 2928 (0.240) | intergenic (+261/+65) | USA300HOU_RS14895/USA300HOU_RS14900 | hypothetical protein/hypothetical protein | |||||
* | ? | NC_012417 | = 1997 | 2604 (0.220) | 132 (0.010) | 20/148 | NT | 5.8% | intergenic (+230/+96) | USA300HOU_RS14895/USA300HOU_RS14900 | hypothetical protein/hypothetical protein |
? | NC_012417 | = 2014 | 1871 (0.170) | intergenic (+247/+79) | USA300HOU_RS14895/USA300HOU_RS14900 | hypothetical protein/hypothetical protein | |||||
* | ? | NC_012417 | 2133 = | 7289 (0.610) | 380 (0.030) | 41/148 | NT | 5.2% | coding (542/582 nt) | USA300HOU_RS14900 | hypothetical protein |
? | NC_012417 | 2167 = | 7181 (0.650) | coding (508/582 nt) | USA300HOU_RS14900 | hypothetical protein | |||||
* | ? | NC_012417 | = 2148 | 7684 (0.640) | 417 (0.040) | 29/148 | NT | 5.5% | coding (527/582 nt) | USA300HOU_RS14900 | hypothetical protein |
? | NC_012417 | = 2154 | 7365 (0.670) | coding (521/582 nt) | USA300HOU_RS14900 | hypothetical protein | |||||
* | ? | NC_012417 | = 2937 | 9008 (0.750) | 1313 (0.120) | 59/150 | NT | 13.3% | intergenic (‑263/–) | USA300HOU_RS14900/– | hypothetical protein/– |
? | NC_012417 | = 2949 | 8679 (0.770) | intergenic (‑275/–) | USA300HOU_RS14900/– | hypothetical protein/– | |||||
* | ? | NC_012417 | = 3077 | 3566 (0.300) | 189 (0.020) | 21/146 | NT | 8.7% | intergenic (‑403/–) | USA300HOU_RS14900/– | hypothetical protein/– |
? | NC_012417 | = 3108 | 716 (0.070) | intergenic (‑434/–) | USA300HOU_RS14900/– | hypothetical protein/– | |||||
* | ? | USA300TCH1516_ALE | = 2161 | 198 (1.040) | 23 (0.130) | 14/152 | NT | 10.3% | intergenic (+256/‑22) | dnaA/dnaN | Chromosomal replication initiator protein DnaA/DNA polymerase III subunit beta |
? | USA300TCH1516_ALE | = 2172 | 214 (1.180) | intergenic (+267/‑11) | dnaA/dnaN | Chromosomal replication initiator protein DnaA/DNA polymerase III subunit beta | |||||
* | ? | USA300TCH1516_ALE | = 29630 | 182 (0.960) | 22 (0.130) | 13/142 | NT | 11.4% | intergenic (+22/‑368) | yycI/yycJ | Two‑component system WalR/WalK regulatory protein YycI/Putative metallo‑hydrolase YycJ |
? | USA300TCH1516_ALE | = 29658 | 182 (1.080) | intergenic (+50/‑340) | yycI/yycJ | Two‑component system WalR/WalK regulatory protein YycI/Putative metallo‑hydrolase YycJ | |||||
* | ? | USA300TCH1516_ALE | 42499 = | 208 (1.090) | 18 (0.120) | 13/124 | NT | 12.3% | coding (1467/1524 nt) | USA300TCH1516_00035 | hypothetical protein |
? | USA300TCH1516_ALE | 42544 = | 97 (0.660) | coding (1422/1524 nt) | USA300TCH1516_00035 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 42564 = | 92 (0.480) | 70 (0.490) +TACATTATAAAATACATATC |
13/120 | NT | 50.5% | coding (1402/1524 nt) | USA300TCH1516_00035 | hypothetical protein |
? | USA300TCH1516_ALE | 1803072 = | NA (NA) | coding (796/807 nt) | USA300HOU_RS12765 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 46314 | 204 (1.070) | 12 (0.060) | 9/156 | NT | 5.3% | coding (1207/1629 nt) | hin_1 | DNA‑invertase hin |
? | USA300TCH1516_ALE | = 46361 | 228 (1.230) | coding (1160/1629 nt) | hin_1 | DNA‑invertase hin | |||||
* | ? | USA300TCH1516_ALE | 68500 = | NA (NA) | 7 (0.040) | 7/154 | NT | 5.7% | coding (616/852 nt) | USA300TCH1516_00061 | hypothetical protein |
? | USA300TCH1516_ALE | 68542 = | 120 (0.630) | coding (658/852 nt) | USA300TCH1516_00061 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 75971 = | 237 (1.240) | 25 (0.160) | 12/128 | NT | 13.3% | intergenic (+29/‑244) | USA300HOU_RS00335/USA300HOU_RS00140 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 76020 = | 136 (0.900) | intergenic (+78/‑195) | USA300HOU_RS00335/USA300HOU_RS00140 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 77142 | 208 (1.090) | 12 (0.070) | 10/140 | NT | 5.9% | coding (67/816 nt) | USA300HOU_RS00350 | Monoacylglycerol lipase |
? | USA300TCH1516_ALE | = 77155 | 203 (1.220) | coding (80/816 nt) | USA300HOU_RS00350 | Monoacylglycerol lipase | |||||
* | ? | USA300TCH1516_ALE | 88662 = | 238 (1.250) | 10 (0.070) | 6/126 | NT | 5.7% | intergenic (+35/‑730) | nusG_1/USA300TCH1516_00080 | Transcription termination/antitermination protein NusG/hypothetical protein |
? | USA300TCH1516_ALE | 88722 = | 143 (0.960) | intergenic (+95/‑670) | nusG_1/USA300TCH1516_00080 | Transcription termination/antitermination protein NusG/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 102238 = | 191 (1.000) | 10 (0.060) | 8/142 | NT | 5.6% | intergenic (+224/+131) | gltR/USA300HOU_RS00485 | HTH‑type transcriptional regulator GltR/hypothetical protein |
? | USA300TCH1516_ALE | 102291 = | 169 (1.000) | intergenic (+277/+78) | gltR/USA300HOU_RS00485 | HTH‑type transcriptional regulator GltR/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 110682 | 232 (1.220) | 17 (0.100) | 8/150 | NT | 6.6% | coding (541/771 nt) | USA300HOU_RS00515 | putative lipoprotein |
? | USA300TCH1516_ALE | = 110687 | 260 (1.460) | coding (546/771 nt) | USA300HOU_RS00515 | putative lipoprotein | |||||
* | ? | USA300TCH1516_ALE | = 110692 | 280 (1.470) | 13 (0.070) | 5/150 | NT | 5.4% | coding (551/771 nt) | USA300HOU_RS00515 | putative lipoprotein |
? | USA300TCH1516_ALE | = 112333 | 192 (1.080) | coding (536/771 nt) | USA300HOU_RS00525 | putative lipoprotein | |||||
* | ? | USA300TCH1516_ALE | = 127847 | 137 (0.720) | 17 (0.100) | 11/138 | NT | 11.3% | intergenic (+67/+262) | lctP_1/spa | L‑lactate permease/Immunoglobulin G‑binding protein A |
? | USA300TCH1516_ALE | = 127871 | 149 (0.910) | intergenic (+91/+238) | lctP_1/spa | L‑lactate permease/Immunoglobulin G‑binding protein A | |||||
* | ? | USA300TCH1516_ALE | 141111 = | 158 (0.830) | 22 (0.130) | 9/146 | NT | 14.5% | coding (36/1779 nt) | iucC_2 | Aerobactin synthase |
? | USA300TCH1516_ALE | 141138 = | 116 (0.670) | coding (63/1779 nt) | iucC_2 | Aerobactin synthase | |||||
* | ? | USA300TCH1516_ALE | = 145658 | 178 (0.930) | 9 (0.050) | 6/140 | NT | 5.3% | intergenic (+83/‑113) | noc_1/USA300HOU_RS00655 | Nucleoid occlusion protein/hypothetical protein |
? | USA300TCH1516_ALE | = 145678 | 165 (0.990) | intergenic (+103/‑93) | noc_1/USA300HOU_RS00655 | Nucleoid occlusion protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 147873 | 148 (0.780) | 10 (0.060) | 6/142 | NT | 6.5% | intergenic (+31/‑314) | butA/wbgU | Diacetyl reductase [(S)‑acetoin forming]/UDP‑N‑acetylglucosamine 4‑epimerase |
? | USA300TCH1516_ALE | = 147897 | 158 (0.940) | intergenic (+55/‑290) | butA/wbgU | Diacetyl reductase [(S)‑acetoin forming]/UDP‑N‑acetylglucosamine 4‑epimerase | |||||
* | ? | USA300TCH1516_ALE | 161003 = | 186 (0.980) | 18 (0.120) | 10/124 | NT | 12.3% | intergenic (+17/+114) | deoB/phnE_1 | Phosphopentomutase/Phosphate‑import permease protein PhnE |
? | USA300TCH1516_ALE | 161059 = | 113 (0.770) | intergenic (+73/+58) | deoB/phnE_1 | Phosphopentomutase/Phosphate‑import permease protein PhnE | |||||
* | ? | USA300TCH1516_ALE | 181969 = | 199 (1.040) | 16 (0.090) | 10/150 | NT | 8.1% | coding (32/1110 nt) | glgA | Glycogen synthase |
? | USA300TCH1516_ALE | 181998 = | 178 (1.000) | coding (61/1110 nt) | glgA | Glycogen synthase | |||||
* | ? | USA300TCH1516_ALE | 260284 = | 171 (0.900) | 10 (0.060) | 9/138 | NT | 6.8% | intergenic (‑398/‑190) | potD_1/pflB | Spermidine/putrescine‑binding periplasmic protein/Formate acetyltransferase |
? | USA300TCH1516_ALE | 260324 = | 129 (0.790) | intergenic (‑438/‑150) | potD_1/pflB | Spermidine/putrescine‑binding periplasmic protein/Formate acetyltransferase | |||||
* | ? | USA300TCH1516_ALE | 278631 = | 206 (1.080) | 30 (0.180) | 15/140 | NT | 16.5% | intergenic (+226/+88) | USA300HOU_RS01215/gsiB | hypothetical protein/Glutathione‑binding protein GsiB |
? | USA300TCH1516_ALE | 278672 = | 124 (0.750) | intergenic (+267/+47) | USA300HOU_RS01215/gsiB | hypothetical protein/Glutathione‑binding protein GsiB | |||||
* | ? | USA300TCH1516_ALE | = 280894 | 202 (1.060) | 18 (0.110) +TTAATTGGGAGTA |
7/134 | NT | 10.5% | intergenic (‑146/+11) | USA300HOU_RS01225/USA300HOU_RS01230 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 855632 = | 165 (0.870) | intergenic (+163/‑597) | zipA_1/cggR | Cell division protein ZipA/Central glycolytic genes regulator | |||||
* | ? | USA300TCH1516_ALE | = 282679 | 139 (0.730) | 13 (0.080) | 9/140 | NT | 8.7% | intergenic (‑430/‑143) | hmp/ldh1 | Flavohemoprotein/L‑lactate dehydrogenase 1 |
? | USA300TCH1516_ALE | = 282694 | 150 (0.900) | intergenic (‑445/‑128) | hmp/ldh1 | Flavohemoprotein/L‑lactate dehydrogenase 1 | |||||
* | ? | USA300TCH1516_ALE | 309797 = | 182 (0.960) | 10 (0.060) | 9/134 | NT | 7.8% | intergenic (+54/+54) | lrgB/yydK | Antiholin‑like protein LrgB/putative HTH‑type transcriptional regulator YydK |
? | USA300TCH1516_ALE | 309842 = | 86 (0.540) | intergenic (+99/+9) | lrgB/yydK | Antiholin‑like protein LrgB/putative HTH‑type transcriptional regulator YydK | |||||
* | ? | USA300TCH1516_ALE | = 311196 | 163 (0.860) | 15 (0.090) | 9/148 | NT | 8.8% | coding (493/792 nt) | ptsG_3 | PTS system glucose‑specific EIICBA component |
? | USA300TCH1516_ALE | = 311222 | 159 (0.900) | coding (519/792 nt) | ptsG_3 | PTS system glucose‑specific EIICBA component | |||||
* | ? | USA300TCH1516_ALE | 326015 = | 176 (0.920) | 20 (0.120) | 13/142 | NT | 11.8% | intergenic (‑19/+49) | USA300HOU_RS01460/USA300HOU_RS01465 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 326051 = | 143 (0.850) | intergenic (‑55/+13) | USA300HOU_RS01460/USA300HOU_RS01465 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 329202 = | 181 (0.950) | 28 (0.170) | 13/140 | NT | 15.1% | intergenic (+70/+73) | USA300HOU_RS01475/ssaA2_1 | hypothetical protein/Staphylococcal secretory antigen ssaA2 |
? | USA300TCH1516_ALE | 329255 = | 158 (0.950) | intergenic (+123/+20) | USA300HOU_RS01475/ssaA2_1 | hypothetical protein/Staphylococcal secretory antigen ssaA2 | |||||
* | ? | USA300TCH1516_ALE | = 329211 | 183 (0.960) | 30 (0.180) | 17/140 | NT | 15.9% | intergenic (+79/+64) | USA300HOU_RS01475/ssaA2_1 | hypothetical protein/Staphylococcal secretory antigen ssaA2 |
? | USA300TCH1516_ALE | = 329244 | 158 (0.950) | intergenic (+112/+31) | USA300HOU_RS01475/ssaA2_1 | hypothetical protein/Staphylococcal secretory antigen ssaA2 | |||||
* | ? | USA300TCH1516_ALE | = 344445 | 212 (1.110) | 20 (0.130) +ACATTAAGATAGTTTA |
8/128 | NT | 10.7% | intergenic (+44/‑164) | yezG_1/USA300HOU_RS01545 | putative antitoxin YezG/hypothetical protein |
? | USA300TCH1516_ALE | = 348041 | 206 (1.080) | coding (288/300 nt) | yezG_1 | putative antitoxin YezG | |||||
* | ? | USA300TCH1516_ALE | 349720 = | 193 (1.010) | 12 (0.070) | 8/142 | NT | 7.5% | intergenic (+272/‑314) | USA300HOU_RS01580/yezG_6 | hypothetical protein/putative antitoxin YezG |
? | USA300TCH1516_ALE | 349754 = | 125 (0.740) | intergenic (+306/‑280) | USA300HOU_RS01580/yezG_6 | hypothetical protein/putative antitoxin YezG | |||||
* | ? | USA300TCH1516_ALE | = 356004 | 159 (0.830) | 16 (0.090) | 10/148 | NT | 9.4% | coding (696/1308 nt) | brnQ_2 | Branched‑chain amino acid transport system 2 carrier protein |
? | USA300TCH1516_ALE | = 356029 | 160 (0.910) | coding (671/1308 nt) | brnQ_2 | Branched‑chain amino acid transport system 2 carrier protein | |||||
* | ? | USA300TCH1516_ALE | 365029 = | 140 (0.730) | 19 (0.120) | 13/136 | NT | 13.3% | intergenic (+39/+66) | nupC_1/sglT | Nucleoside permease NupC/Sodium/glucose cotransporter |
? | USA300TCH1516_ALE | 365083 = | 128 (0.790) | intergenic (+93/+12) | nupC_1/sglT | Nucleoside permease NupC/Sodium/glucose cotransporter | |||||
* | ? | USA300TCH1516_ALE | = 365040 | 144 (0.760) | 15 (0.090) | 11/136 | NT | 10.7% | intergenic (+50/+55) | nupC_1/sglT | Nucleoside permease NupC/Sodium/glucose cotransporter |
? | USA300TCH1516_ALE | = 365070 | 128 (0.790) | intergenic (+80/+25) | nupC_1/sglT | Nucleoside permease NupC/Sodium/glucose cotransporter | |||||
* | ? | USA300TCH1516_ALE | = 371234 | 159 (0.830) | 28 (0.160) | 14/150 | NT | 14.9% | coding (707/1362 nt) | ylbJ | Sporulation integral membrane protein YlbJ |
? | USA300TCH1516_ALE | = 371261 | 171 (0.960) | coding (680/1362 nt) | ylbJ | Sporulation integral membrane protein YlbJ | |||||
* | ? | USA300TCH1516_ALE | 374491 = | 136 (0.710) | 16 (0.090) | 11/144 | NT | 11.1% | intergenic (+109/+133) | lip2/USA300HOU_RS01705 | Lipase 2/hypothetical protein |
? | USA300TCH1516_ALE | 374527 = | 135 (0.790) | intergenic (+145/+97) | lip2/USA300HOU_RS01705 | Lipase 2/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 374498 | 141 (0.740) | 27 (0.160) | 14/144 | NT | 17.1% | intergenic (+116/+126) | lip2/USA300HOU_RS01705 | Lipase 2/hypothetical protein |
? | USA300TCH1516_ALE | = 374518 | 135 (0.790) | intergenic (+136/+106) | lip2/USA300HOU_RS01705 | Lipase 2/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 393589 = | 139 (0.730) | 21 (0.120) | 12/142 | NT | 14.0% | intergenic (+12/+48) | USA300HOU_RS01800/USA300HOU_RS01805 | NAD(P)H‑dependent FAD/FMN reductase/hypothetical protein |
? | USA300TCH1516_ALE | 393631 = | 135 (0.800) | intergenic (+54/+6) | USA300HOU_RS01800/USA300HOU_RS01805 | NAD(P)H‑dependent FAD/FMN reductase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 393597 | 136 (0.710) | 11 (0.070) | 6/142 | NT | 7.9% | intergenic (+20/+40) | USA300HOU_RS01800/USA300HOU_RS01805 | NAD(P)H‑dependent FAD/FMN reductase/hypothetical protein |
? | USA300TCH1516_ALE | = 393621 | 135 (0.800) | intergenic (+44/+16) | USA300HOU_RS01800/USA300HOU_RS01805 | NAD(P)H‑dependent FAD/FMN reductase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 412131 = | 181 (0.950) | 13 (0.080) | 8/144 | NT | 7.6% | coding (1028/1161 nt) | metC | Cystathionine beta‑lyase MetC |
? | USA300TCH1516_ALE | 412165 = | 152 (0.890) | coding (994/1161 nt) | metC | Cystathionine beta‑lyase MetC | |||||
* | ? | USA300TCH1516_ALE | 414290 = | 183 (0.960) | 16 (0.090) | 8/148 | NT | 8.4% | intergenic (‑32/‑632) | metI/spo0C | Cystathionine gamma‑synthase/O‑acetylhomoserine (thiol)‑lyase/Chromosome‑partitioning protein Spo0J |
? | USA300TCH1516_ALE | 414341 = | 181 (1.030) | intergenic (‑83/‑581) | metI/spo0C | Cystathionine gamma‑synthase/O‑acetylhomoserine (thiol)‑lyase/Chromosome‑partitioning protein Spo0J | |||||
* | ? | USA300TCH1516_ALE | = 422512 | 181 (0.950) | 21 (0.130) | 8/136 | NT | 11.4% | coding (581/612 nt) | USA300HOU_RS01965 | hypothetical protein |
? | USA300TCH1516_ALE | = 422533 | 174 (1.080) | coding (602/612 nt) | USA300HOU_RS01965 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 425019 | 204 (1.070) | 14 (0.080) | 10/146 | NT | 6.7% | intergenic (+34/‑392) | USA300HOU_RS01985/gpmA_1 | hypothetical protein/2,3‑bisphosphoglycerate‑dependent phosphoglycerate mutase |
? | USA300TCH1516_ALE | = 425031 | 207 (1.190) | intergenic (+46/‑380) | USA300HOU_RS01985/gpmA_1 | hypothetical protein/2,3‑bisphosphoglycerate‑dependent phosphoglycerate mutase | |||||
* | ? | USA300TCH1516_ALE | 426001 = | 221 (1.160) | 12 (0.070) | 7/140 | NT | 6.1% | intergenic (+9/+57) | gpmA_1/USA300HOU_RS02000 | 2,3‑bisphosphoglycerate‑dependent phosphoglycerate mutase/hypothetical protein |
? | USA300TCH1516_ALE | 426042 = | 177 (1.060) | intergenic (+50/+16) | gpmA_1/USA300HOU_RS02000 | 2,3‑bisphosphoglycerate‑dependent phosphoglycerate mutase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 435390 = | 184 (0.970) | 18 (0.110) | 12/144 | NT | 10.9% | intergenic (‑86/+57) | USA300HOU_RS02045/USA300HOU_RS02050 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 435420 = | 130 (0.760) | intergenic (‑116/+27) | USA300HOU_RS02045/USA300HOU_RS02050 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 441303 | 165 (0.870) | 24 (0.140) | 17/142 | NT | 13.8% | intergenic (+20/+93) | guaA/USA300HOU_RS02075 | GMP synthase [glutamine‑hydrolyzing]/hypothetical protein |
? | USA300TCH1516_ALE | = 441313 | 154 (0.910) | intergenic (+30/+83) | guaA/USA300HOU_RS02075 | GMP synthase [glutamine‑hydrolyzing]/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 478764 | 134 (0.700) | 7 (0.040) | 6/140 | NT | 5.3% | coding (1288/1485 nt) | nuoL | NADH‑quinone oxidoreductase subunit L |
? | USA300TCH1516_ALE | = 478800 | 132 (0.790) | coding (1324/1485 nt) | nuoL | NADH‑quinone oxidoreductase subunit L | |||||
* | ? | USA300TCH1516_ALE | = 482264 | 125 (0.660) | 19 (0.110) | 8/146 | NT | 14.0% | intergenic (+61/‑622) | USA300HOU_RS02285/USA300HOU_RS02295 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 482286 | 119 (0.690) | intergenic (+83/‑600) | USA300HOU_RS02285/USA300HOU_RS02295 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 492708 = | 102 (0.540) | 23 (0.150) | 10/128 | NT | 20.6% | intergenic (+130/+55) | sle1_1/USA300HOU_RS02345 | N‑acetylmuramoyl‑L‑alanine amidase sle1/hypothetical protein |
? | USA300TCH1516_ALE | 492758 = | 96 (0.630) | intergenic (+180/+5) | sle1_1/USA300HOU_RS02345 | N‑acetylmuramoyl‑L‑alanine amidase sle1/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 492723 | 99 (0.520) | 29 (0.190) | 16/128 | NT | 24.9% | intergenic (+145/+40) | sle1_1/USA300HOU_RS02345 | N‑acetylmuramoyl‑L‑alanine amidase sle1/hypothetical protein |
? | USA300TCH1516_ALE | = 492741 | 96 (0.630) | intergenic (+163/+22) | sle1_1/USA300HOU_RS02345 | N‑acetylmuramoyl‑L‑alanine amidase sle1/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 494152 = | 175 (0.920) | 22 (0.130) | 11/142 | NT | 13.3% | intergenic (+101/+68) | bltD_1/USA300HOU_RS02360 | Spermine/spermidine acetyltransferase/hypothetical protein |
? | USA300TCH1516_ALE | 494194 = | 133 (0.790) | intergenic (+143/+26) | bltD_1/USA300HOU_RS02360 | Spermine/spermidine acetyltransferase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 511377 = | 165 (0.870) | 12 (0.070) | 10/146 | NT | 7.6% | coding (42/597 nt) | recR | Recombination protein RecR |
? | USA300TCH1516_ALE | 511430 = | 143 (0.820) | coding (95/597 nt) | recR | Recombination protein RecR | |||||
* | ? | USA300TCH1516_ALE | = 511978 | 156 (0.820) | 19 (0.110) | 13/150 | NT | 11.4% | intergenic (+46/‑6717) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
? | USA300TCH1516_ALE | = 511998 | 150 (0.840) | intergenic (+66/‑6697) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase | |||||
* | ? | USA300TCH1516_ALE | = 515946 | NA (NA) | 12 (0.070) | 8/146 | NT | NA | intergenic (+4014/‑2749) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
? | USA300TCH1516_ALE | = 515981 | NA (NA) | intergenic (+4049/‑2714) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase | |||||
* | ? | USA300TCH1516_ALE | = 518607 | 161 (0.850) | 14 (0.080) | 8/142 | NT | 8.0% | intergenic (+6675/‑88) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
? | USA300TCH1516_ALE | = 518622 | 180 (1.070) | intergenic (+6690/‑73) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase | |||||
* | ? | USA300TCH1516_ALE | 553211 = | 179 (0.940) | 10 (0.060) | 5/138 | NT | 6.7% | coding (182/477 nt) | folK | 2‑amino‑4‑hydroxy‑6‑ hydroxymethyldihydropteridine pyrophosphokinase |
? | USA300TCH1516_ALE | 553257 = | 124 (0.760) | coding (228/477 nt) | folK | 2‑amino‑4‑hydroxy‑6‑ hydroxymethyldihydropteridine pyrophosphokinase | |||||
* | ? | USA300TCH1516_ALE | = 557240 | NA (NA) | 19 (0.110) | 9/152 | NT | NA | intergenic (+298/‑1471) | USA300TCH1516_00504/USA300TCH1516_00505 | tRNA‑Ala/tRNA‑Ile |
? | USA300TCH1516_ALE | = 557277 | NA (NA) | intergenic (+335/‑1434) | USA300TCH1516_00504/USA300TCH1516_00505 | tRNA‑Ala/tRNA‑Ile | |||||
* | ? | USA300TCH1516_ALE | 598632 = | 200 (1.050) | 12 (0.080) | 8/124 | NT | 8.4% | intergenic (+181/+101) | tuf/yxeP_2 | Elongation factor Tu/putative hydrolase YxeP |
? | USA300TCH1516_ALE | 598687 = | 107 (0.730) | intergenic (+236/+46) | tuf/yxeP_2 | Elongation factor Tu/putative hydrolase YxeP | |||||
* | ? | USA300TCH1516_ALE | 598636 = | 202 (1.060) | 20 (0.130) | 8/132 | NT | 11.5% | intergenic (+185/+97) | tuf/yxeP_2 | Elongation factor Tu/putative hydrolase YxeP |
? | USA300TCH1516_ALE | = 974254 | 143 (0.910) | intergenic (+97/‑450) | mrp/oatA_1 | Iron‑sulfur cluster carrier protein/O‑acetyltransferase OatA | |||||
* | ? | USA300TCH1516_ALE | 633311 = | 143 (0.750) | 16 (0.100) | 12/134 | NT | 10.8% | intergenic (+35/‑509) | proP/yhfT | Proline/betaine transporter/putative acyl‑‑CoA ligase YhfT |
? | USA300TCH1516_ALE | 633354 = | 146 (0.920) | intergenic (+78/‑466) | proP/yhfT | Proline/betaine transporter/putative acyl‑‑CoA ligase YhfT | |||||
* | ? | USA300TCH1516_ALE | = 633323 | 138 (0.720) | 17 (0.110) | 11/134 | NT | 11.5% | intergenic (+47/‑497) | proP/yhfT | Proline/betaine transporter/putative acyl‑‑CoA ligase YhfT |
? | USA300TCH1516_ALE | = 633340 | 146 (0.920) | intergenic (+64/‑480) | proP/yhfT | Proline/betaine transporter/putative acyl‑‑CoA ligase YhfT | |||||
* | ? | USA300TCH1516_ALE | 641988 = | 198 (1.040) | 17 (0.100) | 13/144 | NT | 9.2% | intergenic (+7/+135) | yhdG_1/USA300HOU_RS03060 | putative amino acid permease YhdG/hypothetical protein |
? | USA300TCH1516_ALE | 642033 = | 157 (0.920) | intergenic (+52/+90) | yhdG_1/USA300HOU_RS03060 | putative amino acid permease YhdG/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 646656 = | 224 (1.180) | 23 (0.140) | 10/140 | NT | 11.5% | intergenic (+10/‑577) | lipL/galK | Octanoyl‑[GcvH]:protein N‑octanoyltransferase/Galactokinase |
? | USA300TCH1516_ALE | 646692 = | 159 (0.960) | intergenic (+46/‑541) | lipL/galK | Octanoyl‑[GcvH]:protein N‑octanoyltransferase/Galactokinase | |||||
* | ? | USA300TCH1516_ALE | 650751 = | 209 (1.100) | 27 (0.150) | 15/152 | NT | 13.3% | intergenic (+3/+49) | USA300HOU_RS03100/rclA | hypothetical protein/putative pyridine nucleotide‑disulfide oxidoreductase RclA |
? | USA300TCH1516_ALE | 650786 = | 155 (0.860) | intergenic (+38/+14) | USA300HOU_RS03100/rclA | hypothetical protein/putative pyridine nucleotide‑disulfide oxidoreductase RclA | |||||
* | ? | USA300TCH1516_ALE | 668580 = | 197 (1.030) | 15 (0.080) | 9/152 | NT | 7.7% | coding (565/1011 nt) | adh | Alcohol dehydrogenase |
? | USA300TCH1516_ALE | 668601 = | 172 (0.950) | coding (586/1011 nt) | adh | Alcohol dehydrogenase | |||||
* | ? | USA300TCH1516_ALE | = 669094 | 189 (0.990) | 28 (0.170) | 15/142 | NT | 12.6% | intergenic (+68/‑7) | adh/USA300TCH1516_00602 | Alcohol dehydrogenase/hypothetical protein |
? | USA300TCH1516_ALE | = 669118 | 222 (1.320) | coding (18/108 nt) | USA300TCH1516_00602 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 671388 = | 211 (1.110) | 11 (0.070) | 8/140 | NT | 6.1% | intergenic (+13/‑375) | argS/nth_1 | Arginine‑‑tRNA ligase/Endonuclease III |
? | USA300TCH1516_ALE | 671434 = | 152 (0.910) | intergenic (+59/‑329) | argS/nth_1 | Arginine‑‑tRNA ligase/Endonuclease III | |||||
* | ? | USA300TCH1516_ALE | 671631 = | 107 (0.560) | 19 (0.110) | 6/152 | NT | 13.4% | intergenic (+256/‑132) | argS/nth_1 | Arginine‑‑tRNA ligase/Endonuclease III |
? | USA300TCH1516_ALE | = 801042 | 145 (0.800) | intergenic (+176/‑175) | hisC_1/USA300HOU_RS03915 | Histidinol‑phosphate aminotransferase/Putative 5'(3')‑deoxyribonucleotidase | |||||
* | ? | USA300TCH1516_ALE | = 672729 | 217 (1.140) | 16 (0.090) | 8/148 | NT | 7.0% | intergenic (+331/‑48) | nth_1/btuF | Endonuclease III/Vitamin B12‑binding protein |
? | USA300TCH1516_ALE | = 672751 | 224 (1.270) | intergenic (+353/‑26) | nth_1/btuF | Endonuclease III/Vitamin B12‑binding protein | |||||
* | ? | USA300TCH1516_ALE | 678842 = | 147 (0.770) | 25 (0.150) | 15/136 | NT | 16.6% | intergenic (+45/+206) | pip/sarA | Proline iminopeptidase/Transcriptional regulator SarA |
? | USA300TCH1516_ALE | 678886 = | 127 (0.790) | intergenic (+89/+162) | pip/sarA | Proline iminopeptidase/Transcriptional regulator SarA | |||||
* | ? | USA300TCH1516_ALE | = 678853 | 143 (0.750) | 25 (0.150) | 13/136 | NT | 16.8% | intergenic (+56/+195) | pip/sarA | Proline iminopeptidase/Transcriptional regulator SarA |
? | USA300TCH1516_ALE | = 678873 | 127 (0.790) | intergenic (+76/+175) | pip/sarA | Proline iminopeptidase/Transcriptional regulator SarA | |||||
* | ? | USA300TCH1516_ALE | 681130 = | 171 (0.900) | 34 (0.210) | 18/136 | NT | 20.7% | intergenic (‑200/+8) | USA300HOU_RS03280/USA300TCH1516_00615 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 681182 = | 115 (0.710) | coding (310/354 nt) | USA300TCH1516_00615 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 682222 = | 178 (0.930) | 11 (0.070) | 9/140 | NT | 6.1% | intergenic (‑64/+45) | USA300TCH1516_00616/rcsF_2 | hypothetical protein/Outer membrane lipoprotein RcsF |
? | USA300TCH1516_ALE | 682264 = | 186 (1.120) | intergenic (‑106/+3) | USA300TCH1516_00616/rcsF_2 | hypothetical protein/Outer membrane lipoprotein RcsF | |||||
* | ? | USA300TCH1516_ALE | = 682231 | 188 (0.990) | 24 (0.140) | 14/140 | NT | 12.1% | intergenic (‑73/+36) | USA300TCH1516_00616/rcsF_2 | hypothetical protein/Outer membrane lipoprotein RcsF |
? | USA300TCH1516_ALE | = 682253 | 186 (1.120) | intergenic (‑95/+14) | USA300TCH1516_00616/rcsF_2 | hypothetical protein/Outer membrane lipoprotein RcsF | |||||
* | ? | USA300TCH1516_ALE | = 705329 | 171 (0.900) | 19 (0.110) | 10/142 | NT | 10.3% | intergenic (+1079/+81) | nhaK_1/mntA | Sodium, potassium, lithium and rubidium/H(+) antiporter/Manganese‑binding lipoprotein MntA |
? | USA300TCH1516_ALE | = 705368 | 180 (1.070) | intergenic (+1118/+42) | nhaK_1/mntA | Sodium, potassium, lithium and rubidium/H(+) antiporter/Manganese‑binding lipoprotein MntA | |||||
* | ? | USA300TCH1516_ALE | = 710532 | 187 (0.980) | 32 (0.190) | 12/142 | NT | 15.3% | intergenic (+25/+36) | tarA/tagH_1 | N‑acetylglucosaminyldiphosphoundecaprenol N‑acetyl‑beta‑D‑mannosaminyltransferase/Teichoic acids export ATP‑binding protein TagH |
? | USA300TCH1516_ALE | = 710552 | 189 (1.120) | intergenic (+45/+16) | tarA/tagH_1 | N‑acetylglucosaminyldiphosphoundecaprenol N‑acetyl‑beta‑D‑mannosaminyltransferase/Teichoic acids export ATP‑binding protein TagH | |||||
* | ? | USA300TCH1516_ALE | = 712543 | 147 (0.770) | 23 (0.130) | 12/148 | NT | 13.7% | intergenic (+22/‑77) | tagG/tarB | Teichoic acid translocation permease protein TagG/Teichoic acid glycerol‑phosphate primase |
? | USA300TCH1516_ALE | = 712566 | 153 (0.870) | intergenic (+45/‑54) | tagG/tarB | Teichoic acid translocation permease protein TagG/Teichoic acid glycerol‑phosphate primase | |||||
* | ? | USA300TCH1516_ALE | 715303 = | 139 (0.730) | 16 (0.100) | 8/132 | NT | 11.3% | intergenic (+61/+56) | tarD/dacA | Glycerol‑3‑phosphate cytidylyltransferase/D‑alanyl‑D‑alanine carboxypeptidase DacA |
? | USA300TCH1516_ALE | 715350 = | 138 (0.880) | intergenic (+108/+9) | tarD/dacA | Glycerol‑3‑phosphate cytidylyltransferase/D‑alanyl‑D‑alanine carboxypeptidase DacA | |||||
* | ? | USA300TCH1516_ALE | = 715316 | 155 (0.810) | 15 (0.100) | 10/132 | NT | 10.2% | intergenic (+74/+43) | tarD/dacA | Glycerol‑3‑phosphate cytidylyltransferase/D‑alanyl‑D‑alanine carboxypeptidase DacA |
? | USA300TCH1516_ALE | = 715335 | 138 (0.880) | intergenic (+93/+24) | tarD/dacA | Glycerol‑3‑phosphate cytidylyltransferase/D‑alanyl‑D‑alanine carboxypeptidase DacA | |||||
* | ? | USA300TCH1516_ALE | 720538 = | 154 (0.810) | 18 (0.100) | 12/148 | NT | 11.1% | intergenic (+148/‑377) | nupG/USA300HOU_RS03495 | Purine nucleoside transport protein NupG/hypothetical protein |
? | USA300TCH1516_ALE | 720578 = | 147 (0.830) | intergenic (+188/‑337) | nupG/USA300HOU_RS03495 | Purine nucleoside transport protein NupG/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 724910 | 169 (0.890) | 16 (0.100) | 11/140 | NT | 9.4% | intergenic (+30/‑204) | feuC_1/dhaK | Iron‑uptake system permease protein FeuC/PTS‑dependent dihydroxyacetone kinase, dihydroxyacetone‑binding subunit DhaK |
? | USA300TCH1516_ALE | = 724929 | 160 (0.960) | intergenic (+49/‑185) | feuC_1/dhaK | Iron‑uptake system permease protein FeuC/PTS‑dependent dihydroxyacetone kinase, dihydroxyacetone‑binding subunit DhaK | |||||
* | ? | USA300TCH1516_ALE | 729254 = | 175 (0.920) | 19 (0.120) | 11/136 | NT | 12.3% | intergenic (+55/‑96) | USA300HOU_RS03535/aes | hypothetical protein/Acetyl esterase |
? | USA300TCH1516_ALE | 729295 = | 122 (0.760) | intergenic (+96/‑55) | USA300HOU_RS03535/aes | hypothetical protein/Acetyl esterase | |||||
* | ? | USA300TCH1516_ALE | = 739800 | 182 (0.960) | 21 (0.130) | 10/134 | NT | 10.9% | intergenic (+27/+561) | pitA_1/sle1_2 | Low‑affinity inorganic phosphate transporter 1/N‑acetylmuramoyl‑L‑alanine amidase sle1 |
? | USA300TCH1516_ALE | = 739823 | 192 (1.210) | intergenic (+50/+538) | pitA_1/sle1_2 | Low‑affinity inorganic phosphate transporter 1/N‑acetylmuramoyl‑L‑alanine amidase sle1 | |||||
* | ? | USA300TCH1516_ALE | = 744697 | 190 (1.000) | 16 (0.090) | 10/152 | NT | 7.9% | coding (1838/1980 nt) | melR_1 | Melibiose operon regulatory protein |
? | USA300TCH1516_ALE | = 744717 | 192 (1.060) | coding (1858/1980 nt) | melR_1 | Melibiose operon regulatory protein | |||||
* | ? | USA300TCH1516_ALE | 750720 = | 201 (1.050) | 26 (0.160) | 14/140 | NT | 14.1% | coding (431/489 nt) | USA300HOU_RS03650 | hypothetical protein |
? | USA300TCH1516_ALE | 750744 = | 140 (0.840) | coding (455/489 nt) | USA300HOU_RS03650 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 753677 = | 167 (0.880) | 18 (0.120) | 12/130 | NT | 13.5% | intergenic (+20/+76) | USA300HOU_RS03675/yvdD | hypothetical protein/LOG family protein YvdD |
? | USA300TCH1516_ALE | 753732 = | 96 (0.620) | intergenic (+75/+21) | USA300HOU_RS03675/yvdD | hypothetical protein/LOG family protein YvdD | |||||
* | ? | USA300TCH1516_ALE | 760026 = | 140 (0.730) | 31 (0.200) | 17/132 | NT | 21.3% | coding (1674/1674 nt) | USA300HOU_RS03705 | Putative multidrug export ATP‑binding/permease protein |
? | USA300TCH1516_ALE | 760070 = | 114 (0.730) | intergenic (+44/+83) | USA300HOU_RS03705/mgrA | Putative multidrug export ATP‑binding/permease protein/HTH‑type transcriptional regulator MgrA | |||||
* | ? | USA300TCH1516_ALE | = 760039 | 135 (0.710) | 15 (0.100) | 8/132 | NT | 11.8% | intergenic (+13/+114) | USA300HOU_RS03705/mgrA | Putative multidrug export ATP‑binding/permease protein/HTH‑type transcriptional regulator MgrA |
? | USA300TCH1516_ALE | = 760055 | 114 (0.730) | intergenic (+29/+98) | USA300HOU_RS03705/mgrA | Putative multidrug export ATP‑binding/permease protein/HTH‑type transcriptional regulator MgrA | |||||
* | ? | USA300TCH1516_ALE | = 761262 | 168 (0.880) | 13 (0.070) | 9/148 | NT | 7.4% | coding (440/927 nt) | yciC_2 | Putative metal chaperone YciC |
? | USA300TCH1516_ALE | = 761280 | 168 (0.950) | coding (458/927 nt) | yciC_2 | Putative metal chaperone YciC | |||||
* | ? | USA300TCH1516_ALE | 768843 = | 213 (1.120) | 13 (0.070) | 8/146 | NT | 6.7% | coding (597/1167 nt) | tetA_3 | Tetracycline resistance protein, class B |
? | USA300TCH1516_ALE | 768872 = | 168 (0.970) | coding (626/1167 nt) | tetA_3 | Tetracycline resistance protein, class B | |||||
* | ? | USA300TCH1516_ALE | = 769784 | 151 (0.790) | 10 (0.060) | 8/146 | NT | 6.2% | coding (91/465 nt) | USA300HOU_RS03760 | hypothetical protein |
? | USA300TCH1516_ALE | = 769799 | 165 (0.950) | coding (106/465 nt) | USA300HOU_RS03760 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 774511 | 156 (0.820) | 9 (0.050) | 6/144 | NT | 5.8% | coding (1761/1959 nt) | fruA | PTS system fructose‑specific EIIABC component |
? | USA300TCH1516_ALE | = 774540 | 152 (0.890) | coding (1790/1959 nt) | fruA | PTS system fructose‑specific EIIABC component | |||||
* | ? | USA300TCH1516_ALE | = 782423 | 166 (0.870) | 11 (0.070) | 9/140 | NT | 6.5% | intergenic (‑218/+124) | USA300HOU_RS03820/USA300HOU_RS03825 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 782442 | 169 (1.020) | intergenic (‑237/+105) | USA300HOU_RS03820/USA300HOU_RS03825 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 799573 = | 172 (0.900) | 20 (0.130) | 7/128 | NT | 13.8% | intergenic (+5/‑235) | opuBB/hisC_1 | Choline transport system permease protein OpuBB/Histidinol‑phosphate aminotransferase |
? | USA300TCH1516_ALE | 799622 = | 113 (0.740) | intergenic (+54/‑186) | opuBB/hisC_1 | Choline transport system permease protein OpuBB/Histidinol‑phosphate aminotransferase | |||||
* | ? | USA300TCH1516_ALE | 801949 = | 216 (1.130) | 14 (0.080) | 7/156 | NT | 6.5% | intergenic (+190/+434) | USA300HOU_RS03915/USA300HOU_RS03920 | Putative 5'(3')‑deoxyribonucleotidase/Putative lipid kinase |
? | USA300TCH1516_ALE | = 848322 | 190 (1.020) | intergenic (+327/‑553) | trxB/USA300HOU_RS04145 | Thioredoxin reductase/Nucleotide‑binding protein | |||||
* | ? | USA300TCH1516_ALE | 802131 = | 131 (0.690) | 9 (0.050) | 7/138 | NT | 6.7% | intergenic (+372/+252) | USA300HOU_RS03915/USA300HOU_RS03920 | Putative 5'(3')‑deoxyribonucleotidase/Putative lipid kinase |
? | USA300TCH1516_ALE | 802180 = | 139 (0.850) | intergenic (+421/+203) | USA300HOU_RS03915/USA300HOU_RS03920 | Putative 5'(3')‑deoxyribonucleotidase/Putative lipid kinase | |||||
* | ? | USA300TCH1516_ALE | = 802141 | 128 (0.670) | 14 (0.090) | 8/138 | NT | 10.1% | intergenic (+382/+242) | USA300HOU_RS03915/USA300HOU_RS03920 | Putative 5'(3')‑deoxyribonucleotidase/Putative lipid kinase |
? | USA300TCH1516_ALE | = 802168 | 139 (0.850) | intergenic (+409/+215) | USA300HOU_RS03915/USA300HOU_RS03920 | Putative 5'(3')‑deoxyribonucleotidase/Putative lipid kinase | |||||
* | ? | USA300TCH1516_ALE | 811545 = | 153 (0.800) | 11 (0.060) +CAT |
9/154 | NT | 7.4% | intergenic (+387/‑279) | nrdF/fecD_1 | Ribonucleoside‑diphosphate reductase subunit beta/Fe(3+) dicitrate transport system permease protein FecD |
? | USA300TCH1516_ALE | = 2665005 | 134 (0.700) | intergenic (+240/+198) | pitA_2/USA300TCH1516_02535 | L‑methionine sulfoximine/L‑methionine sulfone acetyltransferase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 842619 = | 189 (0.990) | 15 (0.090) | 13/144 | NT | 8.6% | intergenic (+5/‑657) | uvrA/hprK | UvrABC system protein A/HPr kinase/phosphorylase |
? | USA300TCH1516_ALE | 842662 = | 147 (0.860) | intergenic (+48/‑614) | uvrA/hprK | UvrABC system protein A/HPr kinase/phosphorylase | |||||
* | ? | USA300TCH1516_ALE | 858374 = | 153 (0.800) | 14 (0.080) | 12/146 | NT | 8.9% | intergenic (+69/‑70) | gapA1/pgk | Glyceraldehyde‑3‑phosphate dehydrogenase 1/Phosphoglycerate kinase |
? | USA300TCH1516_ALE | 858405 = | 148 (0.850) | intergenic (+100/‑39) | gapA1/pgk | Glyceraldehyde‑3‑phosphate dehydrogenase 1/Phosphoglycerate kinase | |||||
* | ? | USA300TCH1516_ALE | = 868310 | 166 (0.870) | 15 (0.090) | 7/148 | NT | 8.6% | coding (458/465 nt) | smpB | SsrA‑binding protein |
? | USA300TCH1516_ALE | = 868335 | 165 (0.940) | intergenic (+18/+1304) | smpB/USA300HOU_RS04240 | SsrA‑binding protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 869579 = | 220 (1.150) | 25 (0.150) | 16/140 | NT | 12.4% | intergenic (+1262/+60) | smpB/USA300HOU_RS04240 | SsrA‑binding protein/hypothetical protein |
? | USA300TCH1516_ALE | 869621 = | 162 (0.970) | intergenic (+1304/+18) | smpB/USA300HOU_RS04240 | SsrA‑binding protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 885377 = | 157 (0.820) | 31 (0.190) | 13/134 | NT | 19.5% | intergenic (+6/+67) | pspB/argO | Putative phosphoserine phosphatase 2/Arginine exporter protein ArgO |
? | USA300TCH1516_ALE | 885422 = | 124 (0.780) | intergenic (+51/+22) | pspB/argO | Putative phosphoserine phosphatase 2/Arginine exporter protein ArgO | |||||
* | ? | USA300TCH1516_ALE | = 885389 | 151 (0.790) | 13 (0.080) | 9/134 | NT | 9.4% | intergenic (+18/+55) | pspB/argO | Putative phosphoserine phosphatase 2/Arginine exporter protein ArgO |
? | USA300TCH1516_ALE | = 885408 | 124 (0.780) | intergenic (+37/+36) | pspB/argO | Putative phosphoserine phosphatase 2/Arginine exporter protein ArgO | |||||
* | ? | USA300TCH1516_ALE | = 891727 | 133 (0.700) | 15 (0.080) | 8/152 | NT | 8.7% | intergenic (+145/‑594) | USA300HOU_RS04385/rnmV_2 | hypothetical protein/Ribonuclease M5 |
? | USA300TCH1516_ALE | = 1695091 | 190 (1.050) | intergenic (‑297/+233) | hemN_1/lepA | Oxygen‑independent coproporphyrinogen‑III oxidase‑like protein YqeR/Elongation factor 4 | |||||
* | ? | USA300TCH1516_ALE | 893176 = | 213 (1.120) | 13 (0.080) | 9/136 | NT | 7.2% | intergenic (+177/‑73) | trxA_1/metN2 | Thioredoxin/Methionine import ATP‑binding protein MetN 2 |
? | USA300TCH1516_ALE | 893212 = | 153 (0.950) | intergenic (+213/‑37) | trxA_1/metN2 | Thioredoxin/Methionine import ATP‑binding protein MetN 2 | |||||
* | ? | USA300TCH1516_ALE | 909572 = | 175 (0.920) | 11 (0.060) | 9/144 | NT | 6.6% | intergenic (‑495/‑539) | USA300HOU_RS04500/csbD_1 | hypothetical protein/Stress response protein CsbD |
? | USA300TCH1516_ALE | 909605 = | 155 (0.910) | intergenic (‑528/‑506) | USA300HOU_RS04500/csbD_1 | hypothetical protein/Stress response protein CsbD | |||||
* | ? | USA300TCH1516_ALE | 920377 = | 124 (0.650) | 14 (0.090) | 9/132 | NT | 11.7% | intergenic (+6/‑207) | USA300HOU_RS04555/USA300HOU_RS04565 | Putative monooxygenase/hypothetical protein |
? | USA300TCH1516_ALE | 920443 = | 109 (0.700) | intergenic (+72/‑141) | USA300HOU_RS04555/USA300HOU_RS04565 | Putative monooxygenase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 920390 | 123 (0.650) | 12 (0.080) | 6/132 | NT | 10.2% | intergenic (+19/‑194) | USA300HOU_RS04555/USA300HOU_RS04565 | Putative monooxygenase/hypothetical protein |
? | USA300TCH1516_ALE | = 920428 | 109 (0.700) | intergenic (+57/‑156) | USA300HOU_RS04555/USA300HOU_RS04565 | Putative monooxygenase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 932460 = | 154 (0.810) | 17 (0.110) | 13/136 | NT | 10.6% | intergenic (+6/+257) | USA300HOU_RS04635/nfuA | hypothetical protein/Fe/S biogenesis protein NfuA |
? | USA300TCH1516_ALE | 932506 = | 155 (0.960) | intergenic (+52/+211) | USA300HOU_RS04635/nfuA | hypothetical protein/Fe/S biogenesis protein NfuA | |||||
* | ? | USA300TCH1516_ALE | = 932471 | 154 (0.810) | 17 (0.110) | 15/136 | NT | 10.6% | intergenic (+17/+246) | USA300HOU_RS04635/nfuA | hypothetical protein/Fe/S biogenesis protein NfuA |
? | USA300TCH1516_ALE | = 932493 | 155 (0.960) | intergenic (+39/+224) | USA300HOU_RS04635/nfuA | hypothetical protein/Fe/S biogenesis protein NfuA | |||||
* | ? | USA300TCH1516_ALE | 932628 = | 220 (1.150) | 24 (0.140) | 14/142 | NT | 12.1% | intergenic (+174/+89) | USA300HOU_RS04635/nfuA | hypothetical protein/Fe/S biogenesis protein NfuA |
? | USA300TCH1516_ALE | 932675 = | 154 (0.910) | intergenic (+221/+42) | USA300HOU_RS04635/nfuA | hypothetical protein/Fe/S biogenesis protein NfuA | |||||
* | ? | USA300TCH1516_ALE | = 940821 | 169 (0.890) | 30 (0.170) | 13/148 | NT | 17.5% | intergenic (+2/+54) | USA300HOU_RS04680/ptlE | Putative esterase/Neopentalenolactone D synthase |
? | USA300TCH1516_ALE | = 940872 | 126 (0.720) | intergenic (+53/+3) | USA300HOU_RS04680/ptlE | Putative esterase/Neopentalenolactone D synthase | |||||
* | ? | USA300TCH1516_ALE | 940823 = | 172 (0.900) | 12 (0.070) | 8/140 | NT | 7.7% | intergenic (+4/+52) | USA300HOU_RS04680/ptlE | Putative esterase/Neopentalenolactone D synthase |
? | USA300TCH1516_ALE | 940872 = | 137 (0.820) | intergenic (+53/+3) | USA300HOU_RS04680/ptlE | Putative esterase/Neopentalenolactone D synthase | |||||
* | ? | USA300TCH1516_ALE | 954365 = | 103 (0.540) | 16 (0.100) | 8/138 | NT | 13.9% | intergenic (+19/+484) | gluD/glpQ_1 | NAD‑specific glutamate dehydrogenase/Glycerophosphodiester phosphodiesterase |
? | USA300TCH1516_ALE | 954407 = | 109 (0.660) | intergenic (+61/+442) | gluD/glpQ_1 | NAD‑specific glutamate dehydrogenase/Glycerophosphodiester phosphodiesterase | |||||
* | ? | USA300TCH1516_ALE | = 954375 | 107 (0.560) | 9 (0.050) | 6/138 | NT | 8.2% | intergenic (+29/+474) | gluD/glpQ_1 | NAD‑specific glutamate dehydrogenase/Glycerophosphodiester phosphodiesterase |
? | USA300TCH1516_ALE | = 954395 | 109 (0.660) | intergenic (+49/+454) | gluD/glpQ_1 | NAD‑specific glutamate dehydrogenase/Glycerophosphodiester phosphodiesterase | |||||
* | ? | USA300TCH1516_ALE | 954695 = | 155 (0.810) | 51 (0.290) +GGCAAG |
11/148 | NT | 24.7% | intergenic (+349/+154) | gluD/glpQ_1 | NAD‑specific glutamate dehydrogenase/Glycerophosphodiester phosphodiesterase |
? | USA300TCH1516_ALE | 1873938 = | 181 (0.950) | intergenic (‑614/+136) | USA300HOU_RS09300/USA300HOU_RS09305 | Putative dipeptidase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 971394 = | 154 (0.810) | 25 (0.150) | 14/142 | NT | 16.1% | intergenic (+22/+149) | USA300HOU_RS04810/cdr | hypothetical protein/Coenzyme A disulfide reductase |
? | USA300TCH1516_ALE | 971435 = | 125 (0.740) | intergenic (+63/+108) | USA300HOU_RS04810/cdr | hypothetical protein/Coenzyme A disulfide reductase | |||||
* | ? | USA300TCH1516_ALE | = 971402 | 149 (0.780) | 9 (0.050) | 8/142 | NT | 6.5% | intergenic (+30/+141) | USA300HOU_RS04810/cdr | hypothetical protein/Coenzyme A disulfide reductase |
? | USA300TCH1516_ALE | = 971425 | 125 (0.740) | intergenic (+53/+118) | USA300HOU_RS04810/cdr | hypothetical protein/Coenzyme A disulfide reductase | |||||
* | ? | USA300TCH1516_ALE | = 987447 | 117 (0.610) | 27 (0.180) | 18/128 | NT | 20.4% | intergenic (+20/+35) | fabF/USA300HOU_RS04885 | 3‑oxoacyl‑[acyl‑carrier‑protein] synthase 2/hypothetical protein |
? | USA300TCH1516_ALE | = 987456 | 118 (0.780) | intergenic (+29/+26) | fabF/USA300HOU_RS04885 | 3‑oxoacyl‑[acyl‑carrier‑protein] synthase 2/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1005781 = | 204 (1.070) | 29 (0.180) | 13/138 | NT | 15.4% | intergenic (+417/+43) | pepF1_1/USA300HOU_RS04965 | Oligoendopeptidase F, plasmid/hypothetical protein |
? | USA300TCH1516_ALE | 1005817 = | 142 (0.870) | intergenic (+453/+7) | pepF1_1/USA300HOU_RS04965 | Oligoendopeptidase F, plasmid/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1021264 = | 173 (0.910) | 9 (0.050) | 6/144 | NT | 6.2% | coding (871/1176 nt) | ugtP | Processive diacylglycerol beta‑glucosyltransferase |
? | USA300TCH1516_ALE | 1021300 = | 118 (0.690) | coding (835/1176 nt) | ugtP | Processive diacylglycerol beta‑glucosyltransferase | |||||
* | ? | USA300TCH1516_ALE | 1036446 = | 211 (1.110) | 14 (0.090) | 6/138 | NT | 7.7% | intergenic (+376/‑968) | USA300TCH1516_00963/USA300TCH1516_00964 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 1036485 = | 152 (0.930) | intergenic (+415/‑929) | USA300TCH1516_00963/USA300TCH1516_00964 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1040357 = | 218 (1.140) | 18 (0.110) | 12/132 | NT | 9.6% | intergenic (+18/+70) | USA300TCH1516_00966/USA300TCH1516_00967 | putative ABC transporter ATP‑binding protein/hypothetical protein |
? | USA300TCH1516_ALE | 1040412 = | 160 (1.020) | intergenic (+73/+15) | USA300TCH1516_00966/USA300TCH1516_00967 | putative ABC transporter ATP‑binding protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1046453 | 164 (0.860) | 16 (0.090) | 12/144 | NT | 9.2% | coding (361/939 nt) | menA | 1,4‑dihydroxy‑2‑naphthoate octaprenyltransferase |
? | USA300TCH1516_ALE | = 1046472 | 167 (0.980) | coding (342/939 nt) | menA | 1,4‑dihydroxy‑2‑naphthoate octaprenyltransferase | |||||
* | ? | USA300TCH1516_ALE | 1061336 = | 181 (0.950) | 12 (0.070) | 6/144 | NT | 7.4% | coding (601/3771 nt) | atl_1 | Bifunctional autolysin |
? | USA300TCH1516_ALE | 1061375 = | 136 (0.790) | coding (562/3771 nt) | atl_1 | Bifunctional autolysin | |||||
* | ? | USA300TCH1516_ALE | = 1071475 | 158 (0.830) | 10 (0.060) | 7/148 | NT | 6.1% | coding (54/318 nt) | USA300HOU_RS05290 | Pesticidal crystal protein Cry22Aa |
? | USA300TCH1516_ALE | = 1071489 | 164 (0.930) | coding (40/318 nt) | USA300HOU_RS05290 | Pesticidal crystal protein Cry22Aa | |||||
* | ? | USA300TCH1516_ALE | 1072018 = | 174 (0.910) | 11 (0.070) | 6/126 | NT | 7.7% | intergenic (‑490/+315) | USA300HOU_RS05290/folD | Pesticidal crystal protein Cry22Aa/Bifunctional protein FolD protein |
? | USA300TCH1516_ALE | 1072073 = | 129 (0.860) | intergenic (‑545/+260) | USA300HOU_RS05290/folD | Pesticidal crystal protein Cry22Aa/Bifunctional protein FolD protein | |||||
* | ? | USA300TCH1516_ALE | 1073608 = | 171 (0.900) | 11 (0.060) | 8/152 | NT | 6.4% | coding (215/483 nt) | purE | N5‑carboxyaminoimidazole ribonucleotide mutase |
? | USA300TCH1516_ALE | 1073634 = | 160 (0.880) | coding (241/483 nt) | purE | N5‑carboxyaminoimidazole ribonucleotide mutase | |||||
* | ? | USA300TCH1516_ALE | 1084754 = | 154 (0.810) | 17 (0.100) | 13/140 | NT | 11.5% | intergenic (+126/+139) | purD/ykoC_1 | Phosphoribosylamine‑‑glycine ligase/Putative HMP/thiamine permease protein YkoC |
? | USA300TCH1516_ALE | 1084817 = | 126 (0.760) | intergenic (+189/+76) | purD/ykoC_1 | Phosphoribosylamine‑‑glycine ligase/Putative HMP/thiamine permease protein YkoC | |||||
* | ? | USA300TCH1516_ALE | = 1084763 | 151 (0.790) | 12 (0.070) | 9/140 | NT | 8.5% | intergenic (+135/+130) | purD/ykoC_1 | Phosphoribosylamine‑‑glycine ligase/Putative HMP/thiamine permease protein YkoC |
? | USA300TCH1516_ALE | = 1084806 | 126 (0.760) | intergenic (+178/+87) | purD/ykoC_1 | Phosphoribosylamine‑‑glycine ligase/Putative HMP/thiamine permease protein YkoC | |||||
* | ? | USA300TCH1516_ALE | = 1086971 | 157 (0.820) | 23 (0.140) | 12/140 | NT | 13.3% | coding (122/1401 nt) | ykoD_1 | Putative HMP/thiamine import ATP‑binding protein YkoD |
? | USA300TCH1516_ALE | = 1086989 | 162 (0.970) | coding (104/1401 nt) | ykoD_1 | Putative HMP/thiamine import ATP‑binding protein YkoD | |||||
* | ? | USA300TCH1516_ALE | 1114090 = | 129 (0.680) | 12 (0.080) | 9/126 | NT | 10.5% | intergenic (+19/+63) | USA300HOU_RS05510/mntH_1 | hypothetical protein/Divalent metal cation transporter MntH |
? | USA300TCH1516_ALE | 1114149 = | 104 (0.700) | intergenic (+78/+4) | USA300HOU_RS05510/mntH_1 | hypothetical protein/Divalent metal cation transporter MntH | |||||
* | ? | USA300TCH1516_ALE | = 1114106 | 137 (0.720) | 17 (0.110) | 11/126 | NT | 13.8% | intergenic (+35/+47) | USA300HOU_RS05510/mntH_1 | hypothetical protein/Divalent metal cation transporter MntH |
? | USA300TCH1516_ALE | = 1114131 | 104 (0.700) | intergenic (+60/+22) | USA300HOU_RS05510/mntH_1 | hypothetical protein/Divalent metal cation transporter MntH | |||||
* | ? | USA300TCH1516_ALE | = 1115642 | 170 (0.890) | 17 (0.100) | 11/146 | NT | 10.3% | intergenic (‑137/+47) | mntH_1/USA300TCH1516_01038 | Divalent metal cation transporter MntH/hypothetical protein |
? | USA300TCH1516_ALE | = 1115662 | 142 (0.820) | intergenic (‑157/+27) | mntH_1/USA300TCH1516_01038 | Divalent metal cation transporter MntH/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1117293 = | 171 (0.900) | 15 (0.100) | 9/130 | NT | 10.7% | intergenic (+6/+148) | suhB_1/USA300TCH1516_01040 | Inositol‑1‑monophosphatase/hypothetical protein |
? | USA300TCH1516_ALE | 1117341 = | 112 (0.730) | intergenic (+54/+100) | suhB_1/USA300TCH1516_01040 | Inositol‑1‑monophosphatase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1119593 = | 164 (0.860) | 19 (0.120) | 9/136 | NT | 11.8% | intergenic (+12/+297) | typA/USA300HOU_RS05545 | GTP‑binding protein TypA/BipA/hypothetical protein |
? | USA300TCH1516_ALE | 1119635 = | 144 (0.890) | intergenic (+54/+255) | typA/USA300HOU_RS05545 | GTP‑binding protein TypA/BipA/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1119604 | 153 (0.800) | 34 (0.210) | 16/136 | NT | 19.9% | intergenic (+23/+286) | typA/USA300HOU_RS05545 | GTP‑binding protein TypA/BipA/hypothetical protein |
? | USA300TCH1516_ALE | = 1119622 | 144 (0.890) | intergenic (+41/+268) | typA/USA300HOU_RS05545 | GTP‑binding protein TypA/BipA/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1119914 = | 190 (1.000) | 14 (0.080) | 7/148 | NT | 7.6% | coding (459/483 nt) | USA300HOU_RS05545 | hypothetical protein |
? | USA300TCH1516_ALE | 1119940 = | 165 (0.940) | coding (433/483 nt) | USA300HOU_RS05545 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1129293 = | 184 (0.970) | 13 (0.080) | 10/144 | NT | 7.6% | intergenic (+71/‑256) | USA300HOU_RS05575/USA300HOU_RS05585 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 1129331 = | 149 (0.870) | intergenic (+109/‑218) | USA300HOU_RS05575/USA300HOU_RS05585 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1129920 | 179 (0.940) | 14 (0.080) | 9/148 | NT | 7.3% | coding (372/1038 nt) | USA300HOU_RS05585 | hypothetical protein |
? | USA300TCH1516_ALE | = 1129939 | 188 (1.070) | coding (391/1038 nt) | USA300HOU_RS05585 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1131036 = | 188 (0.990) | 11 (0.070) | 10/126 | NT | 7.6% | coding (435/435 nt) | USA300HOU_RS05590 | hypothetical protein |
? | USA300TCH1516_ALE | 1131101 = | 120 (0.800) | coding (925/927 nt) | glpQ1 | putative glycerophosphodiester phosphodiesterase 1 | |||||
* | ? | USA300TCH1516_ALE | 1134014 = | 231 (1.210) | 12 (0.080) | 5/132 | NT | 6.6% | intergenic (+8/+54) | coaD/USA300HOU_RS05620 | Phosphopantetheine adenylyltransferase/Nicotinamide‑nucleotide adenylyltransferase |
? | USA300TCH1516_ALE | 1134060 = | 147 (0.940) | intergenic (+54/+8) | coaD/USA300HOU_RS05620 | Phosphopantetheine adenylyltransferase/Nicotinamide‑nucleotide adenylyltransferase | |||||
* | ? | USA300TCH1516_ALE | = 1138356 | 191 (1.000) | 18 (0.110) | 15/140 | NT | 9.2% | intergenic (‑121/+82) | isdB/isdA | Iron‑regulated surface determinant protein B/Iron‑regulated surface determinant protein A |
? | USA300TCH1516_ALE | = 1138378 | 190 (1.140) | intergenic (‑143/+60) | isdB/isdA | Iron‑regulated surface determinant protein B/Iron‑regulated surface determinant protein A | |||||
* | ? | USA300TCH1516_ALE | 1140472 = | 196 (1.030) | 18 (0.110) | 10/140 | NT | 10.3% | coding (91/1077 nt) | USA300HOU_RS05655 | hypothetical protein |
? | USA300TCH1516_ALE | 1140504 = | 144 (0.870) | coding (123/1077 nt) | USA300HOU_RS05655 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1149564 = | 166 (0.870) | 10 (0.060) | 7/142 | NT | 6.5% | intergenic (+150/+21) | pheT_1/rnhC | Phenylalanine‑‑tRNA ligase beta subunit/Ribonuclease HIII |
? | USA300TCH1516_ALE | 1149598 = | 139 (0.820) | coding (926/939 nt) | rnhC | Ribonuclease HIII | |||||
* | ? | USA300TCH1516_ALE | = 1164949 | 200 (1.050) | 15 (0.090) | 10/148 | NT | 6.9% | intergenic (+13/+356) | fib_1/flr_1 | Fibrinogen‑binding protein/FPRL1 inhibitory protein |
? | USA300TCH1516_ALE | = 1164961 | 219 (1.240) | intergenic (+25/+344) | fib_1/flr_1 | Fibrinogen‑binding protein/FPRL1 inhibitory protein | |||||
* | ? | USA300TCH1516_ALE | 1165242 = | 229 (1.200) | 33 (0.190) | 18/146 | NT | 14.1% | intergenic (+306/+63) | fib_1/flr_1 | Fibrinogen‑binding protein/FPRL1 inhibitory protein |
? | USA300TCH1516_ALE | 1165280 = | 193 (1.110) | intergenic (+344/+25) | fib_1/flr_1 | Fibrinogen‑binding protein/FPRL1 inhibitory protein | |||||
* | ? | USA300TCH1516_ALE | = 1168159 | 177 (0.930) | 38 (0.230) | 24/140 | NT | 18.2% | intergenic (+15/+638) | scn_2/USA300HOU_RS05810 | Staphylococcal complement inhibitor/hypothetical protein |
? | USA300TCH1516_ALE | = 1168177 | 186 (1.120) | intergenic (+33/+620) | scn_2/USA300HOU_RS05810 | Staphylococcal complement inhibitor/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1168751 | 165 (0.870) | 20 (0.140) | 9/124 | NT | 11.6% | intergenic (+607/+46) | scn_2/USA300HOU_RS05810 | Staphylococcal complement inhibitor/hypothetical protein |
? | USA300TCH1516_ALE | = 1168764 | 176 (1.200) | intergenic (+620/+33) | scn_2/USA300HOU_RS05810 | Staphylococcal complement inhibitor/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1168782 | 226 (1.190) | 9 (0.060) | 4/124 | NT | 5.3% | intergenic (+638/+15) | scn_2/USA300HOU_RS05810 | Staphylococcal complement inhibitor/hypothetical protein |
? | USA300TCH1516_ALE | = 2220770 | 146 (0.990) | intergenic (‑421/+141) | USA300HOU_RS11345/atpC | hypothetical protein/ATP synthase epsilon chain | |||||
* | ? | USA300TCH1516_ALE | 1181842 = | 189 (0.990) | 18 (0.110) | 13/144 | NT | 10.7% | intergenic (+409/+65) | USA300HOU_RS05885/USA300TCH1516_01103 | hypothetical protein/tRNA‑Arg |
? | USA300TCH1516_ALE | 1181881 = | 130 (0.760) | intergenic (+448/+26) | USA300HOU_RS05885/USA300TCH1516_01103 | hypothetical protein/tRNA‑Arg | |||||
* | ? | USA300TCH1516_ALE | 1182136 = | 210 (1.100) | 12 (0.070) | 8/140 | NT | 6.6% | intergenic (‑154/‑209) | USA300TCH1516_01103/USA300HOU_RS05895 | tRNA‑Arg/Antibacterial protein 3 |
? | USA300TCH1516_ALE | 1182166 = | 156 (0.940) | intergenic (‑184/‑179) | USA300TCH1516_01103/USA300HOU_RS05895 | tRNA‑Arg/Antibacterial protein 3 | |||||
* | ? | USA300TCH1516_ALE | 1182690 = | 233 (1.220) | 18 (0.110) | 10/136 | NT | 8.7% | intergenic (+20/‑113) | USA300HOU_RS05900/yfnB | Antibacterial protein 3/Putative HAD‑hydrolase YfnB |
? | USA300TCH1516_ALE | 1182741 = | 179 (1.110) | intergenic (+71/‑62) | USA300HOU_RS05900/yfnB | Antibacterial protein 3/Putative HAD‑hydrolase YfnB | |||||
* | ? | USA300TCH1516_ALE | 1183547 = | 196 (1.030) | 13 (0.080) | 10/140 | NT | 7.1% | intergenic (+58/+51) | yfnB/USA300HOU_RS05910 | Putative HAD‑hydrolase YfnB/putative N‑acetyltransferase |
? | USA300TCH1516_ALE | 1183585 = | 168 (1.010) | intergenic (+96/+13) | yfnB/USA300HOU_RS05910 | Putative HAD‑hydrolase YfnB/putative N‑acetyltransferase | |||||
* | ? | USA300TCH1516_ALE | = 1183556 | 188 (0.990) | 13 (0.080) | 8/140 | NT | 7.3% | intergenic (+67/+42) | yfnB/USA300HOU_RS05910 | Putative HAD‑hydrolase YfnB/putative N‑acetyltransferase |
? | USA300TCH1516_ALE | = 1183574 | 168 (1.010) | intergenic (+85/+24) | yfnB/USA300HOU_RS05910 | Putative HAD‑hydrolase YfnB/putative N‑acetyltransferase | |||||
* | ? | USA300TCH1516_ALE | = 1199293 | 128 (0.670) | 14 (0.080) | 9/144 | NT | 9.7% | intergenic (+20/‑63) | USA300HOU_RS05980/USA300HOU_RS05985 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 1199312 | 147 (0.860) | intergenic (+39/‑44) | USA300HOU_RS05980/USA300HOU_RS05985 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1242672 | 149 (0.780) | 13 (0.080) | 8/138 | NT | 8.5% | coding (110/987 nt) | plsX | Phosphate acyltransferase |
? | USA300TCH1516_ALE | = 1242683 | 151 (0.920) | coding (121/987 nt) | plsX | Phosphate acyltransferase | |||||
* | ? | USA300TCH1516_ALE | = 1255843 | 197 (1.030) | 13 (0.080) | 11/138 | NT | 6.8% | intergenic (+59/+185) | rplS/USA300HOU_RS06250 | 50S ribosomal protein L19/hypothetical protein |
? | USA300TCH1516_ALE | = 1255864 | 189 (1.150) | intergenic (+80/+164) | rplS/USA300HOU_RS06250 | 50S ribosomal protein L19/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1255967 = | 131 (0.690) | 21 (0.130) | 17/134 | NT | 16.6% | intergenic (+183/+61) | rplS/USA300HOU_RS06250 | 50S ribosomal protein L19/hypothetical protein |
? | USA300TCH1516_ALE | 1256006 = | 102 (0.640) | intergenic (+222/+22) | rplS/USA300HOU_RS06250 | 50S ribosomal protein L19/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1255979 | 129 (0.680) | 26 (0.160) | 14/134 | NT | 19.9% | intergenic (+195/+49) | rplS/USA300HOU_RS06250 | 50S ribosomal protein L19/hypothetical protein |
? | USA300TCH1516_ALE | = 1255992 | 102 (0.640) | intergenic (+208/+36) | rplS/USA300HOU_RS06250 | 50S ribosomal protein L19/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1262900 = | 146 (0.770) | 13 (0.080) | 7/140 | NT | 9.1% | intergenic (+25/‑202) | sucD/lytN_1 | Succinate‑‑CoA ligase [ADP‑forming] subunit alpha/putative cell wall hydrolase LytN |
? | USA300TCH1516_ALE | 1262943 = | 132 (0.790) | intergenic (+68/‑159) | sucD/lytN_1 | Succinate‑‑CoA ligase [ADP‑forming] subunit alpha/putative cell wall hydrolase LytN | |||||
* | ? | USA300TCH1516_ALE | = 1262909 | 146 (0.770) | 27 (0.160) | 10/140 | NT | 17.2% | intergenic (+34/‑193) | sucD/lytN_1 | Succinate‑‑CoA ligase [ADP‑forming] subunit alpha/putative cell wall hydrolase LytN |
? | USA300TCH1516_ALE | = 1262932 | 132 (0.790) | intergenic (+57/‑170) | sucD/lytN_1 | Succinate‑‑CoA ligase [ADP‑forming] subunit alpha/putative cell wall hydrolase LytN | |||||
* | ? | USA300TCH1516_ALE | = 1265511 | 171 (0.900) | 21 (0.140) | 14/130 | NT | 12.3% | intergenic (+19/‑154) | femA_1/dprA | Aminoacyltransferase FemA/DNA processing protein DprA |
? | USA300TCH1516_ALE | = 1265527 | 160 (1.040) | intergenic (+35/‑138) | femA_1/dprA | Aminoacyltransferase FemA/DNA processing protein DprA | |||||
* | ? | USA300TCH1516_ALE | = 1267714 | 156 (0.820) | 13 (0.070) | 9/150 | NT | 7.6% | coding (1004/2076 nt) | topA | DNA topoisomerase 1 |
? | USA300TCH1516_ALE | = 1267733 | 170 (0.950) | coding (1023/2076 nt) | topA | DNA topoisomerase 1 | |||||
* | ? | USA300TCH1516_ALE | 1278212 = | 183 (0.960) | 23 (0.140) | 11/140 | NT | 13.9% | intergenic (+237/‑136) | frr/uppS | Ribosome‑recycling factor/Isoprenyl transferase |
? | USA300TCH1516_ALE | 1278244 = | 124 (0.750) | intergenic (+269/‑104) | frr/uppS | Ribosome‑recycling factor/Isoprenyl transferase | |||||
* | ? | USA300TCH1516_ALE | 1279936 = | 200 (1.050) | 20 (0.150) +25 bp |
9/110 | NT | 13.4% | intergenic (+29/‑233) | cdsA/USA300HOU_RS06360 | Phosphatidate cytidylyltransferase/Putative zinc metalloprotease |
? | USA300TCH1516_ALE | 1279975 = | 177 (0.930) | intergenic (+68/‑194) | cdsA/USA300HOU_RS06360 | Phosphatidate cytidylyltransferase/Putative zinc metalloprotease | |||||
* | ? | USA300TCH1516_ALE | = 1283492 | 181 (0.950) | 17 (0.100) | 8/138 | NT | 9.1% | coding (57/4317 nt) | polC_1 | DNA polymerase III PolC‑type |
? | USA300TCH1516_ALE | = 1283506 | 184 (1.120) | coding (71/4317 nt) | polC_1 | DNA polymerase III PolC‑type | |||||
* | ? | USA300TCH1516_ALE | 1292484 = | 124 (0.650) | 16 (0.110) | 11/128 | NT | 13.4% | intergenic (+38/‑348) | infB/rbfA | Translation initiation factor IF‑2/Ribosome‑binding factor A |
? | USA300TCH1516_ALE | 1292539 = | 108 (0.710) | intergenic (+93/‑293) | infB/rbfA | Translation initiation factor IF‑2/Ribosome‑binding factor A | |||||
* | ? | USA300TCH1516_ALE | = 1292499 | 124 (0.650) | 13 (0.090) | 6/128 | NT | 11.2% | intergenic (+53/‑333) | infB/rbfA | Translation initiation factor IF‑2/Ribosome‑binding factor A |
? | USA300TCH1516_ALE | = 1292522 | 108 (0.710) | intergenic (+76/‑310) | infB/rbfA | Translation initiation factor IF‑2/Ribosome‑binding factor A | |||||
* | ? | USA300TCH1516_ALE | = 1314645 | 184 (0.970) | 24 (0.130) | 15/150 | NT | 11.7% | intergenic (+66/‑74) | USA300HOU_RS06490/korA | hypothetical protein/2‑oxoglutarate oxidoreductase subunit KorA |
? | USA300TCH1516_ALE | = 1314663 | 190 (1.060) | intergenic (+84/‑56) | USA300HOU_RS06490/korA | hypothetical protein/2‑oxoglutarate oxidoreductase subunit KorA | |||||
* | ? | USA300TCH1516_ALE | = 1330548 | 182 (0.960) | 25 (0.140) | 13/148 | NT | 12.4% | intergenic (+23/‑124) | glpD/USA300HOU_RS06555 | Aerobic glycerol‑3‑phosphate dehydrogenase/Monoacylglycerol lipase |
? | USA300TCH1516_ALE | = 1330568 | 185 (1.050) | intergenic (+43/‑104) | glpD/USA300HOU_RS06555 | Aerobic glycerol‑3‑phosphate dehydrogenase/Monoacylglycerol lipase | |||||
* | ? | USA300TCH1516_ALE | = 1332949 | 156 (0.820) | 21 (0.140) | 12/124 | NT | 13.4% | intergenic (+159/+63) | hfq/bsaA_1 | RNA‑binding protein Hfq/Glutathione peroxidase BsaA |
? | USA300TCH1516_ALE | = 1332971 | 152 (1.030) | intergenic (+181/+41) | hfq/bsaA_1 | RNA‑binding protein Hfq/Glutathione peroxidase BsaA | |||||
* | ? | USA300TCH1516_ALE | 1341822 = | 270 (1.420) | 17 (0.100) | 9/148 | NT | 7.0% | intergenic (+230/‑282) | USA300HOU_RS06615/USA300TCH1516_01244 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 1341877 = | 202 (1.150) | intergenic (+285/‑227) | USA300HOU_RS06615/USA300TCH1516_01244 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1353894 = | 166 (0.870) | 12 (0.080) | 8/134 | NT | 8.2% | intergenic (+87/+56) | nucH/USA300HOU_RS06735 | Thermonuclease/hypothetical protein |
? | USA300TCH1516_ALE | 1353946 = | 131 (0.820) | intergenic (+139/+4) | nucH/USA300HOU_RS06735 | Thermonuclease/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1353906 | 170 (0.890) | 15 (0.090) | 12/134 | NT | 9.9% | intergenic (+99/+44) | nucH/USA300HOU_RS06735 | Thermonuclease/hypothetical protein |
? | USA300TCH1516_ALE | = 1353932 | 131 (0.820) | intergenic (+125/+18) | nucH/USA300HOU_RS06735 | Thermonuclease/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1355713 = | 213 (1.120) | 18 (0.110) | 12/138 | NT | 9.9% | intergenic (+3/+51) | USA300HOU_RS06740/yclM | hypothetical protein/Aspartokinase 3 |
? | USA300TCH1516_ALE | 1355761 = | 143 (0.870) | intergenic (+51/+3) | USA300HOU_RS06740/yclM | hypothetical protein/Aspartokinase 3 | |||||
* | ? | USA300TCH1516_ALE | = 1361481 | 142 (0.750) | 22 (0.130) | 12/140 | NT | 12.8% | intergenic (+20/+273) | USA300HOU_RS06765/USA300TCH1516_01271 | Putative phosphatase/hypothetical protein |
? | USA300TCH1516_ALE | = 1361509 | 176 (1.060) | intergenic (+48/+245) | USA300HOU_RS06765/USA300TCH1516_01271 | Putative phosphatase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1365739 | 186 (0.980) | 25 (0.140) | 10/148 | NT | 12.5% | intergenic (+38/‑416) | rpmG2_1/rpsN2 | 50S ribosomal protein L33 2/Alternate 30S ribosomal protein S14 |
? | USA300TCH1516_ALE | = 1365764 | 177 (1.010) | intergenic (+63/‑391) | rpmG2_1/rpsN2 | 50S ribosomal protein L33 2/Alternate 30S ribosomal protein S14 | |||||
* | ? | USA300TCH1516_ALE | = 1366496 | 163 (0.860) | 12 (0.070) | 7/152 | NT | 6.8% | intergenic (+72/‑85) | rpsN2/guaC | Alternate 30S ribosomal protein S14/GMP reductase |
? | USA300TCH1516_ALE | = 1366530 | 175 (0.970) | intergenic (+106/‑51) | rpsN2/guaC | Alternate 30S ribosomal protein S14/GMP reductase | |||||
* | ? | USA300TCH1516_ALE | = 1380306 | 150 (0.790) | 18 (0.110) | 10/144 | NT | 10.7% | intergenic (+120/‑772) | opuD_1/acnA | Glycine betaine transporter OpuD/Aconitate hydratase A |
? | USA300TCH1516_ALE | = 1380322 | 166 (0.970) | intergenic (+136/‑756) | opuD_1/acnA | Glycine betaine transporter OpuD/Aconitate hydratase A | |||||
* | ? | USA300TCH1516_ALE | 1392266 = | 136 (0.710) | 19 (0.110) | 9/140 | NT | 12.9% | intergenic (+40/‑460) | alsT/glcT | Amino‑acid carrier protein AlsT/GlcA/glcB genes antiterminator |
? | USA300TCH1516_ALE | 1392308 = | 137 (0.820) | intergenic (+82/‑418) | alsT/glcT | Amino‑acid carrier protein AlsT/GlcA/glcB genes antiterminator | |||||
* | ? | USA300TCH1516_ALE | = 1392275 | 139 (0.730) | 22 (0.130) | 11/140 | NT | 14.6% | intergenic (+49/‑451) | alsT/glcT | Amino‑acid carrier protein AlsT/GlcA/glcB genes antiterminator |
? | USA300TCH1516_ALE | = 1392297 | 137 (0.820) | intergenic (+71/‑429) | alsT/glcT | Amino‑acid carrier protein AlsT/GlcA/glcB genes antiterminator | |||||
* | ? | USA300TCH1516_ALE | = 1394937 | 170 (0.890) | 26 (0.170) | 14/132 | NT | 14.1% | intergenic (+17/‑464) | tqsA/mprF | AI‑2 transport protein TqsA/Phosphatidylglycerol lysyltransferase |
? | USA300TCH1516_ALE | = 1394951 | 176 (1.120) | intergenic (+31/‑450) | tqsA/mprF | AI‑2 transport protein TqsA/Phosphatidylglycerol lysyltransferase | |||||
* | ? | USA300TCH1516_ALE | 1404075 = | 167 (0.880) | 18 (0.100) | 13/148 | NT | 11.2% | intergenic (+213/‑279) | ysdC_1/trpE | Putative aminopeptidase YsdC/Anthranilate synthase component 1 |
? | USA300TCH1516_ALE | 1404118 = | 132 (0.750) | intergenic (+256/‑236) | ysdC_1/trpE | Putative aminopeptidase YsdC/Anthranilate synthase component 1 | |||||
* | ? | USA300TCH1516_ALE | = 1404080 | 172 (0.900) | 15 (0.090) | 9/148 | NT | 9.3% | intergenic (+218/‑274) | ysdC_1/trpE | Putative aminopeptidase YsdC/Anthranilate synthase component 1 |
? | USA300TCH1516_ALE | = 1404111 | 132 (0.750) | intergenic (+249/‑243) | ysdC_1/trpE | Putative aminopeptidase YsdC/Anthranilate synthase component 1 | |||||
* | ? | USA300TCH1516_ALE | 1425261 = | 204 (1.070) | 15 (0.080) | 10/150 | NT | 7.8% | intergenic (‑166/+25) | pstC1/pstS | Phosphate transport system permease protein PstC 1/Phosphate‑binding protein PstS |
? | USA300TCH1516_ALE | 1425285 = | 164 (0.920) | intergenic (‑190/+1) | pstC1/pstS | Phosphate transport system permease protein PstC 1/Phosphate‑binding protein PstS | |||||
* | ? | USA300TCH1516_ALE | = 1426689 | 10 (0.050) | 11 (0.060) | 7/146 | NT | 54.7% | intergenic (‑420/+552) | pstS/cvfB | Phosphate‑binding protein PstS/Conserved virulence factor B |
? | USA300TCH1516_ALE | = 1426728 | NA (NA) | intergenic (‑459/+513) | pstS/cvfB | Phosphate‑binding protein PstS/Conserved virulence factor B | |||||
* | ? | USA300TCH1516_ALE | 1439018 = | 172 (0.900) | 22 (0.130) | 13/146 | NT | 11.9% | intergenic (+16/+224) | lysA/USA300HOU_RS07135 | Diaminopimelate decarboxylase/hypothetical protein |
? | USA300TCH1516_ALE | 1439055 = | 168 (0.970) | intergenic (+53/+187) | lysA/USA300HOU_RS07135 | Diaminopimelate decarboxylase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1439024 | 182 (0.960) | 21 (0.120) | 12/146 | NT | 11.2% | intergenic (+22/+218) | lysA/USA300HOU_RS07135 | Diaminopimelate decarboxylase/hypothetical protein |
? | USA300TCH1516_ALE | = 1439047 | 168 (0.970) | intergenic (+45/+195) | lysA/USA300HOU_RS07135 | Diaminopimelate decarboxylase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1442468 | 193 (1.010) | 14 (0.080) | 9/148 | NT | 7.2% | coding (838/1137 nt) | USA300HOU_RS07165 | TelA‑like protein |
? | USA300TCH1516_ALE | = 1442491 | 182 (1.030) | coding (861/1137 nt) | USA300HOU_RS07165 | TelA‑like protein | |||||
* | ? | USA300TCH1516_ALE | = 1443620 | 75 (0.390) | 26 (0.150) | 6/150 | NT | 27.0% | intergenic (‑193/+160) | USA300TCH1516_01342/brnQ_3 | hypothetical protein/Branched‑chain amino acid transport system 2 carrier protein |
? | USA300TCH1516_ALE | = 1804927 | NA (NA) | intergenic (‑215/+426) | USA300TCH1516_01684/pyk | hypothetical protein/Pyruvate kinase | |||||
* | ? | USA300TCH1516_ALE | = 1443621 | 72 (0.380) | 21 (0.120) | 4/152 | NT | 22.7% | intergenic (‑194/+159) | USA300TCH1516_01342/brnQ_3 | hypothetical protein/Branched‑chain amino acid transport system 2 carrier protein |
? | USA300TCH1516_ALE | 1910815 = | 75 (0.410) | intergenic (+348/‑207) | crcB_2/USA300TCH1516_01771 | Putative fluoride ion transporter CrcB/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1456948 = | 216 (1.130) | 38 (0.210) +GTTTT |
14/150 | NT | 16.8% | intergenic (‑62/‑182) | USA300HOU_RS07230/USA300HOU_RS07235 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 1918540 | 187 (0.980) | intergenic (‑258/+240) | USA300HOU_RS07235/USA300HOU_RS09510 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1494261 | 146 (0.770) | 18 (0.100) | 11/150 | NT | 12.0% | coding (7763/31266 nt) | ebh_1 | Extracellular matrix‑binding protein ebh |
? | USA300TCH1516_ALE | = 1494291 | 128 (0.720) | coding (7733/31266 nt) | ebh_1 | Extracellular matrix‑binding protein ebh | |||||
* | ? | USA300TCH1516_ALE | 1507967 = | 183 (0.960) | 25 (0.160) | 15/128 | NT | 17.2% | intergenic (‑392/+83) | ald1/ypcP | Alanine dehydrogenase 1/5'‑3' exonuclease |
? | USA300TCH1516_ALE | 1508010 = | 95 (0.630) | intergenic (‑435/+40) | ald1/ypcP | Alanine dehydrogenase 1/5'‑3' exonuclease | |||||
* | ? | USA300TCH1516_ALE | 1525192 = | 179 (0.940) | 11 (0.070) | 7/138 | NT | 6.8% | intergenic (‑265/+57) | asnS/dinG_1 | Asparagine‑‑tRNA ligase/putative ATP‑dependent helicase DinG |
? | USA300TCH1516_ALE | 1525239 = | 149 (0.910) | intergenic (‑312/+10) | asnS/dinG_1 | Asparagine‑‑tRNA ligase/putative ATP‑dependent helicase DinG | |||||
* | ? | USA300TCH1516_ALE | 1532094 = | 214 (1.120) | 14 (0.080) | 9/146 | NT | 7.0% | intergenic (‑263/+74) | USA300HOU_RS07465/USA300HOU_RS07470 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 1532129 = | 179 (1.030) | intergenic (‑298/+39) | USA300HOU_RS07465/USA300HOU_RS07470 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1533866 = | 159 (0.830) | 35 (0.210) | 15/138 | NT | 21.4% | coding (219/588 nt) | USA300HOU_RS07480 | hypothetical protein |
? | USA300TCH1516_ALE | 1533900 = | 120 (0.730) | coding (185/588 nt) | USA300HOU_RS07480 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1535925 | 175 (0.920) | 9 (0.050) | 8/144 | NT | 5.3% | coding (711/1299 nt) | aroA | 3‑phosphoshikimate 1‑carboxyvinyltransferase |
? | USA300TCH1516_ALE | = 1535948 | 163 (0.950) | coding (688/1299 nt) | aroA | 3‑phosphoshikimate 1‑carboxyvinyltransferase | |||||
* | ? | USA300TCH1516_ALE | = 1539773 | 162 (0.850) | 10 (0.060) | 8/148 | NT | 5.8% | coding (373/450 nt) | ndk | Nucleoside diphosphate kinase |
? | USA300TCH1516_ALE | = 1539799 | 177 (1.010) | coding (347/450 nt) | ndk | Nucleoside diphosphate kinase | |||||
* | ? | USA300TCH1516_ALE | 1555332 = | 194 (1.020) | 20 (0.120) | 13/140 | NT | 11.5% | intergenic (+28/+78) | USA300HOU_RS07605/ribU | Ferredoxin/Riboflavin transporter RibU |
? | USA300TCH1516_ALE | 1555376 = | 139 (0.840) | intergenic (+72/+34) | USA300HOU_RS07605/ribU | Ferredoxin/Riboflavin transporter RibU | |||||
* | ? | USA300TCH1516_ALE | 1572911 = | 154 (0.810) | 14 (0.080) | 7/148 | NT | 9.7% | coding (4606/6201 nt) | USA300HOU_RS07705 | Glycyl‑glycine endopeptidase ALE‑1 |
? | USA300TCH1516_ALE | 1572951 = | 118 (0.670) | coding (4566/6201 nt) | USA300HOU_RS07705 | Glycyl‑glycine endopeptidase ALE‑1 | |||||
* | ? | USA300TCH1516_ALE | 1574495 = | 207 (1.090) | 20 (0.110) | 9/150 | NT | 9.8% | coding (3022/6201 nt) | USA300HOU_RS07705 | Glycyl‑glycine endopeptidase ALE‑1 |
? | USA300TCH1516_ALE | 1574518 = | 176 (0.990) | coding (2999/6201 nt) | USA300HOU_RS07705 | Glycyl‑glycine endopeptidase ALE‑1 | |||||
* | ? | USA300TCH1516_ALE | = 1586059 | 238 (1.250) | 16 (0.090) | 5/148 | NT | 6.6% | intergenic (‑52/+75) | USA300HOU_RS07770/USA300TCH1516_01451 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 1586098 | 235 (1.330) | intergenic (‑91/+36) | USA300HOU_RS07770/USA300TCH1516_01451 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1611382 = | 181 (0.950) | 10 (0.060) | 5/148 | NT | 5.7% | coding (197/726 nt) | srrA | Transcriptional regulatory protein SrrA |
? | USA300TCH1516_ALE | 1611415 = | 166 (0.940) | coding (164/726 nt) | srrA | Transcriptional regulatory protein SrrA | |||||
* | ? | USA300TCH1516_ALE | = 1611738 | 154 (0.810) | 17 (0.100) | 14/148 | NT | 10.5% | coding (711/738 nt) | rluB | Ribosomal large subunit pseudouridine synthase B |
? | USA300TCH1516_ALE | = 1611757 | 146 (0.830) | coding (692/738 nt) | rluB | Ribosomal large subunit pseudouridine synthase B | |||||
* | ? | USA300TCH1516_ALE | 1614319 = | 184 (0.970) | 17 (0.100) | 9/150 | NT | 8.3% | intergenic (+14/+64) | USA300HOU_RS08000/xerD_3 | hypothetical protein/Tyrosine recombinase XerD |
? | USA300TCH1516_ALE | 1614368 = | 202 (1.130) | intergenic (+63/+15) | USA300HOU_RS08000/xerD_3 | hypothetical protein/Tyrosine recombinase XerD | |||||
* | ? | USA300TCH1516_ALE | 1634329 = | 161 (0.850) | 18 (0.100) | 8/150 | NT | 10.7% | coding (958/993 nt) | bfmBAA | 2‑oxoisovalerate dehydrogenase subunit alpha |
? | USA300TCH1516_ALE | 1634371 = | 149 (0.830) | coding (916/993 nt) | bfmBAA | 2‑oxoisovalerate dehydrogenase subunit alpha | |||||
* | ? | USA300TCH1516_ALE | 1647574 = | 198 (1.040) | 24 (0.140) | 13/148 | NT | 11.5% | intergenic (+4/+60) | USA300HOU_RS08180/lipM | hypothetical protein/Octanoyltransferase LipM |
? | USA300TCH1516_ALE | 1647624 = | 188 (1.070) | intergenic (+54/+10) | USA300HOU_RS08180/lipM | hypothetical protein/Octanoyltransferase LipM | |||||
* | ? | USA300TCH1516_ALE | = 1647578 | 197 (1.030) | 19 (0.110) | 13/144 | NT | 9.5% | intergenic (+8/+56) | USA300HOU_RS08180/lipM | hypothetical protein/Octanoyltransferase LipM |
? | USA300TCH1516_ALE | = 1647617 | 186 (1.090) | intergenic (+47/+17) | USA300HOU_RS08180/lipM | hypothetical protein/Octanoyltransferase LipM | |||||
* | ? | USA300TCH1516_ALE | 1660749 = | 221 (1.160) | 12 (0.070) | 11/142 | NT | 6.2% | coding (560/1464 nt) | gluP | Rhomboid protease GluP |
? | USA300TCH1516_ALE | 1660775 = | 166 (0.980) | coding (534/1464 nt) | gluP | Rhomboid protease GluP | |||||
* | ? | USA300TCH1516_ALE | 1662000 = | 222 (1.170) | 28 (0.170) | 19/136 | NT | 14.3% | intergenic (‑87/+68) | USA300HOU_RS08275/rpmG2_2 | 5‑formyltetrahydrofolate cyclo‑ligase/50S ribosomal protein L33 2 |
? | USA300TCH1516_ALE | 1662039 = | 146 (0.900) | intergenic (‑126/+29) | USA300HOU_RS08275/rpmG2_2 | 5‑formyltetrahydrofolate cyclo‑ligase/50S ribosomal protein L33 2 | |||||
* | ? | USA300TCH1516_ALE | 1665337 = | 78 (0.410) | 17 (0.130) | 14/108 | NT | 24.2% | intergenic (‑212/+65) | sodA/zur | Superoxide dismutase [Mn] 1/Zinc‑specific metallo‑regulatory protein |
? | USA300TCH1516_ALE | 1665405 = | 54 (0.420) | coding (408/411 nt) | zur | Zinc‑specific metallo‑regulatory protein | |||||
* | ? | USA300TCH1516_ALE | = 1665362 | 81 (0.430) | 14 (0.110) | 10/108 | NT | 20.5% | intergenic (‑237/+40) | sodA/zur | Superoxide dismutase [Mn] 1/Zinc‑specific metallo‑regulatory protein |
? | USA300TCH1516_ALE | = 1665378 | 54 (0.420) | intergenic (‑253/+24) | sodA/zur | Superoxide dismutase [Mn] 1/Zinc‑specific metallo‑regulatory protein | |||||
* | ? | USA300TCH1516_ALE | 1671778 = | 208 (1.090) | 19 (0.110) | 10/146 | NT | 9.5% | intergenic (‑23/+108) | trmK/sigA | tRNA (adenine(22)‑N(1))‑methyltransferase/RNA polymerase sigma factor SigA |
? | USA300TCH1516_ALE | 1671809 = | 171 (0.980) | intergenic (‑54/+77) | trmK/sigA | tRNA (adenine(22)‑N(1))‑methyltransferase/RNA polymerase sigma factor SigA | |||||
* | ? | USA300TCH1516_ALE | = 1676788 | 181 (0.950) | 24 (0.130) | 14/156 | NT | 11.7% | intergenic (‑344/‑75) | ccpN/glyQS | Transcriptional repressor CcpN/Glycine‑‑tRNA ligase |
? | USA300TCH1516_ALE | = 1676835 | 186 (1.000) | intergenic (‑391/‑28) | ccpN/glyQS | Transcriptional repressor CcpN/Glycine‑‑tRNA ligase | |||||
* | ? | USA300TCH1516_ALE | 1682514 = | 141 (0.740) | 25 (0.150) | 13/140 | NT | 16.9% | intergenic (‑259/+45) | USA300HOU_RS08380/USA300HOU_RS08385 | PhoH‑like protein/hypothetical protein |
? | USA300TCH1516_ALE | 1682550 = | 122 (0.730) | intergenic (‑295/+9) | USA300HOU_RS08380/USA300HOU_RS08385 | PhoH‑like protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1682523 | 145 (0.760) | 34 (0.200) | 16/140 | NT | 21.5% | intergenic (‑268/+36) | USA300HOU_RS08380/USA300HOU_RS08385 | PhoH‑like protein/hypothetical protein |
? | USA300TCH1516_ALE | = 1682539 | 122 (0.730) | intergenic (‑284/+20) | USA300HOU_RS08380/USA300HOU_RS08385 | PhoH‑like protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1693755 = | 192 (1.010) | 12 (0.070) | 5/140 | NT | 7.0% | coding (1040/1158 nt) | hemN_1 | Oxygen‑independent coproporphyrinogen‑III oxidase‑like protein YqeR |
? | USA300TCH1516_ALE | 1693791 = | 153 (0.920) | coding (1004/1158 nt) | hemN_1 | Oxygen‑independent coproporphyrinogen‑III oxidase‑like protein YqeR | |||||
* | ? | USA300TCH1516_ALE | = 1695186 | 163 (0.860) | 21 (0.120) | 13/142 | NT | 11.7% | intergenic (‑392/+138) | hemN_1/lepA | Oxygen‑independent coproporphyrinogen‑III oxidase‑like protein YqeR/Elongation factor 4 |
? | USA300TCH1516_ALE | 1873591 = | 173 (1.020) | intergenic (‑267/+483) | USA300HOU_RS09300/USA300HOU_RS09305 | Putative dipeptidase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1702257 = | 142 (0.750) | 17 (0.100) | 12/138 | NT | 11.4% | intergenic (‑1/+48) | comEA/tylM1 | ComE operon protein 1/dTDP‑3‑amino‑3,6‑dideoxy‑alpha‑D‑glucopyranose N,N‑dimethyltransferase |
? | USA300TCH1516_ALE | 1702302 = | 141 (0.860) | intergenic (‑46/+3) | comEA/tylM1 | ComE operon protein 1/dTDP‑3‑amino‑3,6‑dideoxy‑alpha‑D‑glucopyranose N,N‑dimethyltransferase | |||||
* | ? | USA300TCH1516_ALE | = 1702267 | 144 (0.760) | 16 (0.100) | 10/138 | NT | 10.8% | intergenic (‑11/+38) | comEA/tylM1 | ComE operon protein 1/dTDP‑3‑amino‑3,6‑dideoxy‑alpha‑D‑glucopyranose N,N‑dimethyltransferase |
? | USA300TCH1516_ALE | = 1702290 | 141 (0.860) | intergenic (‑34/+15) | comEA/tylM1 | ComE operon protein 1/dTDP‑3‑amino‑3,6‑dideoxy‑alpha‑D‑glucopyranose N,N‑dimethyltransferase | |||||
* | ? | USA300TCH1516_ALE | 1708636 = | 227 (1.190) | 18 (0.110) | 11/132 | NT | 9.9% | intergenic (+81/+121) | USA300HOU_RS08530/entA_3 | hypothetical protein/Enterotoxin type A |
? | USA300TCH1516_ALE | 1708685 = | 141 (0.900) | intergenic (+130/+72) | USA300HOU_RS08530/entA_3 | hypothetical protein/Enterotoxin type A | |||||
* | ? | USA300TCH1516_ALE | 1721519 = | 196 (1.030) | 19 (0.110) | 14/142 | NT | 10.4% | intergenic (‑236/+49) | USA300HOU_RS08595/USA300HOU_RS08600 | Putative O‑methyltransferase/MSMEI_4947/hypothetical protein |
? | USA300TCH1516_ALE | 1721556 = | 155 (0.920) | intergenic (‑273/+12) | USA300HOU_RS08595/USA300HOU_RS08600 | Putative O‑methyltransferase/MSMEI_4947/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1732959 = | 126 (0.660) | 11 (0.070) | 7/136 | NT | 8.2% | intergenic (+145/+92) | limB_2/USA300HOU_RS08645 | Limonene 1,2‑monooxygenase/hypothetical protein |
? | USA300TCH1516_ALE | 1733016 = | 139 (0.860) | intergenic (+202/+35) | limB_2/USA300HOU_RS08645 | Limonene 1,2‑monooxygenase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1732970 | 117 (0.610) | 19 (0.120) | 11/136 | NT | 13.8% | intergenic (+156/+81) | limB_2/USA300HOU_RS08645 | Limonene 1,2‑monooxygenase/hypothetical protein |
? | USA300TCH1516_ALE | = 1733003 | 139 (0.860) | intergenic (+189/+48) | limB_2/USA300HOU_RS08645 | Limonene 1,2‑monooxygenase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1747135 | 151 (0.790) | 16 (0.100) | 11/132 | NT | 10.2% | intergenic (‑169/+34) | recJ/USA300HOU_RS08710 | Single‑stranded‑DNA‑specific exonuclease RecJ/Heme uptake protein MmpL11 |
? | USA300TCH1516_ALE | = 1747146 | 157 (1.000) | intergenic (‑180/+23) | recJ/USA300HOU_RS08710 | Single‑stranded‑DNA‑specific exonuclease RecJ/Heme uptake protein MmpL11 | |||||
* | ? | USA300TCH1516_ALE | 1759667 = | 202 (1.060) | 13 (0.080) | 7/132 | NT | 8.5% | intergenic (‑374/+100) | USA300HOU_RS08780/USA300HOU_RS08785 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 1759723 = | 114 (0.730) | intergenic (‑430/+44) | USA300HOU_RS08780/USA300HOU_RS08785 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1766678 = | 153 (0.800) | 14 (0.080) | 6/140 | NT | 8.9% | intergenic (+22/+201) | tag/USA300HOU_RS08820 | DNA‑3‑methyladenine glycosylase 1/hypothetical protein |
? | USA300TCH1516_ALE | 1766721 = | 154 (0.930) | intergenic (+65/+158) | tag/USA300HOU_RS08820 | DNA‑3‑methyladenine glycosylase 1/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1766687 | 153 (0.800) | 15 (0.090) | 9/140 | NT | 9.4% | intergenic (+31/+192) | tag/USA300HOU_RS08820 | DNA‑3‑methyladenine glycosylase 1/hypothetical protein |
? | USA300TCH1516_ALE | = 1766710 | 154 (0.930) | intergenic (+54/+169) | tag/USA300HOU_RS08820 | DNA‑3‑methyladenine glycosylase 1/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1775185 = | 160 (0.840) | 10 (0.060) | 7/142 | NT | 6.9% | intergenic (‑78/+76) | engB/clpX | putative GTP‑binding protein EngB/ATP‑dependent Clp protease ATP‑binding subunit ClpX |
? | USA300TCH1516_ALE | 1775239 = | 129 (0.760) | intergenic (‑132/+22) | engB/clpX | putative GTP‑binding protein EngB/ATP‑dependent Clp protease ATP‑binding subunit ClpX | |||||
* | ? | USA300TCH1516_ALE | = 1775193 | 151 (0.790) | 13 (0.080) | 8/142 | NT | 9.0% | intergenic (‑86/+68) | engB/clpX | putative GTP‑binding protein EngB/ATP‑dependent Clp protease ATP‑binding subunit ClpX |
? | USA300TCH1516_ALE | = 1775229 | 129 (0.760) | intergenic (‑122/+32) | engB/clpX | putative GTP‑binding protein EngB/ATP‑dependent Clp protease ATP‑binding subunit ClpX | |||||
* | ? | USA300TCH1516_ALE | 1789630 = | 195 (1.020) | 18 (0.110) | 12/138 | NT | 11.0% | intergenic (‑111/+59) | gapA2/coaE | Glyceraldehyde‑3‑phosphate dehydrogenase 2/Dephospho‑CoA kinase |
? | USA300TCH1516_ALE | 1789673 = | 123 (0.750) | intergenic (‑154/+16) | gapA2/coaE | Glyceraldehyde‑3‑phosphate dehydrogenase 2/Dephospho‑CoA kinase | |||||
* | ? | USA300TCH1516_ALE | = 1797508 | 171 (0.900) | 22 (0.130) | 15/146 | NT | 11.7% | coding (283/1665 nt) | phoR | Alkaline phosphatase synthesis sensor protein PhoR |
? | USA300TCH1516_ALE | = 1797517 | 176 (1.010) | coding (274/1665 nt) | phoR | Alkaline phosphatase synthesis sensor protein PhoR | |||||
* | ? | USA300TCH1516_ALE | 1810695 = | 202 (1.060) | 10 (0.060) | 6/150 | NT | 5.0% | coding (900/1230 nt) | USA300HOU_RS09025 | NAD‑dependent malic enzyme |
? | USA300TCH1516_ALE | 1810720 = | 187 (1.050) | coding (875/1230 nt) | USA300HOU_RS09025 | NAD‑dependent malic enzyme | |||||
* | ? | USA300TCH1516_ALE | = 1822873 | 129 (0.680) | 12 (0.070) | 10/142 | NT | 8.3% | intergenic (+194/+52) | USA300HOU_RS09070/ackA | Putative universal stress protein/Acetate kinase |
? | USA300TCH1516_ALE | = 1822899 | 151 (0.890) | intergenic (+220/+26) | USA300HOU_RS09070/ackA | Putative universal stress protein/Acetate kinase | |||||
* | ? | USA300TCH1516_ALE | 1836934 = | 131 (0.690) | 31 (0.200) | 12/132 | NT | 22.1% | intergenic (+18/+132) | serA/gph_2 | D‑3‑phosphoglycerate dehydrogenase/Phosphoglycolate phosphatase |
? | USA300TCH1516_ALE | 1836982 = | 111 (0.710) | intergenic (+66/+84) | serA/gph_2 | D‑3‑phosphoglycerate dehydrogenase/Phosphoglycolate phosphatase | |||||
* | ? | USA300TCH1516_ALE | = 1836947 | 130 (0.680) | 17 (0.110) | 10/132 | NT | 13.5% | intergenic (+31/+119) | serA/gph_2 | D‑3‑phosphoglycerate dehydrogenase/Phosphoglycolate phosphatase |
? | USA300TCH1516_ALE | = 1836967 | 111 (0.710) | intergenic (+51/+99) | serA/gph_2 | D‑3‑phosphoglycerate dehydrogenase/Phosphoglycolate phosphatase | |||||
* | ? | USA300TCH1516_ALE | = 1838263 | 188 (0.990) | 17 (0.100) | 9/140 | NT | 8.7% | intergenic (‑67/+40) | gph_2/nagE | Phosphoglycolate phosphatase/PTS system N‑acetylglucosamine‑specific EIICBA component |
? | USA300TCH1516_ALE | = 1838279 | 193 (1.160) | intergenic (‑83/+24) | gph_2/nagE | Phosphoglycolate phosphatase/PTS system N‑acetylglucosamine‑specific EIICBA component | |||||
* | ? | USA300TCH1516_ALE | 1841984 = | 192 (1.010) | 16 (0.100) | 11/134 | NT | 10.1% | intergenic (+24/+70) | htrA/tyrS | Serine protease Do‑like HtrA/Tyrosine‑‑tRNA ligase |
? | USA300TCH1516_ALE | 1842029 = | 123 (0.770) | intergenic (+69/+25) | htrA/tyrS | Serine protease Do‑like HtrA/Tyrosine‑‑tRNA ligase | |||||
* | ? | USA300TCH1516_ALE | 1844653 = | 241 (1.260) | 19 (0.110) | 11/142 | NT | 8.7% | intergenic (+50/+153) | mrcA/isdH | Penicillin‑binding protein 1A/Iron‑regulated surface determinant protein H |
? | USA300TCH1516_ALE | 1844699 = | 186 (1.100) | intergenic (+96/+107) | mrcA/isdH | Penicillin‑binding protein 1A/Iron‑regulated surface determinant protein H | |||||
* | ? | USA300TCH1516_ALE | 1853635 = | 205 (1.080) | 17 (0.100) | 10/144 | NT | 8.9% | intergenic (+38/+60) | acuC/ccpA | Acetoin utilization protein AcuC/Catabolite control protein A |
? | USA300TCH1516_ALE | 1853683 = | 162 (0.950) | intergenic (+86/+12) | acuC/ccpA | Acetoin utilization protein AcuC/Catabolite control protein A | |||||
* | ? | USA300TCH1516_ALE | 1858390 = | 128 (0.670) | 23 (0.150) | 13/126 | NT | 16.8% | intergenic (‑17/+57) | USA300HOU_RS09235/USA300HOU_RS09240 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 1858437 = | 127 (0.850) | intergenic (‑64/+10) | USA300HOU_RS09235/USA300HOU_RS09240 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1858406 | 132 (0.690) | 16 (0.110) | 10/126 | NT | 12.2% | intergenic (‑33/+41) | USA300HOU_RS09235/USA300HOU_RS09240 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 1858419 | 127 (0.850) | intergenic (‑46/+28) | USA300HOU_RS09235/USA300HOU_RS09240 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1868935 = | 162 (0.850) | 29 (0.170) | 18/142 | NT | 16.2% | intergenic (‑342/+128) | ytnP/trmB | putative quorum‑quenching lactonase YtnP/tRNA (guanine‑N(7)‑)‑methyltransferase |
? | USA300TCH1516_ALE | 1868982 = | 156 (0.920) | intergenic (‑389/+81) | ytnP/trmB | putative quorum‑quenching lactonase YtnP/tRNA (guanine‑N(7)‑)‑methyltransferase | |||||
* | ? | USA300TCH1516_ALE | = 1868943 | 170 (0.890) | 17 (0.100) | 10/142 | NT | 10.0% | intergenic (‑350/+120) | ytnP/trmB | putative quorum‑quenching lactonase YtnP/tRNA (guanine‑N(7)‑)‑methyltransferase |
? | USA300TCH1516_ALE | = 1868972 | 156 (0.920) | intergenic (‑379/+91) | ytnP/trmB | putative quorum‑quenching lactonase YtnP/tRNA (guanine‑N(7)‑)‑methyltransferase | |||||
* | ? | USA300TCH1516_ALE | 1870432 = | 192 (1.010) | 11 (0.060) | 7/150 | NT | 5.7% | coding (82/792 nt) | srkA | Stress response kinase A |
? | USA300TCH1516_ALE | 1870465 = | 183 (1.030) | coding (49/792 nt) | srkA | Stress response kinase A | |||||
* | ? | USA300TCH1516_ALE | 1878597 = | 176 (0.920) | 18 (0.120) | 10/124 | NT | 13.8% | intergenic (+56/+61) | USA300HOU_RS09320/ebh_2 | Ferredoxin‑‑NADP reductase/Extracellular matrix‑binding protein ebh |
? | USA300TCH1516_ALE | 1878652 = | 89 (0.600) | intergenic (+111/+6) | USA300HOU_RS09320/ebh_2 | Ferredoxin‑‑NADP reductase/Extracellular matrix‑binding protein ebh | |||||
* | ? | USA300TCH1516_ALE | 1901310 = | 184 (0.970) | 17 (0.100) | 12/142 | NT | 10.9% | intergenic (‑306/‑217) | USA300HOU_RS09405/sdpR | hypothetical protein/Transcriptional repressor SdpR |
? | USA300TCH1516_ALE | 1901351 = | 115 (0.680) | intergenic (‑347/‑176) | USA300HOU_RS09405/sdpR | hypothetical protein/Transcriptional repressor SdpR | |||||
* | ? | USA300TCH1516_ALE | 1908173 = | 190 (1.000) | 26 (0.150) | 24/148 | NT | 13.7% | intergenic (+392/+48) | USA300HOU_RS09450/tal | hypothetical protein/Transaldolase |
? | USA300TCH1516_ALE | 1908206 = | 152 (0.860) | intergenic (+425/+15) | USA300HOU_RS09450/tal | hypothetical protein/Transaldolase | |||||
* | ? | USA300TCH1516_ALE | 1928287 = | 180 (0.940) | 25 (0.150) | 13/140 | NT | 14.0% | intergenic (‑241/+60) | USA300HOU_RS09565/USA300HOU_RS09575 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 1928329 = | 151 (0.910) | intergenic (‑283/+18) | USA300HOU_RS09565/USA300HOU_RS09575 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1928296 | 177 (0.930) | 18 (0.110) | 8/140 | NT | 10.5% | intergenic (‑250/+51) | USA300HOU_RS09565/USA300HOU_RS09575 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 1928318 | 151 (0.910) | intergenic (‑272/+29) | USA300HOU_RS09565/USA300HOU_RS09575 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1933839 = | 213 (1.120) | 10 (0.060) | 7/142 | NT | 5.5% | coding (1409/3816 nt) | USA300HOU_RS09605 | hypothetical protein |
? | USA300TCH1516_ALE | 1933862 = | 158 (0.940) | coding (1386/3816 nt) | USA300HOU_RS09605 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1939370 = | 204 (1.070) | 15 (0.080) | 8/154 | NT | 7.4% | intergenic (‑229/+134) | hsdM_2/splF | Type I restriction enzyme EcoKI M protein/Serine protease SplF |
? | USA300TCH1516_ALE | 1939419 = | 178 (0.970) | intergenic (‑278/+85) | hsdM_2/splF | Type I restriction enzyme EcoKI M protein/Serine protease SplF | |||||
* | ? | USA300TCH1516_ALE | = 1939372 | 197 (1.030) | 15 (0.080) | 9/154 | NT | 7.5% | intergenic (‑231/+132) | hsdM_2/splF | Type I restriction enzyme EcoKI M protein/Serine protease SplF |
? | USA300TCH1516_ALE | = 1939415 | 178 (0.970) | intergenic (‑274/+89) | hsdM_2/splF | Type I restriction enzyme EcoKI M protein/Serine protease SplF | |||||
* | ? | USA300TCH1516_ALE | = 1945259 | 231 (1.210) | 16 (0.090) | 11/144 | NT | 6.8% | intergenic (‑840/‑124) | splA/USA300HOU_RS09665 | Serine protease SplA/hypothetical protein |
? | USA300TCH1516_ALE | = 1945265 | 229 (1.340) | intergenic (‑846/‑118) | splA/USA300HOU_RS09665 | Serine protease SplA/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1946068 = | 205 (1.080) | 15 (0.090) | 9/142 | NT | 8.0% | intergenic (+119/+355) | USA300HOU_RS09665/USA300HOU_RS15380 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 1946105 = | 164 (0.970) | intergenic (+156/+318) | USA300HOU_RS09665/USA300HOU_RS15380 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1954420 = | 246 (1.290) | 18 (0.100) | 11/152 | NT | 7.5% | coding (319/2994 nt) | nisB | Nisin biosynthesis protein NisB |
? | USA300TCH1516_ALE | 1954445 = | 209 (1.160) | coding (294/2994 nt) | nisB | Nisin biosynthesis protein NisB | |||||
* | ? | USA300TCH1516_ALE | = 1963219 | 180 (0.940) | 14 (0.080) | 11/152 | NT | 7.5% | intergenic (‑82/+241) | ydeN/hemY | Putative hydrolase YdeN/Protoporphyrinogen oxidase |
? | USA300TCH1516_ALE | = 1963263 | 176 (0.970) | intergenic (‑126/+197) | ydeN/hemY | Putative hydrolase YdeN/Protoporphyrinogen oxidase | |||||
* | ? | USA300TCH1516_ALE | 1967716 = | 166 (0.870) | 14 (0.080) | 10/146 | NT | 9.1% | intergenic (+48/+76) | traP/USA300HOU_RS09810 | Signal transduction protein TRAP/hypothetical protein |
? | USA300TCH1516_ALE | 1967758 = | 129 (0.740) | intergenic (+90/+34) | traP/USA300HOU_RS09810 | Signal transduction protein TRAP/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1970888 = | 156 (0.820) | 22 (0.130) | 10/142 | NT | 13.0% | intergenic (+77/‑656) | USA300HOU_RS09825/USA300HOU_RS09830 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 1970925 = | 155 (0.920) | intergenic (+114/‑619) | USA300HOU_RS09825/USA300HOU_RS09830 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1970896 | 158 (0.830) | 19 (0.110) | 11/142 | NT | 11.4% | intergenic (+85/‑648) | USA300HOU_RS09825/USA300HOU_RS09830 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 1970915 | 155 (0.920) | intergenic (+104/‑629) | USA300HOU_RS09825/USA300HOU_RS09830 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 1980867 = | 134 (0.700) | 19 (0.110) | 13/140 | NT | 15.0% | intergenic (‑109/+70) | USA300HOU_RS09865/USA300HOU_RS09870 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 1980913 = | 98 (0.590) | intergenic (‑155/+24) | USA300HOU_RS09865/USA300HOU_RS09870 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1980876 | 132 (0.690) | 17 (0.100) | 8/140 | NT | 13.7% | intergenic (‑118/+61) | USA300HOU_RS09865/USA300HOU_RS09870 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 1980902 | 98 (0.590) | intergenic (‑144/+35) | USA300HOU_RS09865/USA300HOU_RS09870 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 1990358 | 136 (0.710) | 22 (0.150) | 14/124 | NT | 14.8% | intergenic (‑107/+44) | queG/tcyC_1 | Epoxyqueuosine reductase/L‑cystine import ATP‑binding protein TcyC |
? | USA300TCH1516_ALE | = 1990373 | 149 (1.010) | intergenic (‑122/+29) | queG/tcyC_1 | Epoxyqueuosine reductase/L‑cystine import ATP‑binding protein TcyC | |||||
* | ? | USA300TCH1516_ALE | 2008942 = | 127 (0.670) | 12 (0.080) | 7/132 | NT | 9.9% | intergenic (+70/+121) | USA300HOU_RS10115/USA300HOU_RS10125 | hypothetical protein/Putative multidrug export ATP‑binding/permease protein |
? | USA300TCH1516_ALE | 2008991 = | 115 (0.730) | intergenic (+119/+72) | USA300HOU_RS10115/USA300HOU_RS10125 | hypothetical protein/Putative multidrug export ATP‑binding/permease protein | |||||
* | ? | USA300TCH1516_ALE | = 2008955 | 126 (0.660) | 21 (0.130) | 11/132 | NT | 16.1% | intergenic (+83/+108) | USA300HOU_RS10115/USA300HOU_RS10125 | hypothetical protein/Putative multidrug export ATP‑binding/permease protein |
? | USA300TCH1516_ALE | = 2008976 | 115 (0.730) | intergenic (+104/+87) | USA300HOU_RS10115/USA300HOU_RS10125 | hypothetical protein/Putative multidrug export ATP‑binding/permease protein | |||||
* | ? | USA300TCH1516_ALE | = 2014149 | 193 (1.010) | 15 (0.090) | 11/148 | NT | 7.5% | intergenic (+49/+212) | USA300HOU_RS10140/USA300HOU_RS10150 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 2014182 | 192 (1.090) | intergenic (+82/+179) | USA300HOU_RS10140/USA300HOU_RS10150 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2021453 = | 138 (0.720) | 13 (0.080) | 6/140 | NT | 9.2% | intergenic (+12/+248) | queE_2/USA300HOU_RS10190 | 7‑carboxy‑7‑deazaguanine synthase/putative acyl‑CoA thioester hydrolase |
? | USA300TCH1516_ALE | 2021493 = | 136 (0.820) | intergenic (+52/+208) | queE_2/USA300HOU_RS10190 | 7‑carboxy‑7‑deazaguanine synthase/putative acyl‑CoA thioester hydrolase | |||||
* | ? | USA300TCH1516_ALE | = 2021462 | 141 (0.740) | 31 (0.190) | 14/140 | NT | 19.3% | intergenic (+21/+239) | queE_2/USA300HOU_RS10190 | 7‑carboxy‑7‑deazaguanine synthase/putative acyl‑CoA thioester hydrolase |
? | USA300TCH1516_ALE | = 2021482 | 136 (0.820) | intergenic (+41/+219) | queE_2/USA300HOU_RS10190 | 7‑carboxy‑7‑deazaguanine synthase/putative acyl‑CoA thioester hydrolase | |||||
* | ? | USA300TCH1516_ALE | = 2031959 | 156 (0.820) | 22 (0.130) | 12/146 | NT | 12.8% | intergenic (+425/+65) | USA300HOU_RS10250/USA300HOU_RS10255 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 2031978 | 157 (0.900) | intergenic (+444/+46) | USA300HOU_RS10250/USA300HOU_RS10255 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2032547 = | 202 (1.060) | 14 (0.080) | 11/144 | NT | 7.4% | intergenic (‑110/+115) | USA300HOU_RS10255/cobQ | hypothetical protein/Cobyric acid synthase |
? | USA300TCH1516_ALE | 2032589 = | 169 (0.990) | intergenic (‑152/+73) | USA300HOU_RS10255/cobQ | hypothetical protein/Cobyric acid synthase | |||||
* | ? | USA300TCH1516_ALE | 2055574 = | 186 (0.980) | 10 (0.060) | 8/142 | NT | 5.9% | intergenic (‑715/‑146) | purB/sspP | Adenylosuccinate lyase/Staphopain A |
? | USA300TCH1516_ALE | 2055599 = | 152 (0.900) | intergenic (‑740/‑121) | purB/sspP | Adenylosuccinate lyase/Staphopain A | |||||
* | ? | USA300TCH1516_ALE | = 2057471 | 169 (0.890) | 26 (0.170) | 10/132 | NT | 14.5% | intergenic (+228/+64) | USA300HOU_RS10370/USA300HOU_RS10375 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 2057483 | 167 (1.070) | intergenic (+240/+52) | USA300HOU_RS10370/USA300HOU_RS10375 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2062972 | 153 (0.800) | 34 (0.220) | 16/132 | NT | 19.0% | intergenic (+53/+137) | pheA/sdcS | P‑protein/Sodium‑dependent dicarboxylate transporter SdcS |
? | USA300TCH1516_ALE | = 2062986 | 164 (1.050) | intergenic (+67/+123) | pheA/sdcS | P‑protein/Sodium‑dependent dicarboxylate transporter SdcS | |||||
* | ? | USA300TCH1516_ALE | = 2073758 | 170 (0.890) | 17 (0.110) | 9/136 | NT | 9.4% | intergenic (+16/+41) | USA300HOU_RS10455/USA300HOU_RS10460 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 2073772 | 182 (1.130) | intergenic (+30/+27) | USA300HOU_RS10455/USA300HOU_RS10460 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2082368 = | 165 (0.870) | 22 (0.130) | 12/138 | NT | 12.4% | intergenic (+9/+315) | aspC/USA300HOU_RS10520 | Aspartate aminotransferase/65 kDa membrane protein |
? | USA300TCH1516_ALE | 2082406 = | 170 (1.040) | intergenic (+47/+277) | aspC/USA300HOU_RS10520 | Aspartate aminotransferase/65 kDa membrane protein | |||||
* | ? | USA300TCH1516_ALE | = 2082378 | 175 (0.920) | 21 (0.130) | 12/138 | NT | 11.6% | intergenic (+19/+305) | aspC/USA300HOU_RS10520 | Aspartate aminotransferase/65 kDa membrane protein |
? | USA300TCH1516_ALE | = 2082394 | 170 (1.040) | intergenic (+35/+289) | aspC/USA300HOU_RS10520 | Aspartate aminotransferase/65 kDa membrane protein | |||||
* | ? | USA300TCH1516_ALE | 2082519 = | 254 (1.330) | 22 (0.130) | 10/142 | NT | 9.9% | intergenic (+160/+164) | aspC/USA300HOU_RS10520 | Aspartate aminotransferase/65 kDa membrane protein |
? | USA300TCH1516_ALE | 2082566 = | 174 (1.030) | intergenic (+207/+117) | aspC/USA300HOU_RS10520 | Aspartate aminotransferase/65 kDa membrane protein | |||||
* | ? | USA300TCH1516_ALE | = 2090954 | 170 (0.890) | 21 (0.120) | 12/142 | NT | 11.6% | intergenic (‑188/+350) | USA300HOU_RS10575/USA300HOU_RS10590 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 2090971 | 169 (1.000) | intergenic (‑205/+333) | USA300HOU_RS10575/USA300HOU_RS10590 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2091221 | 189 (0.990) | 10 (0.100) +37 bp |
5/86 | NT | 9.2% | intergenic (‑455/+83) | USA300HOU_RS10575/USA300HOU_RS10590 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 2265802 | 181 (0.950) | intergenic (+665/+364) | USA300HOU_RS11590/hin_3 | hypothetical protein/DNA‑invertase hin | |||||
* | ? | USA300TCH1516_ALE | 2121137 = | 220 (1.150) | 15 (0.080) | 11/152 | NT | 7.2% | intergenic (‑63/+32) | USA300HOU_RS10790/USA300HOU_RS10795 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 2121165 = | 180 (1.000) | intergenic (‑91/+4) | USA300HOU_RS10790/USA300HOU_RS10795 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2141638 = | 169 (0.890) | 16 (0.090) | 9/148 | NT | 9.5% | coding (450/1617 nt) | groL | 60 kDa chaperonin |
? | USA300TCH1516_ALE | 2141666 = | 147 (0.830) | coding (422/1617 nt) | groL | 60 kDa chaperonin | |||||
* | ? | USA300TCH1516_ALE | 2141814 = | 175 (0.920) | 15 (0.080) | 8/152 | NT | 8.3% | coding (274/1617 nt) | groL | 60 kDa chaperonin |
? | USA300TCH1516_ALE | 2141841 = | 165 (0.910) | coding (247/1617 nt) | groL | 60 kDa chaperonin | |||||
* | ? | USA300TCH1516_ALE | 2142773 = | 188 (0.990) | 15 (0.090) | 12/148 | NT | 8.6% | coding (152/744 nt) | USA300HOU_RS10935 | hypothetical protein |
? | USA300TCH1516_ALE | 2142794 = | 146 (0.830) | coding (173/744 nt) | USA300HOU_RS10935 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2143370 = | 217 (1.140) | 12 (0.080) | 11/132 | NT | 7.2% | intergenic (+5/+20) | USA300HOU_RS10935/USA300HOU_RS10940 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 2143414 = | 131 (0.840) | coding (1230/1254 nt) | USA300HOU_RS10940 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2150647 = | 195 (1.020) | 18 (0.110) | 13/136 | NT | 11.1% | intergenic (+310/+57) | agrA/scrK | Accessory gene regulator A/Fructokinase |
? | USA300TCH1516_ALE | 2150691 = | 124 (0.770) | intergenic (+354/+13) | agrA/scrK | Accessory gene regulator A/Fructokinase | |||||
* | ? | USA300TCH1516_ALE | 2154654 = | 166 (0.870) | 9 (0.050) | 6/146 | NT | 5.7% | coding (1023/1251 nt) | nrgA | Ammonium transporter NrgA |
? | USA300TCH1516_ALE | 2154684 = | 149 (0.860) | coding (993/1251 nt) | nrgA | Ammonium transporter NrgA | |||||
* | ? | USA300TCH1516_ALE | 2160376 = | 157 (0.820) | 13 (0.080) | 10/136 | NT | 8.5% | intergenic (+9/‑352) | yheS/mutS_2 | putative ABC transporter ATP‑binding protein YheS/DNA mismatch repair protein MutS |
? | USA300TCH1516_ALE | 2160413 = | 148 (0.920) | intergenic (+46/‑315) | yheS/mutS_2 | putative ABC transporter ATP‑binding protein YheS/DNA mismatch repair protein MutS | |||||
* | ? | USA300TCH1516_ALE | = 2160387 | 150 (0.790) | 21 (0.130) | 14/136 | NT | 13.2% | intergenic (+20/‑341) | yheS/mutS_2 | putative ABC transporter ATP‑binding protein YheS/DNA mismatch repair protein MutS |
? | USA300TCH1516_ALE | = 2160400 | 148 (0.920) | intergenic (+33/‑328) | yheS/mutS_2 | putative ABC transporter ATP‑binding protein YheS/DNA mismatch repair protein MutS | |||||
* | ? | USA300TCH1516_ALE | 2186610 = | 206 (1.080) | 9 (0.050) | 7/142 | NT | 5.5% | coding (5/480 nt) | rsbW | Serine‑protein kinase RsbW |
? | USA300TCH1516_ALE | 2186648 = | 128 (0.760) | coding (295/327 nt) | rsbV | Anti‑sigma‑B factor antagonist | |||||
* | ? | USA300TCH1516_ALE | 2201275 = | 141 (0.740) | 17 (0.110) | 10/136 | NT | 11.5% | intergenic (+5/+364) | kdpE/cshA | KDP operon transcriptional regulatory protein KdpE/DEAD‑box ATP‑dependent RNA helicase CshA |
? | USA300TCH1516_ALE | 2201326 = | 141 (0.870) | intergenic (+56/+313) | kdpE/cshA | KDP operon transcriptional regulatory protein KdpE/DEAD‑box ATP‑dependent RNA helicase CshA | |||||
* | ? | USA300TCH1516_ALE | = 2201286 | 152 (0.800) | 30 (0.190) | 16/136 | NT | 18.2% | intergenic (+16/+353) | kdpE/cshA | KDP operon transcriptional regulatory protein KdpE/DEAD‑box ATP‑dependent RNA helicase CshA |
? | USA300TCH1516_ALE | = 2201313 | 141 (0.870) | intergenic (+43/+326) | kdpE/cshA | KDP operon transcriptional regulatory protein KdpE/DEAD‑box ATP‑dependent RNA helicase CshA | |||||
* | ? | USA300TCH1516_ALE | = 2211758 | 190 (1.000) | 24 (0.150) | 11/138 | NT | 12.5% | intergenic (+751/+62) | USA300HOU_RS11275/yidC | hypothetical protein/Membrane protein insertase YidC |
? | USA300TCH1516_ALE | = 2211795 | 172 (1.050) | intergenic (+788/+25) | USA300HOU_RS11275/yidC | hypothetical protein/Membrane protein insertase YidC | |||||
* | ? | USA300TCH1516_ALE | 2218211 = | 208 (1.090) | 16 (0.110) | 11/124 | NT | 10.4% | intergenic (+4/+55) | USA300HOU_RS11330/fabZ | hypothetical protein/3‑hydroxyacyl‑[acyl‑carrier‑protein] dehydratase FabZ |
? | USA300TCH1516_ALE | 2218261 = | 116 (0.790) | intergenic (+54/+5) | USA300HOU_RS11330/fabZ | hypothetical protein/3‑hydroxyacyl‑[acyl‑carrier‑protein] dehydratase FabZ | |||||
* | ? | USA300TCH1516_ALE | 2236023 = | 155 (0.810) | 18 (0.110) | 9/142 | NT | 11.9% | intergenic (‑296/+51) | tdk/rpmE2 | Thymidine kinase/50S ribosomal protein L31 type B |
? | USA300TCH1516_ALE | 2236061 = | 130 (0.770) | intergenic (‑334/+13) | tdk/rpmE2 | Thymidine kinase/50S ribosomal protein L31 type B | |||||
* | ? | USA300TCH1516_ALE | = 2245371 | 175 (0.920) | 32 (0.190) | 16/144 | NT | 16.7% | intergenic (‑230/+106) | pyrG/rpoE | CTP synthase/putative DNA‑directed RNA polymerase subunit delta |
? | USA300TCH1516_ALE | = 2245389 | 163 (0.950) | intergenic (‑248/+88) | pyrG/rpoE | CTP synthase/putative DNA‑directed RNA polymerase subunit delta | |||||
* | ? | USA300TCH1516_ALE | 2252589 = | 178 (0.930) | 15 (0.090) | 10/142 | NT | 9.5% | intergenic (+25/+127) | luxS/USA300HOU_RS11525 | S‑ribosylhomocysteine lyase/hypothetical protein |
? | USA300TCH1516_ALE | 2252638 = | 128 (0.760) | intergenic (+74/+78) | luxS/USA300HOU_RS11525 | S‑ribosylhomocysteine lyase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2252663 | 137 (0.720) | 13 (0.070) | 7/148 | NT | 8.4% | intergenic (+99/+53) | luxS/USA300HOU_RS11525 | S‑ribosylhomocysteine lyase/hypothetical protein |
? | USA300TCH1516_ALE | = 2252697 | 158 (0.900) | intergenic (+133/+19) | luxS/USA300HOU_RS11525 | S‑ribosylhomocysteine lyase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2256396 = | 114 (0.600) | 24 (0.150) | 12/132 | NT | 18.6% | intergenic (+49/+72) | deoD1/dps | Purine nucleoside phosphorylase DeoD‑type 1/General stress protein 20U |
? | USA300TCH1516_ALE | 2256443 = | 116 (0.740) | intergenic (+96/+25) | deoD1/dps | Purine nucleoside phosphorylase DeoD‑type 1/General stress protein 20U | |||||
* | ? | USA300TCH1516_ALE | = 2256409 | 114 (0.600) | 28 (0.180) | 13/132 | NT | 21.1% | intergenic (+62/+59) | deoD1/dps | Purine nucleoside phosphorylase DeoD‑type 1/General stress protein 20U |
? | USA300TCH1516_ALE | = 2256428 | 116 (0.740) | intergenic (+81/+40) | deoD1/dps | Purine nucleoside phosphorylase DeoD‑type 1/General stress protein 20U | |||||
* | ? | USA300TCH1516_ALE | = 2259599 | 156 (0.820) | 19 (0.110) | 9/142 | NT | 11.3% | intergenic (‑244/+428) | USA300HOU_RS11560/USA300HOU_RS11565 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 2259613 | 159 (0.940) | intergenic (‑258/+414) | USA300HOU_RS11560/USA300HOU_RS11565 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2270512 = | 168 (0.880) | 14 (0.080) | 9/144 | NT | 9.0% | intergenic (‑155/+77) | ylmA/glmS | putative ABC transporter ATP‑binding protein YlmA/Glutamine‑‑fructose‑6‑phosphate aminotransferase [isomerizing] |
? | USA300TCH1516_ALE | 2270545 = | 133 (0.780) | intergenic (‑188/+44) | ylmA/glmS | putative ABC transporter ATP‑binding protein YlmA/Glutamine‑‑fructose‑6‑phosphate aminotransferase [isomerizing] | |||||
* | ? | USA300TCH1516_ALE | 2306141 = | 172 (0.900) | 25 (0.170) | 15/126 | NT | 17.1% | intergenic (+7/+125) | USA300HOU_RS11765/USA300HOU_RS11770 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | 2306185 = | 107 (0.720) | intergenic (+51/+81) | USA300HOU_RS11765/USA300HOU_RS11770 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2326404 = | 168 (0.880) | 24 (0.140) | 17/146 | NT | 13.9% | intergenic (‑149/+117) | USA300HOU_RS11860/lacG | hypothetical protein/6‑phospho‑beta‑galactosidase |
? | USA300TCH1516_ALE | 2326426 = | 143 (0.820) | intergenic (‑171/+95) | USA300HOU_RS11860/lacG | hypothetical protein/6‑phospho‑beta‑galactosidase | |||||
* | ? | USA300TCH1516_ALE | = 2349040 | 176 (0.920) | 22 (0.130) | 15/146 | NT | 11.2% | coding (915/1137 nt) | clpB_3 | Chaperone protein ClpB |
? | USA300TCH1516_ALE | = 2349060 | 189 (1.090) | coding (895/1137 nt) | clpB_3 | Chaperone protein ClpB | |||||
* | ? | USA300TCH1516_ALE | 2357381 = | 144 (0.760) | 23 (0.140) | 11/140 | NT | 15.4% | intergenic (‑331/+207) | ecfA1/rplQ | Energy‑coupling factor transporter ATP‑binding protein EcfA1/50S ribosomal protein L17 |
? | USA300TCH1516_ALE | 2357417 = | 126 (0.760) | intergenic (‑367/+171) | ecfA1/rplQ | Energy‑coupling factor transporter ATP‑binding protein EcfA1/50S ribosomal protein L17 | |||||
* | ? | USA300TCH1516_ALE | = 2357390 | 140 (0.730) | 19 (0.110) | 10/140 | NT | 13.3% | intergenic (‑340/+198) | ecfA1/rplQ | Energy‑coupling factor transporter ATP‑binding protein EcfA1/50S ribosomal protein L17 |
? | USA300TCH1516_ALE | = 2357406 | 126 (0.760) | intergenic (‑356/+182) | ecfA1/rplQ | Energy‑coupling factor transporter ATP‑binding protein EcfA1/50S ribosomal protein L17 | |||||
* | ? | USA300TCH1516_ALE | 2368663 = | 153 (0.800) | 20 (0.110) | 12/148 | NT | 12.8% | intergenic (‑16/+51) | rpsS/rplB | 30S ribosomal protein S19/50S ribosomal protein L2 |
? | USA300TCH1516_ALE | 2368705 = | 131 (0.740) | intergenic (‑58/+9) | rpsS/rplB | 30S ribosomal protein S19/50S ribosomal protein L2 | |||||
* | ? | USA300TCH1516_ALE | 2377221 = | 166 (0.870) | 30 (0.180) | 14/142 | NT | 18.1% | intergenic (+124/‑57) | USA300HOU_RS12205/glcU_2 | hypothetical protein/putative glucose uptake protein GlcU |
? | USA300TCH1516_ALE | 2377253 = | 124 (0.730) | intergenic (+156/‑25) | USA300HOU_RS12205/glcU_2 | hypothetical protein/putative glucose uptake protein GlcU | |||||
* | ? | USA300TCH1516_ALE | 2380461 = | 161 (0.850) | 22 (0.140) | 17/132 | NT | 13.7% | intergenic (+134/+53) | USA300HOU_RS12230/swrC | hypothetical protein/Swarming motility protein SwrC |
? | USA300TCH1516_ALE | 2380507 = | 145 (0.920) | intergenic (+180/+7) | USA300HOU_RS12230/swrC | hypothetical protein/Swarming motility protein SwrC | |||||
* | ? | USA300TCH1516_ALE | = 2380474 | 170 (0.890) | 36 (0.230) | 13/132 | NT | 20.2% | intergenic (+147/+40) | USA300HOU_RS12230/swrC | hypothetical protein/Swarming motility protein SwrC |
? | USA300TCH1516_ALE | = 2380492 | 145 (0.920) | intergenic (+165/+22) | USA300HOU_RS12230/swrC | hypothetical protein/Swarming motility protein SwrC | |||||
* | ? | USA300TCH1516_ALE | 2383746 = | 125 (0.660) | 17 (0.110) | 9/136 | NT | 12.7% | intergenic (‑65/+52) | swrC/femX | Swarming motility protein SwrC/Lipid II:glycine glycyltransferase |
? | USA300TCH1516_ALE | 2383787 = | 128 (0.790) | intergenic (‑106/+11) | swrC/femX | Swarming motility protein SwrC/Lipid II:glycine glycyltransferase | |||||
* | ? | USA300TCH1516_ALE | = 2383757 | 136 (0.710) | 28 (0.170) | 15/136 | NT | 18.7% | intergenic (‑76/+41) | swrC/femX | Swarming motility protein SwrC/Lipid II:glycine glycyltransferase |
? | USA300TCH1516_ALE | = 2383774 | 128 (0.790) | intergenic (‑93/+24) | swrC/femX | Swarming motility protein SwrC/Lipid II:glycine glycyltransferase | |||||
* | ? | USA300TCH1516_ALE | = 2388299 | 158 (0.830) | 15 (0.100) | 8/126 | NT | 9.6% | intergenic (+34/+68) | ribZ_1/sarV | Riboflavin transporter RibZ/HTH‑type transcriptional regulator SarV |
? | USA300TCH1516_ALE | = 2388344 | 158 (1.060) | intergenic (+79/+23) | ribZ_1/sarV | Riboflavin transporter RibZ/HTH‑type transcriptional regulator SarV | |||||
* | ? | USA300TCH1516_ALE | 2421921 = | 155 (0.810) | 16 (0.090) | 9/146 | NT | 10.1% | intergenic (+37/+55) | USA300HOU_RS12475/hpxO | Putative 2‑hydroxyacid dehydrogenase/FAD‑dependent urate hydroxylase |
? | USA300TCH1516_ALE | 2421962 = | 145 (0.840) | intergenic (+78/+14) | USA300HOU_RS12475/hpxO | Putative 2‑hydroxyacid dehydrogenase/FAD‑dependent urate hydroxylase | |||||
* | ? | USA300TCH1516_ALE | = 2421927 | 149 (0.780) | 35 (0.200) | 18/146 | NT | 20.0% | intergenic (+43/+49) | USA300HOU_RS12475/hpxO | Putative 2‑hydroxyacid dehydrogenase/FAD‑dependent urate hydroxylase |
? | USA300TCH1516_ALE | = 2421954 | 145 (0.840) | intergenic (+70/+22) | USA300HOU_RS12475/hpxO | Putative 2‑hydroxyacid dehydrogenase/FAD‑dependent urate hydroxylase | |||||
* | ? | USA300TCH1516_ALE | = 2434877 | 165 (0.870) | 11 (0.070) | 8/140 | NT | 6.3% | intergenic (+145/+242) | ybbH_3/yifK | putative HTH‑type transcriptional regulator YbbH/putative transport protein YifK |
? | USA300TCH1516_ALE | = 2434908 | 183 (1.100) | intergenic (+176/+211) | ybbH_3/yifK | putative HTH‑type transcriptional regulator YbbH/putative transport protein YifK | |||||
* | ? | USA300TCH1516_ALE | = 2440052 | 166 (0.870) | 16 (0.100) | 10/136 | NT | 9.2% | intergenic (+13/+53) | USA300HOU_RS12570/malP | hypothetical protein/PTS system maltose‑specific EIICB component |
? | USA300TCH1516_ALE | = 2440086 | 176 (1.090) | intergenic (+47/+19) | USA300HOU_RS12570/malP | hypothetical protein/PTS system maltose‑specific EIICB component | |||||
* | ? | USA300TCH1516_ALE | 2442806 = | 127 (0.670) | 19 (0.130) | 14/128 | NT | 16.9% | intergenic (+3/+55) | glvR/USA300HOU_RS12585 | HTH‑type transcriptional regulator GlvR/hypothetical protein |
? | USA300TCH1516_ALE | 2442855 = | 86 (0.570) | intergenic (+52/+6) | glvR/USA300HOU_RS12585 | HTH‑type transcriptional regulator GlvR/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2442821 | 131 (0.690) | 10 (0.070) | 8/128 | NT | 9.5% | intergenic (+18/+40) | glvR/USA300HOU_RS12585 | HTH‑type transcriptional regulator GlvR/hypothetical protein |
? | USA300TCH1516_ALE | = 2442838 | 86 (0.570) | intergenic (+35/+23) | glvR/USA300HOU_RS12585 | HTH‑type transcriptional regulator GlvR/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2442880 | 94 (0.490) | 12 (0.070) | 9/142 | NT | 10.4% | coding (488/507 nt) | USA300HOU_RS12585 | hypothetical protein |
? | USA300TCH1516_ALE | = 2442902 | 123 (0.730) | coding (466/507 nt) | USA300HOU_RS12585 | hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2444885 | 173 (0.910) | 23 (0.140) | 14/140 | NT | 12.4% | intergenic (‑38/+187) | mleN_2/USA300HOU_RS12595 | Malate‑2H(+)/Na(+)‑lactate antiporter/hypothetical protein |
? | USA300TCH1516_ALE | = 2444897 | 174 (1.050) | intergenic (‑50/+175) | mleN_2/USA300HOU_RS12595 | Malate‑2H(+)/Na(+)‑lactate antiporter/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2455747 = | 166 (0.870) | 10 (0.060) | 5/132 | NT | 7.2% | intergenic (+5/+61) | lyrA/rpiA | Lysostaphin resistance protein A/Ribose‑5‑phosphate isomerase A |
? | USA300TCH1516_ALE | 2455795 = | 121 (0.770) | intergenic (+53/+13) | lyrA/rpiA | Lysostaphin resistance protein A/Ribose‑5‑phosphate isomerase A | |||||
* | ? | USA300TCH1516_ALE | 2467825 = | 221 (1.160) | 20 (0.110) | 14/150 | NT | 9.3% | intergenic (+42/+66) | USA300HOU_RS12705/lipY | hypothetical protein/Triacylglycerol lipase |
? | USA300TCH1516_ALE | 2467878 = | 185 (1.040) | intergenic (+95/+13) | USA300HOU_RS12705/lipY | hypothetical protein/Triacylglycerol lipase | |||||
* | ? | USA300TCH1516_ALE | 2469808 = | 176 (0.920) | 13 (0.080) | 9/142 | NT | 8.2% | intergenic (+151/+95) | USA300HOU_RS12715/emrB | hypothetical protein/Multidrug export protein EmrB |
? | USA300TCH1516_ALE | 2469843 = | 134 (0.790) | intergenic (+186/+60) | USA300HOU_RS12715/emrB | hypothetical protein/Multidrug export protein EmrB | |||||
* | ? | USA300TCH1516_ALE | 2483085 = | 181 (0.950) | 23 (0.140) | 12/136 | NT | 13.3% | intergenic (+5/‑158) | hssS/USA300HOU_RS12790 | Heme sensor protein HssS/putative HTH‑type transcriptional regulator |
? | USA300TCH1516_ALE | 2483126 = | 146 (0.900) | intergenic (+46/‑117) | hssS/USA300HOU_RS12790 | Heme sensor protein HssS/putative HTH‑type transcriptional regulator | |||||
* | ? | USA300TCH1516_ALE | = 2483096 | 184 (0.970) | 24 (0.150) | 12/136 | NT | 13.7% | intergenic (+16/‑147) | hssS/USA300HOU_RS12790 | Heme sensor protein HssS/putative HTH‑type transcriptional regulator |
? | USA300TCH1516_ALE | = 2483113 | 146 (0.900) | intergenic (+33/‑130) | hssS/USA300HOU_RS12790 | Heme sensor protein HssS/putative HTH‑type transcriptional regulator | |||||
* | ? | USA300TCH1516_ALE | = 2484170 | 151 (0.790) | 20 (0.130) | 11/132 | NT | 12.2% | intergenic (+32/+34) | USA300HOU_RS12795/mqo1 | hypothetical protein/putative malate:quinone oxidoreductase 1 |
? | USA300TCH1516_ALE | = 2484183 | 163 (1.040) | intergenic (+45/+21) | USA300HOU_RS12795/mqo1 | hypothetical protein/putative malate:quinone oxidoreductase 1 | |||||
* | ? | USA300TCH1516_ALE | 2493152 = | 220 (1.150) | 11 (0.060) | 6/146 | NT | 5.5% | coding (823/1035 nt) | USA300HOU_RS12835 | Ferredoxin‑‑NADP reductase |
? | USA300TCH1516_ALE | 2493184 = | 176 (1.010) | coding (791/1035 nt) | USA300HOU_RS12835 | Ferredoxin‑‑NADP reductase | |||||
* | ? | USA300TCH1516_ALE | 2494782 = | 188 (0.990) | 20 (0.120) | 13/138 | NT | 12.0% | intergenic (‑145/+62) | USA300HOU_RS12845/mnmC_2 | hypothetical protein/tRNA 5‑methylaminomethyl‑2‑thiouridine biosynthesis bifunctional protein MnmC |
? | USA300TCH1516_ALE | 2494828 = | 131 (0.800) | intergenic (‑191/+16) | USA300HOU_RS12845/mnmC_2 | hypothetical protein/tRNA 5‑methylaminomethyl‑2‑thiouridine biosynthesis bifunctional protein MnmC | |||||
* | ? | USA300TCH1516_ALE | 2499443 = | 176 (0.920) | 16 (0.090) | 6/142 | NT | 10.1% | intergenic (‑20/‑163) | treP_2/USA300HOU_RS12875 | PTS system trehalose‑specific EIIBC component/hypothetical protein |
? | USA300TCH1516_ALE | 2499482 = | 129 (0.760) | intergenic (‑59/‑124) | treP_2/USA300HOU_RS12875 | PTS system trehalose‑specific EIIBC component/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2508438 = | 213 (1.120) | 30 (0.180) | 14/138 | NT | 16.0% | intergenic (+26/+81) | USA300TCH1516_02393/narT | Acid shock protein/putative nitrate transporter NarT |
? | USA300TCH1516_ALE | 2508486 = | 132 (0.800) | intergenic (+74/+33) | USA300TCH1516_02393/narT | Acid shock protein/putative nitrate transporter NarT | |||||
* | ? | USA300TCH1516_ALE | 2511885 = | 194 (1.020) | 17 (0.100) | 6/144 | NT | 9.4% | intergenic (+194/+64) | mta/nreC | HTH‑type transcriptional activator mta/Oxygen regulatory protein NreC |
? | USA300TCH1516_ALE | 2511923 = | 152 (0.890) | intergenic (+232/+26) | mta/nreC | HTH‑type transcriptional activator mta/Oxygen regulatory protein NreC | |||||
* | ? | USA300TCH1516_ALE | 2520876 = | 151 (0.790) | 15 (0.080) | 10/150 | NT | 9.5% | intergenic (‑245/+64) | narG/nasF | Respiratory nitrate reductase 1 alpha chain/Uroporphyrinogen‑III C‑methyltransferase |
? | USA300TCH1516_ALE | 2520917 = | 144 (0.810) | intergenic (‑286/+23) | narG/nasF | Respiratory nitrate reductase 1 alpha chain/Uroporphyrinogen‑III C‑methyltransferase | |||||
* | ? | USA300TCH1516_ALE | 2525159 = | 214 (1.120) | 11 (0.060) | 7/148 | NT | 5.5% | coding (270/732 nt) | sirB | Sirohydrochlorin ferrochelatase |
? | USA300TCH1516_ALE | 2525195 = | 181 (1.030) | coding (234/732 nt) | sirB | Sirohydrochlorin ferrochelatase | |||||
* | ? | USA300TCH1516_ALE | = 2525589 | 160 (0.840) | 12 (0.080) | 7/130 | NT | 7.7% | intergenic (‑161/+69) | sirB/ytmI | Sirohydrochlorin ferrochelatase/putative N‑acetyltransferase YtmI |
? | USA300TCH1516_ALE | = 2525624 | 157 (1.020) | intergenic (‑196/+34) | sirB/ytmI | Sirohydrochlorin ferrochelatase/putative N‑acetyltransferase YtmI | |||||
* | ? | USA300TCH1516_ALE | 2533537 = | 156 (0.820) | 25 (0.150) | 17/142 | NT | 14.7% | intergenic (+33/+64) | femA_3/tcyC_2 | Aminoacyltransferase FemA/L‑cystine import ATP‑binding protein TcyC |
? | USA300TCH1516_ALE | 2533595 = | 153 (0.910) | intergenic (+91/+6) | femA_3/tcyC_2 | Aminoacyltransferase FemA/L‑cystine import ATP‑binding protein TcyC | |||||
* | ? | USA300TCH1516_ALE | = 2533545 | 159 (0.830) | 16 (0.090) | 11/142 | NT | 9.8% | intergenic (+41/+56) | femA_3/tcyC_2 | Aminoacyltransferase FemA/L‑cystine import ATP‑binding protein TcyC |
? | USA300TCH1516_ALE | = 2533585 | 153 (0.910) | intergenic (+81/+16) | femA_3/tcyC_2 | Aminoacyltransferase FemA/L‑cystine import ATP‑binding protein TcyC | |||||
* | ? | USA300TCH1516_ALE | = 2537764 | 149 (0.780) | 22 (0.130) | 14/138 | NT | 13.0% | intergenic (+118/+36) | USA300TCH1516_02423/gpmA_2 | hypothetical protein/2,3‑bisphosphoglycerate‑dependent phosphoglycerate mutase |
? | USA300TCH1516_ALE | = 2537785 | 166 (1.010) | intergenic (+139/+15) | USA300TCH1516_02423/gpmA_2 | hypothetical protein/2,3‑bisphosphoglycerate‑dependent phosphoglycerate mutase | |||||
* | ? | USA300TCH1516_ALE | 2541808 = | 202 (1.060) | 27 (0.170) | 18/136 | NT | 15.4% | intergenic (+67/‑433) | sbi/hlgA | Immunoglobulin‑binding protein sbi/Gamma‑hemolysin component A |
? | USA300TCH1516_ALE | 2541850 = | 126 (0.780) | intergenic (+109/‑391) | sbi/hlgA | Immunoglobulin‑binding protein sbi/Gamma‑hemolysin component A | |||||
* | ? | USA300TCH1516_ALE | 2561162 = | 172 (0.900) | 18 (0.100) | 9/146 | NT | 10.6% | coding (648/657 nt) | USA300HOU_RS13195 | hypothetical protein |
? | USA300TCH1516_ALE | 2561195 = | 147 (0.850) | intergenic (+24/+39) | USA300HOU_RS13195/cpdA | hypothetical protein/3',5'‑cyclic adenosine monophosphate phosphodiesterase CpdA | |||||
* | ? | USA300TCH1516_ALE | 2573677 = | 160 (0.840) | 19 (0.120) | 11/138 | NT | 13.1% | intergenic (‑203/+91) | norB_5/opuCD | Quinolone resistance protein NorB/Carnitine transport permease protein OpuCD |
? | USA300TCH1516_ALE | 2573715 = | 115 (0.700) | intergenic (‑241/+53) | norB_5/opuCD | Quinolone resistance protein NorB/Carnitine transport permease protein OpuCD | |||||
* | ? | USA300TCH1516_ALE | = 2577878 | 151 (0.790) | 24 (0.140) | 11/140 | NT | 14.5% | intergenic (‑599/+71) | opuCA/USA300HOU_RS13285 | Carnitine transport ATP‑binding protein OpuCA/hypothetical protein |
? | USA300TCH1516_ALE | = 2577890 | 152 (0.910) | intergenic (‑611/+59) | opuCA/USA300HOU_RS13285 | Carnitine transport ATP‑binding protein OpuCA/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2580412 = | 187 (0.980) | 30 (0.180) | 16/142 | NT | 17.3% | intergenic (+47/‑561) | yveA/pnbA | Aspartate‑proton symporter/Para‑nitrobenzyl esterase |
? | USA300TCH1516_ALE | 2580445 = | 122 (0.720) | intergenic (+80/‑528) | yveA/pnbA | Aspartate‑proton symporter/Para‑nitrobenzyl esterase | |||||
* | ? | USA300TCH1516_ALE | = 2582348 | 153 (0.800) | 23 (0.130) | 10/144 | NT | 13.3% | intergenic (+23/+39) | pnbA/pbuE | Para‑nitrobenzyl esterase/Purine efflux pump PbuE |
? | USA300TCH1516_ALE | = 2582368 | 163 (0.950) | intergenic (+43/+19) | pnbA/pbuE | Para‑nitrobenzyl esterase/Purine efflux pump PbuE | |||||
* | ? | USA300TCH1516_ALE | 2588434 = | 219 (1.150) | 17 (0.100) | 8/142 | NT | 8.3% | intergenic (+17/+151) | yehR/gltB_2 | putative lipoprotein YehR/Glutamate synthase [NADPH] large chain |
? | USA300TCH1516_ALE | 2588483 = | 184 (1.090) | intergenic (+66/+102) | yehR/gltB_2 | putative lipoprotein YehR/Glutamate synthase [NADPH] large chain | |||||
* | ? | USA300TCH1516_ALE | 2600614 = | 171 (0.900) | 14 (0.080) | 10/148 | NT | 7.7% | intergenic (‑26/+841) | dapF/USA300HOU_RS13395 | Diaminopimelate epimerase/hypothetical protein |
? | USA300TCH1516_ALE | 2600771 = | 178 (1.010) | intergenic (‑183/+684) | dapF/USA300HOU_RS13395 | Diaminopimelate epimerase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2622931 | 177 (0.930) | 14 (0.080) | 10/142 | NT | 8.1% | intergenic (‑261/+123) | USA300HOU_RS13520/USA300TCH1516_02501 | hypothetical protein/Putative surface protein |
? | USA300TCH1516_ALE | = 2622960 | 162 (0.960) | intergenic (‑290/+94) | USA300HOU_RS13520/USA300TCH1516_02501 | hypothetical protein/Putative surface protein | |||||
* | ? | USA300TCH1516_ALE | 2626696 = | 206 (1.080) | 15 (0.090) | 14/144 | NT | 7.7% | intergenic (‑296/+10) | sasG/sarT | Surface protein G/HTH‑type transcriptional regulator SarT |
? | USA300TCH1516_ALE | 2626715 = | 172 (1.000) | coding (348/357 nt) | sarT | HTH‑type transcriptional regulator SarT | |||||
* | ? | USA300TCH1516_ALE | 2632646 = | 169 (0.890) | 9 (0.050) | 8/146 | NT | 5.7% | intergenic (‑437/+245) | fnbA_1/fnbA_2 | Fibronectin‑binding protein A/Fibronectin‑binding protein A |
? | USA300TCH1516_ALE | 2632670 = | 144 (0.830) | intergenic (‑461/+221) | fnbA_1/fnbA_2 | Fibronectin‑binding protein A/Fibronectin‑binding protein A | |||||
* | ? | USA300TCH1516_ALE | 2636356 = | 194 (1.020) | 9 (0.050) | 7/138 | NT | 6.1% | intergenic (‑409/+60) | fnbA_2/gntT | Fibronectin‑binding protein A/High‑affinity gluconate transporter |
? | USA300TCH1516_ALE | 2636404 = | 112 (0.680) | intergenic (‑457/+12) | fnbA_2/gntT | Fibronectin‑binding protein A/High‑affinity gluconate transporter | |||||
* | ? | USA300TCH1516_ALE | 2646130 = | 219 (1.150) | 12 (0.070) | 8/152 | NT | 5.4% | coding (158/1278 nt) | sauU | putative sulfoacetate transporter SauU |
? | USA300TCH1516_ALE | 2646163 = | 209 (1.160) | coding (125/1278 nt) | sauU | putative sulfoacetate transporter SauU | |||||
* | ? | USA300TCH1516_ALE | 2651119 = | 166 (0.870) | 9 (0.050) | 6/146 | NT | 5.3% | intergenic (+62/‑311) | USA300HOU_RS13635/fbp | hypothetical protein/Fructose‑1,6‑bisphosphatase class 3 |
? | USA300TCH1516_ALE | 2651153 = | 170 (0.980) | intergenic (+96/‑277) | USA300HOU_RS13635/fbp | hypothetical protein/Fructose‑1,6‑bisphosphatase class 3 | |||||
* | ? | USA300TCH1516_ALE | = 2651125 | 169 (0.890) | 16 (0.090) | 10/146 | NT | 9.0% | intergenic (+68/‑305) | USA300HOU_RS13635/fbp | hypothetical protein/Fructose‑1,6‑bisphosphatase class 3 |
? | USA300TCH1516_ALE | = 2651145 | 170 (0.980) | intergenic (+88/‑285) | USA300HOU_RS13635/fbp | hypothetical protein/Fructose‑1,6‑bisphosphatase class 3 | |||||
* | ? | USA300TCH1516_ALE | 2654865 = | 197 (1.030) | 25 (0.140) | 10/148 | NT | 12.3% | intergenic (+48/+57) | USA300HOU_RS13650/mhqD | hypothetical protein/Putative hydrolase MhqD |
? | USA300TCH1516_ALE | 2654909 = | 174 (0.990) | intergenic (+92/+13) | USA300HOU_RS13650/mhqD | hypothetical protein/Putative hydrolase MhqD | |||||
* | ? | USA300TCH1516_ALE | = 2661803 | 153 (0.800) | 13 (0.090) | 10/128 | NT | 8.5% | intergenic (‑196/‑125) | ybiV/yydI | Sugar phosphatase YbiV/putative peptide export ATP‑binding protein YydI |
? | USA300TCH1516_ALE | = 2661815 | 157 (1.030) | intergenic (‑208/‑113) | ybiV/yydI | Sugar phosphatase YbiV/putative peptide export ATP‑binding protein YydI | |||||
* | ? | USA300TCH1516_ALE | 2665481 = | 153 (0.800) | 21 (0.130) | 15/138 | NT | 14.2% | intergenic (‑108/+71) | USA300TCH1516_02535/sdhA | hypothetical protein/L‑serine dehydratase, alpha chain |
? | USA300TCH1516_ALE | 2665525 = | 122 (0.740) | intergenic (‑152/+27) | USA300TCH1516_02535/sdhA | hypothetical protein/L‑serine dehydratase, alpha chain | |||||
* | ? | USA300TCH1516_ALE | 2674533 = | 202 (1.060) | 17 (0.100) | 8/140 | NT | 10.0% | intergenic (‑45/+256) | glcB/ydaP | PTS system glucoside‑specific EIICBA component/Putative thiamine pyrophosphate‑containing protein YdaP |
? | USA300TCH1516_ALE | 2674588 = | 131 (0.790) | intergenic (‑100/+201) | glcB/ydaP | PTS system glucoside‑specific EIICBA component/Putative thiamine pyrophosphate‑containing protein YdaP | |||||
* | ? | USA300TCH1516_ALE | = 2679966 | 214 (1.120) | 16 (0.100) | 8/130 | NT | 10.1% | intergenic (+18/+742) | ssaA2_4/USA300HOU_RS13810 | Staphylococcal secretory antigen ssaA2/hypothetical protein |
? | USA300TCH1516_ALE | = 2681449 | 113 (0.730) | intergenic (‑484/+95) | USA300HOU_RS13810/mvaA | hypothetical protein/3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase | |||||
* | ? | USA300TCH1516_ALE | 2681410 = | 133 (0.700) | 12 (0.080) | 8/130 | NT | 9.8% | intergenic (‑445/+134) | USA300HOU_RS13810/mvaA | hypothetical protein/3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase |
? | USA300TCH1516_ALE | 2681465 = | 113 (0.730) | intergenic (‑500/+79) | USA300HOU_RS13810/mvaA | hypothetical protein/3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase | |||||
* | ? | USA300TCH1516_ALE | = 2681424 | 138 (0.720) | 16 (0.100) | 7/130 | NT | 12.5% | intergenic (‑459/+120) | USA300HOU_RS13810/mvaA | hypothetical protein/3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase |
? | USA300TCH1516_ALE | = 2681449 | 113 (0.730) | intergenic (‑484/+95) | USA300HOU_RS13810/mvaA | hypothetical protein/3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase | |||||
* | ? | USA300TCH1516_ALE | 2681949 = | 177 (0.930) | 9 (0.050) | 7/150 | NT | 5.9% | coding (873/1278 nt) | mvaA | 3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase |
? | USA300TCH1516_ALE | 2681984 = | 121 (0.680) | coding (838/1278 nt) | mvaA | 3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase | |||||
* | ? | USA300TCH1516_ALE | 2687471 = | 169 (0.890) | 17 (0.100) | 12/138 | NT | 11.5% | intergenic (+25/+44) | clpL/USA300HOU_RS13835 | ATP‑dependent Clp protease ATP‑binding subunit ClpL/hypothetical protein |
? | USA300TCH1516_ALE | 2687511 = | 116 (0.710) | intergenic (+65/+4) | clpL/USA300HOU_RS13835 | ATP‑dependent Clp protease ATP‑binding subunit ClpL/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | 2693368 = | 153 (0.800) | 20 (0.120) | 11/136 | NT | 14.2% | intergenic (+39/+317) | mtrR/rocA | HTH‑type transcriptional regulator MtrR/1‑pyrroline‑5‑carboxylate dehydrogenase |
? | USA300TCH1516_ALE | 2693417 = | 112 (0.690) | intergenic (+88/+268) | mtrR/rocA | HTH‑type transcriptional regulator MtrR/1‑pyrroline‑5‑carboxylate dehydrogenase | |||||
* | ? | USA300TCH1516_ALE | = 2693372 | 153 (0.800) | 22 (0.130) | 13/144 | NT | 15.1% | intergenic (+43/+313) | mtrR/rocA | HTH‑type transcriptional regulator MtrR/1‑pyrroline‑5‑carboxylate dehydrogenase |
? | USA300TCH1516_ALE | = 2693412 | 110 (0.640) | intergenic (+83/+273) | mtrR/rocA | HTH‑type transcriptional regulator MtrR/1‑pyrroline‑5‑carboxylate dehydrogenase | |||||
* | ? | USA300TCH1516_ALE | 2696548 = | 172 (0.900) | 20 (0.120) | 10/140 | NT | 12.6% | intergenic (+100/‑140) | USA300HOU_RS13875/copA | hypothetical protein/Copper‑exporting P‑type ATPase A |
? | USA300TCH1516_ALE | 2696587 = | 128 (0.770) | intergenic (+139/‑101) | USA300HOU_RS13875/copA | hypothetical protein/Copper‑exporting P‑type ATPase A | |||||
* | ? | USA300TCH1516_ALE | = 2716752 | 146 (0.770) | 9 (0.050) | 8/138 | NT | 5.6% | intergenic (+60/+90) | USA300HOU_RS13965/USA300HOU_RS13970 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 2716804 | 177 (1.080) | intergenic (+112/+38) | USA300HOU_RS13965/USA300HOU_RS13970 | hypothetical protein/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2721747 | 162 (0.850) | 16 (0.090) | 12/146 | NT | 9.4% | intergenic (+28/+119) | USA300HOU_RS14000/yciC_3 | putative hydrolase/Putative metal chaperone YciC |
? | USA300TCH1516_ALE | = 2721776 | 159 (0.920) | intergenic (+57/+90) | USA300HOU_RS14000/yciC_3 | putative hydrolase/Putative metal chaperone YciC | |||||
* | ? | USA300TCH1516_ALE | = 2740979 | 148 (0.780) | 18 (0.110) | 13/132 | NT | 12.6% | intergenic (+21/+60) | yhdG_2/USA300HOU_RS14115 | putative amino acid permease YhdG/Isoleucine 2‑epimerase |
? | USA300TCH1516_ALE | = 2741001 | 127 (0.810) | intergenic (+43/+38) | yhdG_2/USA300HOU_RS14115 | putative amino acid permease YhdG/Isoleucine 2‑epimerase | |||||
* | ? | USA300TCH1516_ALE | = 2751374 | 159 (0.830) | 24 (0.140) | 12/146 | NT | 13.9% | intergenic (‑222/+39) | betA/gbsA | Oxygen‑dependent choline dehydrogenase/Betaine aldehyde dehydrogenase |
? | USA300TCH1516_ALE | = 2751393 | 153 (0.880) | intergenic (‑241/+20) | betA/gbsA | Oxygen‑dependent choline dehydrogenase/Betaine aldehyde dehydrogenase | |||||
* | ? | USA300TCH1516_ALE | 2756955 = | 176 (0.920) | 20 (0.110) | 10/150 | NT | 10.8% | intergenic (‑476/+43) | opuD_3/nrdG | Glycine betaine transporter OpuD/Anaerobic ribonucleoside‑triphosphate reductase‑activating protein |
? | USA300TCH1516_ALE | 2756989 = | 167 (0.940) | intergenic (‑510/+9) | opuD_3/nrdG | Glycine betaine transporter OpuD/Anaerobic ribonucleoside‑triphosphate reductase‑activating protein | |||||
* | ? | USA300TCH1516_ALE | 2787502 = | 220 (1.150) | 20 (0.120) | 14/142 | NT | 10.0% | intergenic (+48/‑192) | zipA_3/manR_2 | Cell division protein ZipA/Transcriptional regulator ManR |
? | USA300TCH1516_ALE | 2787547 = | 165 (0.980) | intergenic (+93/‑147) | zipA_3/manR_2 | Cell division protein ZipA/Transcriptional regulator ManR | |||||
* | ? | USA300TCH1516_ALE | = 2792627 | 131 (0.690) | 23 (0.150) | 13/132 | NT | 16.1% | intergenic (+78/+34) | yvyI/yueB | Putative mannose‑6‑phosphate isomerase YvyI/ESX secretion system protein YueB |
? | USA300TCH1516_ALE | = 2792641 | 132 (0.840) | intergenic (+92/+20) | yvyI/yueB | Putative mannose‑6‑phosphate isomerase YvyI/ESX secretion system protein YueB | |||||
* | ? | USA300TCH1516_ALE | 2829245 = | 179 (0.940) | 19 (0.110) | 11/150 | NT | 10.7% | coding (126/1053 nt) | icaC | putative poly‑beta‑1,6‑N‑acetyl‑D‑glucosamine export protein |
? | USA300TCH1516_ALE | 2829269 = | 151 (0.850) | coding (150/1053 nt) | icaC | putative poly‑beta‑1,6‑N‑acetyl‑D‑glucosamine export protein | |||||
* | ? | USA300TCH1516_ALE | 2830190 = | 151 (0.790) | 15 (0.090) | 10/138 | NT | 11.0% | intergenic (+18/+429) | icaC/lipA_2 | putative poly‑beta‑1,6‑N‑acetyl‑D‑glucosamine export protein/Lipase 1 |
? | USA300TCH1516_ALE | 2830247 = | 112 (0.680) | intergenic (+75/+372) | icaC/lipA_2 | putative poly‑beta‑1,6‑N‑acetyl‑D‑glucosamine export protein/Lipase 1 | |||||
* | ? | USA300TCH1516_ALE | = 2830200 | 148 (0.780) | 12 (0.070) | 8/138 | NT | 9.1% | intergenic (+28/+419) | icaC/lipA_2 | putative poly‑beta‑1,6‑N‑acetyl‑D‑glucosamine export protein/Lipase 1 |
? | USA300TCH1516_ALE | = 2830235 | 112 (0.680) | intergenic (+63/+384) | icaC/lipA_2 | putative poly‑beta‑1,6‑N‑acetyl‑D‑glucosamine export protein/Lipase 1 | |||||
* | ? | USA300TCH1516_ALE | 2850817 = | 116 (0.610) | 25 (0.160) | 9/132 | NT | 19.0% | intergenic (+16/+103) | pcp/USA300HOU_RS14605 | Pyrrolidone‑carboxylate peptidase/hypothetical protein |
? | USA300TCH1516_ALE | 2850866 = | 118 (0.750) | intergenic (+65/+54) | pcp/USA300HOU_RS14605 | Pyrrolidone‑carboxylate peptidase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2850830 | 117 (0.610) | 16 (0.100) | 10/132 | NT | 13.0% | intergenic (+29/+90) | pcp/USA300HOU_RS14605 | Pyrrolidone‑carboxylate peptidase/hypothetical protein |
? | USA300TCH1516_ALE | = 2850851 | 118 (0.750) | intergenic (+50/+69) | pcp/USA300HOU_RS14605 | Pyrrolidone‑carboxylate peptidase/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2854319 | 190 (1.000) | 25 (0.140) | 14/150 | NT | 11.5% | intergenic (+17/+396) | yflS/USA300HOU_RS14625 | Putative malate transporter YflS/hypothetical protein |
? | USA300TCH1516_ALE | = 2854338 | 208 (1.170) | intergenic (+36/+377) | yflS/USA300HOU_RS14625 | Putative malate transporter YflS/hypothetical protein | |||||
* | ? | USA300TCH1516_ALE | = 2863074 | 179 (0.940) | 17 (0.100) | 10/150 | NT | 9.2% | intergenic (+44/+16) | USA300TCH1516_02707/USA300HOU_RS14670 | hypothetical protein/hypothetical protein |
? | USA300TCH1516_ALE | = 2864026 | NA (NA) | intergenic (‑439/‑19) | USA300HOU_RS14670/USA300HOU_RS14675 | hypothetical protein/hypothetical protein |